Studies on sialidases by Augustus, Brian W. J.
 warwick.ac.uk/lib-publications  
 
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/101939  
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
STUDIES ON SIALIDASKS
by
Brian H. J. Augustas B.Sc., M.Sc. (Warwick)
A Thesis submitted In fulfilment of the 
requirements for the degree of Ph.D. of the 
University of Warwick
August. 1980
TABLE OF CONTENTS
Table of Contents Page
Preface i
Declaration ii
Acknowledgements iii
Synopsis iv
CHAPTER 1
GENERAL BACKGROUND
1.0 Introduction 1
1.1 Occurrence Of Sialidases 7
1.1.1 Viral Sialidases 8
1.1.2 Bacterial Sialidases 10
1.1.3 Manmalian Sialidases 12
1.2 Biological Function Of Sialidases 13
1.2.1 Viral Sialidases 13
1.2.2 Bacterial Sialidases 16
1.2.3 Manmalian Sialidases 18
1.3 Sialidase:- Disease and Application 22
1.4 Properties Of Sialidases 28
1.4.1 Size And Shape 28
1.4.1.1 Viral sialidases 28
1.4.1.2 Bacterial sialidases 30
1.4.2 pH Optimum And Km 31
1.4.3 Substrate Specificity 33
1.4.4 Activators And Inhibitors 38
CHAPTER 2
ASSAY OF SIALIDASES
2.0 Introduction 43
2.1 Experimental Procedure 50
2.1.0 Warren Assay 50
2.1.1 Radioactive Assay 50
2.1.1.0 Preparation of the radioactive
substrate 51
2.1.1.1 Determination of the specific 
activity of the tritiated sialic
acid analogue by acid hydrolysis 51
2.1.1.2 Determination of the specific 
activity of the tritiated sialic
acid analogue by enzymic hydrolysis 52
2.1.1.3 Trial application of the radioactive 
assay
2.1.2 Radioimnunoassay (RIA) 52
2.1.2.0 Purification of colominic acid 52
2.1.2.1 Sizing of colominic acid (generation
of the hapten) 53
2.1.2.2 Conjugation of the hapten to BSA
(formation of the BSA-NANA conjugate) 54
2.1.2.3 Immunization 56
2.1.2.4 Imnunodif fusion 56
2.1.2.5 Equilibrivsa dialysis 56
2.1.2.5.0 Determination of the
binding capacity of the 
antibody 58
2.1.2.5.1 The competition assay for 
sialic acid (development 
of the diagnostic plot for
the sialidase assay) 58
2.1.2.5.2 The radioimunoassay 58
2.1.3 Determination Of Bound Sialic Acid (with the
aid of equilibrium dialysis and sialidase) 59
2.1.4 Results And Discussion 59
CHAPTER 3
PURIFICATION OF SIALIDASES
3.0 Introduction 67
3.1 Experimental Procedure 74
3.1.0 Isolation Of Sialidase From The Cell Culture
(S. griseus) 75
3.1.1 Ultrafiltration 75
3.1.2 Calcium Phosphate Treatment 77
3.1.3 Affinity Chromatography 1 77
3.1.4 Affinity Chromatography II 78
3.1.5 Hydroxylapatite Column Chromatography 78
3.1.6 Molecular Height Determination 79
3.1.6.0 By polyacrylamide gel electrophoresis
(PAGE) 79
3.1.6.1 By gel permeation chromatography 80
3.1.7 Determination Of Enzyme Purity 80
3.1.8 Assay Of Protease Activity 81
3.1.9 Assay Of Other Enzyme Activities 81
3.1.10 Protein Determination 81
3.1.11 Glycoprotein Detection 82
3.2 Results And Discussion 83
CHAPTER 4
ACTIVE SITE STUDIES ON SIALIDASES 
(CHEMICAL MODIFICATION - ENZYME MECHANISM) '
Introduction 95
4.0.1 Chemical Modification 102
4.0.1.0 Modification of sulphydryl groupa 103
4.0.1.1 Modification of amino groups 103
4.0.1.2 Modification of guanidinium groups 104
4.0.1.3 Modification of carboxyl groups 105
4.0.1.4 Modification of tryptophanyl groups 107
4.0.1.5 Modification of carbohydrate groups 108
Experimental Procedure 111
4.1.0 Synthesis Of [2-3H] acetophenone 111
4.1.1 Synthesis Of Phenyl[2-3H] glyoxal ill
4.1.2 Trial experiments with Phenyl [2-3H] glyoxal 112
4.1.3 Modification Of Amino Acid Residues In
Sialidases 113
4. 1.3.0 Active site protection and
experimental conditions 113
4. 1.3.1 Modification of arginine residues 113
4.1.3.1.0 By phenylglyoxal 113
4.1.3.1.1 By 2,3 butanedione 114
4. 1.3.2 Modification of carboxyl residues 114
4. 1.3.3 Modification of tryptophanyl
residues 114
4.1.3.3.0 By N-bromosuccinimide 114
4.1.3.3.1 By 7-hydroxy-5-
nitrobenzylbromide 115
4. 1.3.4 Modification of sulphydryl groups 115
4. 1.3.5 Modification of lysine groups 116
4.1.3.5.0 By 2,4,6-trinitro-
benzenesulphonic acid 1 1 6
4.1.3.5.1 By O-methylisourea 116
4.1.3.6 Isolation of the active site
peptide 116
4.1.3.7 Modification of carbohydrate
residues 119
4.1.3.7.0 By periodate oxidation 119
4.1.3.7.1 By f) -elimination 120
4.2 Results And Discussion 121
5 Appendix 147
6 References 151
7 Publications 174
iPREFACE
The work described in this thesis was carried out in the Department of 
Chemistry and Molecular Sciences, University of Warwick, Coventry, 
England, during the period between October 1977 and August 1980. It is 
the original work of the author, except where specific acknowledgement 
is made or implied. This thesis has been submitted at the University of 
Warwick alone, in fulfilment of the requirements for the degree of
Ph.D
il
DECLARATION
The work described In this thesis Is the original work of the author» 
except where acknowledgement is made to work and Ideas previously 
published» It was carried out in the Department of Chemistry and 
Molecular Sciences, University of Warwick, between October, 1977 and 
August, 1980, and has not been submitted previously for a degree at any
institution
iii
acknowledgements
I would like to thank the Chairman of the Department of Chemistry and 
Molecular Sciences, Prof, K.R. Jennings, for the use of departmental 
facilities.
I am also Indebted to Dr. J.E. Fox of the Macromolecular Analysis 
Service, Dr. A.R. Bradwell and Mr. R. Drew of the Immuno Diagnostic 
Research laboratory, at the University of Birmingham, for their 
constructive criticism, useful Ideas and practical assistance.
s
My appreciation Is also meted out to my research colleagues, students 
and staff who have generated an atmosphere conducive to research, even 
during the most strenuous periods.
A special vote of thanks goes to a friend, Krishna Persaud, for sorting 
out the computer gremlins.
I would like to express my thanks to the Ernest Oppenhelmer Memorial 
Trust for their financial support In lieu of the entire project.
Above all, I would like to express my deep gratitude to my supervisor. 
Dr. D.W. Hutchinson, for his unwavering Interest, (personal and 
academic) and encouragement, without which this project would not have 
been possible.
Finally, I would like to sincerely thank my wife Laura for transforming 
a somewhat Illegible manuscript Into a typewritten thesis and for the 
support she has given me throughout.
iv
SYNOPSIS
The subject, "Studies On Sialidases", is Introduced In Chapter 1 by a 
review of the history, biological functions and properties of 
slalldases.
The development of a rapid and sensitive (detection limit 10~6 units) 
assay system for slalldase, using trltlated fetuln labelled at C-8 of 
Its N-acetylneuraminic acid (NANA) units, is discussed In Chapter 2. 
Included In this chapter, Is the design and application of a 
radioimmunoassay for sialidases, In which antibodies specific for 
(NANA) have been obtained* These antibodies were raised in sheep 
challenged with BSA-colominic acid (the colominic acid was hydrolysed 
to a chain length of approximately 3 NANA units) conjugate. Farther, an 
attempt has been made to determine the mole to mole ratio of NANA units 
per sialic add-contalnlng macromolecule.
The extensive purification of the three sialidases is discussed in 
Chapter 3, using a double "affinity" column system and hydroxylapatite 
with which it was possible to separate the two forms of sialidases 
found in S. griseus and V. cholerae.
The main body of the thesis (Chapter 4), reports on the work undertaken 
to xesolve the controversy pertaining to which amino acids are, or- are 
not, Involved in the active centre of sialidases obtained from 
pathogenic (C. perfrlngens and V. cholerae) and non-pathogenlc (S. 
griseus) sources. It was found, by chemical modification, that 
cysteine and lysine amino acid residues do not participate in the 
catalytic process, whereas on the other hand, arginine, tryptophan and 
carboxylic amino acid residues have been found to participate In or
near Che active centre, either by binding or by actual catalysis, 
during the catalytic process. Further, the involvement of arginine has 
been confirmed by differential labelling, isolation of the 
radlolabelled "active site peptide" and amino acid analysis, using 
phenyl (3H]glyoxal. The synthesis of the latter, via an Inexpensive 
method, is elaborated upon as well. Preliminary chemical modification 
studies directed at the carbohydrate residues, covalently attached to 
these enzymes, reveal the possibility of these moieties participating 
in the maintenance of the three-dimensional structure of slalldase.
With the aforegoing information, it is concluded that there is no 
difference between the active centres of sialidases obtained from 
pathogenic and non-pathogenic bacterial sources. Further, a catalytic 
mechanism involving the essential amino acid residues in or near the 
active site of the sialidases is speculated upon.
CHAP TEK 1
GENERAL BACKGROUND
1«0 Introduction
, >One of Che two major discoveries made in Che first forty years of this 
century, reawakening research into the chemistry of mucous secretions, 
concerned a specific constituent of the red blood cell membrane. Hirst 
(1941) and McClelland and Hare (1941) independently reported that 
chicken red blood cells were agglutinated by fluids containing 
infective influenza virus. Exploring this phenomenon, Hirst (1942 a,b) 
showed that at 4* the influenza virus was adsorbed to the red blood 
cells and remained so for 18 hr. Further investigation of this viral 
agglutination of erythrocytes at 3 /  revealed that the adsorption of the 
virus to the red blood cells was equally as fast but after 6 hours 
nearly complete elution of the virus had occurred. Red cells, after 
such treatment, neither adsorbed fresh virus nor were agglutinated by 
fresh virus, whereas the eluted virus was functionally Intact. It was 
further established that the virus, after heat treatment at 55* for 30 
minutes, lost both infective and eluting powers but retained its 
haemagglutlnatlng capacity (Hirst 1942 a,b and Brlody 1948). Such 
crippled virus was called indicator virus (Stone, 1949).
However, as early as 1902 Kraus and Ludwig described heat labile 
bacterial haemagglutlnlns which were destroyed by heating at 5tf .
*TW 01W  m jo r  d lK t m y  m  Ifc. damaraHwdlan by U h l  (19301 and M a n n  (19301 Ifc—  lb . A ,  I  and O  blood ryou, f N l O c  wbi*n *t 
whkl» arc gone controlled and responsible In man for Immunologle el specificity within the A - 1 -0  blood group system, ere present not only 
at the surface of red bleed colls In on Insoluble fane, h it  ore secreted In o woter soluble form In saliva, gastric juice, urine, o«e. by about 
73%  of all persons.
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Thomsen (1927) and Frledenrich (1928) also found that, contrary to the 
high specificity of human erythrocytes In their reaction with 
iso-antibodies, (iso-agglutination), the red blood cells exposed to 
bacteria or to their culture fluids were agglutinated by all human 
serum (panagglutination), known as the Thomsen-Frledenrlch 
phenomenon: yet no explanation was forwarded. Hirst ventured to 
interpret his findings and the rationale behind his explanation is 
illustrated in figure 1.0.
SUBSTRATE ( a )  
Receptors present at the 
red cell surface
♦ ^  
ENZYME ( -c )
Virus particle with enzymes 
embedded in the virus cool
Virus attached to the surface of two 
red cells (haemagglutination)
v  □
Virus unaltered.* Red cells with 
altered receptors ( stabalieed cells)
F ig . 1 .0  In te rp re ta tio n  of the  e ry th ro c yte  haem agglutination phenomena ( H irs t . 1941).
Evidence in favour of Hirst's theory, that an enzyme present on the 
surface of the virus was responsible for inactivating the cellular
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receptor, was published by Burnet and his co-workers In 1946« They 
found that pretreatment of erythrocytes with Influenza virus rendered 
them agglutlnable by adult human serum« This observation was correlated 
(Burnet 1951) with the Thomsen - Frledenrlch phenomenon of 1928, 
namely that erythrocytes became panagglutlnable after treatment with 
culture filtrate of bacteria« Burnet (1948) made further Important 
observations that partially purified material from various mucous 
secretions, a mucoprotein In nature in high dilution. Inhibited 
Indicator virus haemagglutlnation« The same observation was later made 
by McCrea (1948), Gottschalk and Lind (1949) and Rosenberg et al., 
(1956), with different glycoproteins.
It was now firmly established that the carbohydrate moeity of 
erythrocyte surfaces played a role In haemagglutination reactions. 
Burnet and colleagues also found that these mucoprotein materials 
irreversibly lost their virus haemagglutinln inhibitory property when 
treated with living Influenza virus or with purified enzymes from 
Vibrio cholerae or Clostridium perfringens (McCrae, 1947). The 
Vibrio enzyme was called "receptor destroying enzyme" [ROE] because 
it also destroyed the virus receptors at the red cell surface, thus 
protecting them against infection by influenza virus (Burnet, 1951 and 
Gottschalk, 1957 a,b).
Analysis of these results revealed that loss of biological activity of 
the red cell receptors and of the inhibitory mucoids on digestion with 
active influenza virus or with receptor destroying enzyme was due to 
the activity of two similar enzymes.
Information regarding the chemical structure of the substrate-product 
of the viral enzyme and the receptor destroying enzyme was provided by 
Gottschalk and Lind (1949)» They presented evidence that, concomitant 
with the loss of biological activity of the potent Inhibitor ovomucin, 
upon treatment with living virus and receptor destroying enzyme, a low 
molecular weight compound was released. It was characterized as an 
N-acylhexosamlne residue (Gottschalk, 195 Q. Later, from the 
laboratories of Bllx, Klenk and Gottschalk, it was disclosed that all 
virus haemagglutinln inhibitors are glycoproteins containing sialic 
acid and that sialic acid is the constituent split off from the virus 
particle and the receptor destroying enzyme in the inactivation 
reaction (Faillard & Klenk, 1955). The same was shown for the receptor 
substance at the red cell surface (Gottschalk, 1960). The soluble virus 
haemagglutinin inhibitors turned out to be chemical analogues of the 
specific Influenza virus receptor substance at the erythrocyte surface. 
As in the case of the blood-group substances, the specificity 
characterizing the agglutinogen-agglutinin reaction and its inhibition 
was shown to reside in the carbohydrate group of the agglutinogen and 
the inhibitor respectively (Gottschalk, 1972).
Sialic acid now became the centre of attraction. Its structure 
elucidation and its ever-present distribution in nature are so 
Intimately interwoven with the subject of this thesis that a very 
brief account of its history seems appropriate.
At the time of sialic a d d  being discovered by Blix (1936) in bovine 
submaxillary gland mucoproteln, the Interest in mucous secretions was
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•o low that It went unnoticed and waa only named sialic a d d  as late as 
1952 (Bllx, et al., ). A substance with similar properties but 
without reducing power was isolated by Klenk (1941) when he treated 
certain types of human brain glycollpids with 5Z methanollc 
hydrochloric acid at 105* . Klenk (1942) termed the product "methoxy 
neuraminic add" to be recognized later as a me thy lgly coside.
In the nomenclature of Bllx et al., (1957), sialic a d d  Is the group 
name for acylated derivatives of a nine carbon sugar with an amino 
group In the molecule called neuraminic a d d  [Fig* 1* 1] Neuraminic acid 
[Fig. 1.1(1)] never occurs In nature unsubstituted; usually It Is found 
in either Its N-acetylated form [Fig. 1.1(11)] as the N-glycolyl 
derivative [Fig.1.1(111)] or as various disubstltuted derivatives [eg. 
N,0 diacetyl] N-acetylneuraminic acid [Fig. l.l(iv)] and probably 
all other sialic acids occur in the pyraaose • form [Fig. l.l(v).
(1) <m OTI) (IV»
N-occtylnouramlnic acid In pyranosc form. 
(VI
F ig .l.l Structures of some sialic acids.
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N-acetylneuramlnlc acid was first prepared from animal sources by 
Klenk and Faillard (1954). In 1955 (a,b), Gottschalk proposed that NANA 
was formed from pyruvate by an aldol condensation with N-acetyl - 
hexosamine. Comb and Roseman (1958) proved» by enzymic procedure 
(aldolase from Clostridium perfrlngens), that N-acetyl - 
mannosamine is the amino sugar incorporated into N-acetylneuramlnlc 
acid (NANA). The Isolation of various types of sialic acids was 
achieved by Blix and co-workers (Blix et al., 1956 and Blix & 
Lindberg, 1960), a difficult and tedious task when the instability and 
the elucidation of the nature, number and position of their substituent 
acyl groups are considered.
Categorizing the enzyme product required the enzyme to be classed as 
well. Helmer and Meyer (1956) proposed that the name "sialldase" be 
used when the product of enzymic hydrolysis is sialic acid and that 
"receptor destroying enzyme" [RDE] be used when the destruction of 
biological activity is the result [as influenza haemagglutlnatlon could 
be inactivated by enzymes other than slalidase (Muller, 1974a)] . 
Gottschalk, (1957 a,b) suggested that the enzyme be termed 
"neuraminidase", and defined it as the specific a -glycosidase cleaving 
the ketosidlc linkage joining the potential keto group of a terminal 
N-acylated neuraminic acid to an adjacent sugar residue in a 
disaccharide, trisaccharide or polysaccharide (Gottschalk, 1958). The 
term neuraminidase has gained fairly wide acceptance. However, a few 
investigators prefer the term "sialldase" as the more correct term 
because neuraminic acid, the unstable parent compound, is now known not 
to be the product of enzymic action and has not been found as such in
-7-
nature. The produce generated is the free N^, or 0 - substituted 
neuraminic acid, namely sialic acid» It is for this reason we chose the 
term "sialidase" as opposed to "neuraminidase". The systematic name and 
function as listed by the International Union of Biochemistry (1978), 
is Acylneuraminyl hydrolase, EC 3.2.1.18, and it catalyses the 
hydrolysis of 2,3-, 2,6- and 2,8- glycosidic linkages joining terminal 
non-reducing or O-acylneuraminyl residues to galactose, 
N-acetylhexosamine, or N_- or O^-acylated neuraminyl residues in 
oligosaccharides, glycoproteins, glycollplds or colomlnic acid [Fig. 
1. 2 ]
Sordo—
♦*v>
Fig . 1.2 Action of tiulkJoto on lie* giycoiidn of N-acylneuromlnic acidi. Acyl *  acetyl or glycplylin naturally occurring tutelane et;
R »  monosaccharide«, oligosaccharide», "glycoprotein», glycolipldi, aliphatic or aromatic alcohol». For restriction» toe under entyme 
»pec If Icily . Assignment of the anomerk configuration to »iatidate susceptible ketosldet of N-ocylneuraminlc oc Id according to Y u  4  
ledoen (1969) “
1.1 Occurrence Of Sialidase
Sialidase is widely distributed in microorganisms and animal tissues. 
Viruses and bacteria as well as avian and mammalian tissues are known
to possess slalidase activity
1.1.1 Viral Slalldaaes
Viral slalldasea appear to be restricted to myxovlruaes (Table 1.0 froe
Fenner• 1968] and are an integral part of this group of viruses. The
term "myxovirusea" was given to a group of viruses which has a "high 
affinity for mucins" (Andrews et al., 1955), indicating the presence
of slalldase on their surfaces. Further evidence in favour of the 
enzymes' superficial arrangement is that they are inhibited by 
antibodies directed against the envelope components of the virus (Maeno 
& Kilboume, 1970). The myxoviruses are divided into ortho, para 
and, possibly, a third subgroup, meta myxoviruses (Melnlck, 1972).
TeMo I.Q
The S«b-OivWwi Of Mmwbm
* * — • * "» S sw c s -------------------
O r * »
W V it n ts  Type A .  of: M s n , swine, horse 
duck, few!
Slwee type specific nucleoprorein 
antigen. They a ll  peassti sicfidesc
Influence Type t .
Distinctive nuctoepretein antigen recovered 
from man. They e ll  pours* itoiidere
Influence Type C .
Feee
Newcastle Disease
Influence » ,  S , 3 * 4
Slasiee 3 }i1
O e  net possess sialidase
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The e°tyme is described, along with the other major viral surface 
antigen, haemagglutlnln, as being associated with
•Pike-like
projections on the outer surface of the virion (Laver & Valentine, 
1969). The alalldase spikes are thought to be embedded in the
hydrophobic portion of the surface membrane (Kendal et al., 1968), 
between haemagglutlnln spikes (Seto,1964) [Fig. 1.3].
Hacmoggkitinin 
Sie Udos«
Lipid membrane 
Matrix protein 
Nudcoprotcin 
RNA
Fig. 1.3 Schematic diagram of Influenza A Virus (Laver s Valentine.
1969 and Wrigley et al: 1973)
In the case of paramyxoviruses (Leprat & Aymard, 1979) both haemagglu- 
tlnin and slalidase activities reside on the same glycoprotein whereas, 
in the orthomyxoviruses, these activités reside on Independent 
glycoproteins.
Generally, slalidase represents 5Z to IOZ of the total viral protein. 
The synthesis of sialldase is controlled by the viral genome and the 
viral sialldase is not acquired from a cellular supply of the host
-10-
(Llpkind & Tsvetkova, 1967 and Ueda et al», 1978).
Because of the phenomenon of antigenic variation, slalldases from most 
viral strains will differ antigenlcally, physlochemlcally and 
kinetically. However, designation of the antigenic kinship of the 
sialldase of a particular strain of virus is now conventionally 
indicated in the viral nomenclature (Kendal & Made lay, 1969 and Wlldy, 
1971).
1.1.2 Bacterial Slalldaaes
Eubacteriales and Pseudomonadales are the two major orders of bacteria 
producing slalldases (Drzeniek, 1972). It has also been found in the 
orders Mycoplasmatales (Sethi & Muller, 1972 and Roberts, 1967), 
Actinonycetales (Myhlll & Cook, 1972 and Kunimoto et al., 1974) and 
Arthrobacter of the Coryneform group (Flashner et al., 1977 and 
Uchida et al., 1977, 1979) (Table 1.1).
Tcbl. 1.1
The Physical Association O f  SialldaBO And Its Source
Coryncboctcrium diprtmrlo 
Klebsiella
Moriymno A  Barksdale. 1967 
Pardos. 1970 
Schmmmwle t o l . .  1970
Bacteria producing extracellular ilolldaso 
Arthrobacter siolaphilus
Clostridium périr ingem 
Piplococcus pneumoniae
Flaihner et a l . .  1977
Uchidb et a l . . 1977
McCrae. 1947 and Bohn* et e l . .  1997
Chu. 194« and lea A  Hoao. 1966
Hoyena A  Tanaka. 1969
Bacteria producing hath call bound and 
extracellular «ialidase
Actinomyces Ws c o m  
Actinomyces noeslundll
Castel le et a l . .  1979
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The bacterial slalldases are either cell bound or exuded Into their 
growth media.
Because bacterial slalidases were regarded almost exclusively as model 
substances of viral sialldases, Interest flourished and the discovery 
of bacterial slalldase entered a logarithmic phase during 1970 - 1974 
(Muller. 1974$.
As time passed, researchers (Gottschalk & Bhargava, 1971; Muller, 1970 
and Vertiev et al., 1978) began to associate pathogenicity with 
slalldase; the genus Bacterlodes (Muller & Werner, 1970) and Vibrio 
(Muller, 1973) were cited. This relationship between sialidase and 
pathogenicity is now known not to be the case because, in the genus 
Bacillus (Fraser, 1978) and Neisseria (Zhuravleva, 1978), it has been 
shown that pathogenic Clostridium botulinum did not produce sialidase 
as opposed to the pathogenic Clostridium perfrlngens and a 
non-pathogenic strain of Neisseria was a sialidase producer as opposed 
to the pathogenic Neisseria meningitidis which is a sialidase 
producer.
It is now suggested that sialldase production may be of value in (1) 
taxonomic studies (as in the case of viruses) and, (11) In studies of 
pathogenicity and virulence (on the assumption that increased virulence 
Is related to Increased sialidase activity) (Fraser, 1978).
Recent years have seen an Increase in the number of non-pathogenlc 
slalldase producing bacteria of the genus Clostridium (Fraser, 1978),
-12-
Neisseria (Zhuravleva, 1978), Streptomycea (Kunlmoto et al■, 1974) and 
eapeclally Arthrobacter (Flashner, et al«, 1977 and Uchida et 
al.,1977).
Of the higher protlstan, protozoal sialldase is found In the culture 
media of the Mastigophora and Sporozoa orders (Watkins, 1953 and 
Crampen et al., 1979).
1.1.3 Mamnalian Slalidases
Mammalian sialldases, unlike the viral or bacterial slalidases, are an 
integral component of all organs containing sialyl-compounds. The 
period 1962 to 1973 has seen the association of sialldase with 
virtually every major organ of the mammalian body (Carubelli et al., 
1962, Zvetkova, 1965 and Tulsianl et al., 1973). With the emergence 
of more sophisticated methods for Isolation, preparation and 
characterization, the mammalian slalidases, at a cellular and
sub-cellular level, are associated primarily with lysosomes (Jibrll & 
Me Cay, 1965 and Venerando et al., 1978) and plasma membranes
(Schengrund et al., 1972 & 1979) of the various organs. It has been
found in the blood serum (Schauer et al., 1976), brain cytosol 
(Venerando et al., 1978) and cultured epltheliod cell lines (Tallman
et al., 1977 and Thomas et al., 1979) as well.
Schengrund and coworkers (1979) have stated that the slalidase of 
spleen plasma membrane are similar to those associated with the plasma
-13-
membranes of cells from other organs. It Is now clear that mammalian 
slalidase can be found as a soluble enzyme, as a cell surface component 
of Individual organs or In both forms in a single organ (Tulslani & 
Carubelll,1970 and Venerando et al., 1978). High slalldase activity, 
being associated with organs such as the Intestines. brain and liver 
which have a high turn-over of sialic acid containing compounds, is 
governed by the age and physiological condition of the organ (Dickson & 
Messer, 1978).
1.2 Biological Function Of Slalldases
1.2.1 Viral slalidases
Over the years, many roles have been proposed for the function of viral 
sialidase namely, viral binding to the host cell surface by enzyme- 
substrate interaction, viral penetration into the host cell, 
dissemination of newly formed viruses from the host cell and 
destruction of substances which protect the cell surface from virus 
binding. As each theory was put to the test, conflicting lines of 
evidence arose. Few of the important findings are elaborated upon 
below.
Confirmation of Hirst's theory (1965) which is that the binding of 
myxovlruses to cell surfaces is mediated by enzyme-substrate 
interaction, came from an elegant experiment performed by incorporating
-14-
fetuin (containing N-acetylneuraminlc acid) into liposomes: these 
artificial membranes bound ortho and paramyxoviruses but not adeno or 
herpesviruses. Antibodies directed against fetuin aiso prevented the 
binding of these viruses (Tiffany & Blough, 1971). The Inconsistencies 
pertaining to the latter lie In the fact that Indicator virus binds red 
blood cells (Stone. 1949) and that purified viral slalidase does not 
adsorb red blood cells (Laver, 1964 and Drzenlek et al., 1966).
This does not mean that there Is no enzyme-substrate Interaction 
between sidalldase of the myxovlrus and the cell surface containing 
N-acetylneuraminlc add. This enzyme was shown to spilt off 
N-acetylneuraminic acid from substances with which It came Into 
contact (Drzeniek, 1970).
Seto, Kendal, Dowdle and their co-workers (1967, 1970, 1974 
respectively), observed that sialidase-speciflc antibodies do not 
inhibit the adsorbtlon onto or penetration of myxoviruses into 
permissive cells, but affect the release of viruses from the cell by 
binding newly formed viruses to each other and to the membrane of the 
cell surface. Thus it was postulated that the biological function of 
slalidases was to release mature virus from the cell surface. Such 
eluted viruses could then attack fresh cells and increase the 
efficiency of viral propagation by circumventing localized "overkill". 
However, Becht et al., (1971) observed that monovalent antibodies 
which Inhibited slalldase of ortho myxoviruses did not Inhibit the 
release of virus particles from infected cells. Also, high 
concentrations of a viral slalldase inhibitor, 2-deoxy-2, 3
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dehydro-N-acetylneuraminic acid, (dehydro NANA), added Co Newcastle 
disease virus had no effect on the multiplication of the viruses 
(Drzeniek, 1972).
When the environment of the influenza virus is considered, one Is 
Inclined to believe that slalidase is an evolutionary tool required to 
penetrate the mobile mucous of the respiratory tract, thereby not only 
giving the virus access to the underlying cells but also protecting it 
against confinement in a coating of host mucin (Gottschalk & Bhargava, 
1971). The latest theory as proposed by Rosenberg and Schengrund (1976) 
is that newly synthesized sialidase molecules, for which the viral 
genome codes are Incorporated into the surface membrane of the host 
cell and occupy a position similar to the mammalian sialidase. By 
removing adjoining sialic acid residues from the surface of the host 
cell membranes, the enzyme serves to alter the physlochemical 
properties of the plasma membrane so as to permit budding and 
envelopment of the formed and exiting virus. This hypothesis still 
remains to be tested.
To resolve the present uncertainty about the function of viral 
sialidase, it will be necessary to opt for a biochemical and genetic 
approach; the former studying the kinetics, substrate specifications 
and structure-function relationship of the pure solubilized enzyme and 
the latter, verifying Rosenberg and Schengrund's theory and further 
elaborating on the genetics of antigenic variation related to
sialidase
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1.2.2 Bacterial Slalldases
The functlon(s) of bacterial sialidase, although subject to 
speculation, appears slightly more clear-cut than that of viral 
slalldases. Bacterial slalidases are known to alter the characteristics 
of Important sialic acld-contalnlng macromolecules in mammalian cell 
surfaces, matrices and circulatory material (see Table 1.2).
Because of the latter, two possible roles for bacterial slalldases can 
be considered; the first having Its emphasis on the inducible (Pardoe, 
1970; Nees et al., 1975 and Hoffler, et al., 1978) nature of the 
enzyme and the other on cell-cell Interaction.
In the primary areas of bacterial Infection such as the respiratory and 
Intestinal tracts, the Invading bacteria will encounter an adequate 
supply of inducers and substrates for the rapid synthesis of slalidase, 
the initial effect of which is to remove the sialic a d d  and, in turn, 
Is followed by other enzymes (Ashwell & Morell, 1974) which 
subsequently remove other sugars which can also serve as a ready source 
of energy for the parasites. Following from the initial attack and 
rapid generation of sialidase, the protective properties of the mucous 
layer are now drastically altered and Its much reduced viscosity can no 
longer trap and Impede the bacterial onslaught upon the underlying 
cells.
The function of bacterial slalidase at a subcutaneous level Is 
elaborated upon by Costello et al., (1979), who have shown that
sialidase la essential for the adhesion of a human strain of
Eapcrinwntol O f Sialic Acid From »¡ologicoll, Important Sialic Ac id -Contornino Sob* tanca* k y  Microbici Siolidmo*
Substrat« Effect an tubs trat«
H o o d  group antigens 
Blood platelets 
Erythrocytes 
Erythrocytes 
Erythrocytes
Lymphocytes 
Transfused lymphocytes 
Human lymphocytes 
Human lymphocytes 
Human lymphocytes 
Human lymphocytes 
Lymphoid cells 
Chicken fibroblasts 
Hamster kidney fibroblast 
F S H  
M C G
Serum alkaline phosphatase 
7 -G lu ta m yl transpeptidase 
Dopamin 0 -hydroxyla*# 
Erythropoietin 
S y n d i c  structure 
Nervous system cells in cu lture  
Lung tumour cells 
Mouse sarcoma cells 
Leukemia L1210 tumour ce lls  
Membrane glycoproteins 
Macrophages
Mouse islets of Langerhons 
Post coital intravenous in je c ­
tio n  in mice 
Injection into mice 
Mouse trophoblasts 
Embryomesoderm cells 
Glom erular basement membrane 
Macrophage glycol ipids
Lam of M  antigen 
Spontaneous aggregation 
Increased sensitivity to lysis 
' Unmasking o f ASH  blood groups 
Increased ingestion by mocraphogas 
Increased phogocytasis 
Decreased homing
Decrease in  l ymph nodes and spleen, increase in l i r a r
Activatio n  release of growth factor
Increased lysis susceptibility
A c tiv a tio n , release of inhibitor factor
Enhance expression of ce llu la r IgG.'decrease of Ig M
Increased susceptibility to  cytolysis by complement
Stimulation of division and sugar uptake
Stimulated r ic in  binding
Lom of biological activ ity
Less of b iological activ ity
Differential release of sialic acid from isoenzymes
Increase in a c id  stability
Decreases stability to proteolytic degradation
Lass of a c tiv ity  in vivo
Abolishes synaptic transmission
A ctiva tio n  o f ectapyrophosphotose
Reduced metastasis
Increased immunogenecity
Increased immunogenecity
Increased binding to lismr c e ll membranes
Increased bacterial adhesion
Decreased insulin secretion
Suppression o f pregnancy 
D elay of skin graft rejection 
Increases transplant immunity in recipient mice 
A ltered  shape
Lom  of endothelium and epithelium 
Lam of biological activity
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Actlnomycetes Co red blood cells. They observed that bacterial 
haemagglutinatlon Incurred two steps (1) the action of slalldase Is to 
expose the galactosyl groups on the red blood cell surface and (11) the 
binding of the newly exposed groups by lectin-like molecules on the 
Actinomycètes cells. Such a mechanism may enable bacterial surfaces to 
adhere to host cells In the presence of asialo-membrane proteins 
containing the newly exposed galactose termini. This provides support 
for the Idea that Interactions of the lectin- carbohydrate type, 
represents a significant mechanism for the attachment of microorganisms 
Co mammalian cell surfaces (Ofek et al., 1978).
An example where both proposed roles of bacterial slalldases come Into 
play, is the action of V. cholerae where It Is believed that the V. 
choierae sialldase augments the action of cholera toxin by (1) 
degrading the glycoprotein mucosa, thus facilitating the choleragen 
reaching its receptor rapidly and (11) removing the sialic acid 
residues from the gangliosldes, thereby priming the ganglioslde, ggtit' • 
the receptor for choleragen (Stark et al., 1974).
1.2.3 Mammalian Slalldases
A molecule as negatively charged as sialic a d d  will, to some degree, 
control the configuration of the site upon which it is borne in 
addition to any other interaction which it may have with neighbouring 
glycoproteins on the same membrane. Therefore the effect of sialldase 
can be expected not only to uncover previously protected aslalo-
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heterosaccharldes, but also to affect membrane structure In general.
In the endeavour to determine the function of mammalian sialldase, 
virtually every known serum slaloglycoproteln has been subjected to 
bacterial slalidase In vitro and the results have implicated 
sialldase with the biological effects listed in Table 1.2. For a 
possible In vivo interpretation from the table, two significant 
events occur. After the action of sialldase there follows either a 
cell-to-glycoproteln Interaction or a cell-to-cell interaction, both of 
which are synonomous with all the listed biological events.
The cell-to-glycoprotein interaction Is normally associated with the 
catabolism of serum glycoproteins, a catabolic effect regulated by 
sialidase (Fig. 1.4) (Morell et al., 1971).
rival tmm, of h ltla M  o»iologlyrafra*r!io In tta  ro> (Mar.ll » lo l . ,  1971)
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After the removal of the sialic acid» a galactosyl or N_-
acetylgalactosamine-heterosaccharlde core Is exposed and this is 
believed to Increase the susceptibility of asialoglycoproteins to 
phagocytic stimuli (Roseman, 1970) or possibly via the method described 
by Reutter et al., 1978 (Fig. 1.5) In the cell, effected by the 
lysosomes.
S ia l«flv c w f«i* ia
m  N 'Acetylneuram inic acid (N A N A )
F ig . 1 .5  Possible offer «vent of s ia lld a » action intracalfularly 
(Reutter et ol ■, 1978)
In the cell-to-cell interaction, removal of the sialic acid leads to 
increased cell adhesion, possibly in a similar manner as proposed by 
Roseman (1970), (including the action of the sialyltransferase). 
Therefore it can be inferred that, opposed to the aforementioned 
catabolic action of sialidase, it now participates in an anabolic 
process such as embryonic development and tumour formation (Jeanlos & 
Codington, 1976 and Preti et al., 1978).
Of the broad range of possibilities explored in trying to determine the 
biological function of sialidase upon endogenous substrates, a few have 
been chosen to be mentioned, in which the after-event of sialidase
action viz cell-to-glycoprotein and cell-to-cell Interaction could be 
biologically significant.
Reproduction:- slalldase has been found to be part of the sperm 
acrosome by Srivastava et al., (1970). Its role in fertilization is 
to reduce or block polyspermy. Slalldase has been shown to attack the 
hormones In reproduction (Brossmer & Walter, 1958; Sairam & Moudgal, 
1971 and Yaglnuma, 1972). This results In a greatly reduced uptake by 
the ovary, followed by lower biological activity.
Blood clot formation:- The role of adhesion of platelets to each other 
is an essential step in the formation of the haemostatic plug or an 
intravascular thrombolin deposit. Vermylen et al., (1974) showed that 
sialldase treatment of factor VIII gave rise to strong platelet 
aggregation, not only in normal patients, but in haemophilic patients 
as well.
Interaction of hormones with target cells:- Changes in the sialic acid 
content in the plasma membrane of the cell have been found, in some 
cases, to block the ability of the cell to respond to some hormones 
(Hahn et al., 1974; Hughes, 1979 and Haskar et al., 1973).
Neurotransmission:- Increasing evidence indicates that sialic acid is 
involved in neuronal transmission. Several workers (Heilbronn, 1962, 
Augustinsson & Ekedahl, 1962 and Heilbronn & Cedergreen, 1970) have 
shown that cholinesterase contains sialic acid. Brodbeck et al.,
(1973), observed that the removal of the sialyl residues increased its
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speciflclty for acetyl choline. Indicating a possible function for 
synaptic membrane-bound sialldase. Schengrund and Rosenberg (1970) and 
Yohe and Rosenberg (1978) have shown the presence of sialldase within 
the synapse and that it can act upon the endogenous lipid structure 
viz., the gangllo8ide effecting neurotransmission.
Immune response:- The greatest area of debate over the past few years 
pertaining to sialldase, has been its significance in the immune 
system. This enzyme has been implicated in both cellular and humoral 
immunity and the mechanism by which the inmune response is stimulated 
is not clear. Some authors claim that the enzyme uncovers a highly 
immunogenic new antigen which may result in altered handling by 
macrophages (Barth & Single, 1974 and Schmidtke & Simmons, 1973) while 
others claim that it stimulates individual participants of the immune 
response (Weiss et al., 1966, Lee 1968, Knop et al., 1978 and 
Galili & Schlesinger 1978). Yet again, Kuppers and Henney (1977) claim 
that the action of sialldase followed by that of galactose oxidase (~CH2 
OH— *-CH0) induces cell-to-cell crosslinking, thereby altering the 
antigenicity of the lymphoid cell which in turn leads to T. lymphocyte 
proliferation.
1.3 Sialldase: Disease and Application
Disease associated with sialldase is manifested by either (i) an 
increase in sialic acid-containing compounds, (indicating sialldase 
deficiency), such as oligosaccharides, glycoproteins and lysosomal
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enzymes in Che urine, serum, fibroblasts, leucocytes and liver (Durand 
et al. , 1977; O'Brien, 1977; Thomas et al., 1978 and Rapln et
al., 1978), or (ii) an Increase in sialic acid, (indicating slalldase 
hyperactivity), in the blood, urine (Merkhailova et al., 1968, & 
Mutton et al., 1977) and the after-effect of sialic acid removal from 
glycoproteins, glycoliplds and cell surfaces (Heide, 1974 and 
Uhlenbruck & Rothe, 1974). The absence of normal slalidase activities 
has been listed under many disorders such as fucodosis, Mannosidosis 
(Louden & O'Brien, 1979), gangliosidosis (Justice et al., 1977), 
I-cell disease (Minaml et al., 1979), Mucolipidosis (Bach et al.,
1979), Mucopolysaccharidosis (Leroy et al., 1971) and
sialylollgosacchariduria (Durand et al., 1977, and Kelly & Graetz, 
1977). Because of its concurrence with the vast amount of disorders, be 
it primary or secondary, an attempt has been made to catergorlse any 
effect caused by the primary deficiency of slalidase as "sialidosis" 
(Louden & O'Brien 1979 and Thomas et al., 1979).
There are tuo types of sialidosis. The difference betueen them, besides 
the phenotypic features and intelligence, is that Type I accumulates 
slalyloligosaccharides in the urine (IXirand et al., 1977; O'Brien, 
1977; Thomas et al., 1978 and Rapin et al., 1978), uhereas Type II 
accumulates sialylcompounds in the fibroblast (Spranger et al., 1977 
and Spranger & Weidemann, 1970). The type of oligosaccharides Isolated 
from the urine, which is Increased 100 times more than normal, is 
derived from a common precursor which could resemble the compound 
below.
o-NANA-<2-.J}-0-G*i-(l-~l^fl-GIcNAc-U-*«),^
a-NANA.(2— i>/J-G il-(l-* )./}.G IcN A e.(l-.2 )'' M*" ** 4)-GlcNAe
a-N AN A -(2 -^ )-0 -G iI-( I —.4)-/3-GlcK Ac-( I -»2)-a-Man-( I - .6 ) ^
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Of the oligosaccharides in the urine of the patient, more than 80Z of 
the sialyl-linkages are of the a (2-6) configuration (Durand et al., 
1977 and Strecker et al., 1977). Question, is this an iso-enzyme 
deficiency, as only thear(2—3) sialyl linkage is cleared? Sialidosis can 
be classified as an hereditary disease because iL is transmitted as an 
autosomal recessive trait (Thomas et al., 1978 and O'Brien, 1978). 
Both parents of sialidosis patients have half the normal sialidase 
activity forot(2—3) andai(2—6) sialyl linkages (O'Brien, 1977).
In the other disorders lacking sialidase activity, such as 1-cell and 
mucolipidosis III, the enzyme deficiency is only secondary since the 
removal of the sialic acid from the lysosomal enzymes still does not 
improve their uptake (Vladutlu et al., 1977).
Possible therapeutic effectors of sialidase should be explored, 
especially in view of the tragic consequences of debilitating myclonus 
in normally intelligent Type I patients. A possible approach could be 
the targetting of sialidase-loaded liposomes to the affected areas 
(Gregoriadls, 1976 and Flnkelstein & Weissmann, 1978).
High levels of sialic acid in the blood and urine lead one to suspect 
hyperactive sialidase(s). This was suspected for coxarthrosis disease 
(Merkulera et al., 1968) and calculus disease (Mutton et al., 
1977). For the former, enzyme activity was not investigated whereas in 
the latter activity was found to be normal. The disease hypercapnia and 
the resulting respiratory acidosis is believed to be the result of a 
released glycosidase activator which acts upon sialidase, as a loss of
one third of the sialic acid molecules per neuron has been found 
(Louden & Wolfe, 1964).
Slalidase has been associated enpasslng with many other diseases such 
as leukemia, (Kallee et al., 1964) Kwashiokor, (Ittyerah, 1970) and 
polyagglutlnabillty (Lalezari & Al-Mondhlry, 1973), to mention but a 
few.
Although sialidase has not been unequivocally implicated in cancer, the 
following observations have been made:
(i) Schengrund et al., (1973) observed that transformed cells showed 
sialidase activity when gangllosides were used as substrate and that 
the activity, (of the malignant cells), parallelled the degree of 
oncogenicity of a series of herpes simplex virus-transformed hamster 
embryo fibroblasts (Schengrund et al., 1974).
(ii) That the distribution of sialic a d d  on malignant cells was 
concentrated in special zones, despite the fact that malignant cells 
have a lower total sialic acid level than normal cells.
(ill) Many human tumours caused by viral activity share antigens, 
perhaps because of their cotmaon viral etiology (Morton & Malmgren, 1968 
and Rios & Simmons, 1976).
Because of the above, the question now arises as to whether it is 
possible that vlrally induced transformations strategically Incorporate
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viral slalldase Into the transformed cell surface, thereby removing 
contiguous sialic acid residues and leaving pockets of unaffected, 
negatively charged residues« Further, does a similar modus operandl 
exist In the non-vlrally transformed cells?
Another disease attributed to viral slalidase Is the autoimmune disease 
(Kolb-Bachofen & Kolb, 1979), in that the lymphocytes, once 
deslalylated, are taken up by the liver against which the autoinmune 
response is then targetted. This is in keeping with two established 
observations: (1) that the autoimmune response is a pathological event 
and (11) deslalylatlon Increases lmnunogeniclty (Simmons et al., 
1971).
Foetuses and tumours share something in common - that Is, they escape 
the immune attack brought about by the suspected masking effect of 
sialic acid and this is believed to prevent abortion (Granatek et 
al., 1979). It has also been shown that the protozoa, Trichomonas 
foetus which is a producer of sialidase, leads to abortion in cows 
(Crampen et al., 1979). The above observations (removal of sialic 
acid leading to an increased immune response), has become a tool in the 
hands of tumour researchers, who have demonstrated that tumour cells, 
treated in vitro, showed reduced tumouregenlcity in vivo 
(Lindenmann & Klein, 1967; Sanford, 1967 and Sedlacek et al., 1977). 
There have, however, been contradictions (Pimm et al., 1978), thus 
slalidase-treated tumour cells used as a vaccine still remain 
speculative (Sanford, 1974).
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Vaccination against influenza virus using pure viral sialldase has 
again aroused Interest because it has now been found that antigenic 
changes are less frequent in the viral sialidase than in the viral 
haemagglutlnin. The vaccine would therefore be usable for longer 
periods than the presently used inactivated whole-virus vaccine (Arora, 
1979).
The diseases caused by sialidase-producing pathogenic bacteria are as 
numerous and as variegated as portrayed in their names, eg. 
Dlplococcus pneumoniae, Corynebacterlum dlptherla, Coryne- 
bacterium acnes, Vibrio cholerae, Clostridium septlcum and 
Neisseria meningitidis, as discussed previously and in the reviews of 
Muller (1974a & 1974b).
The action of bacterial sialidases upon serum glycoproteins, (Morell 
et al. , 1971 and Schultze & Schwick, 1957) hormones, (Gottschalk et 
al., 1960 and Haksar et al., 1973) enzymes (Higashino et al., 
1972 and Robinson & Pierce, 1964) and cell membranes (Kemp, 1970 and 
Vaherl et al., 1972) in vitro and in vivo have been discussed 
previously. The successful survival of these bacteria is dependent on 
their ability to adapt, of which the foremost is the ability of the 
sialidase to be induced. This removal of substrate and inducers from 
their host leads to their increased virulence and overall deleterious 
effects upon the host such as septicemia, lymphocyte stimulation, 
inflammatory response and thrombocytopenia (Muller, 1974a).
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1.4 GENERAL PROPERTIES OF SIALIDASES
As sialldases are usually glycoproteins (Lazdins et al., 1972 and 
Kabayo & Hutchinson, 1977), the Inevitable presence of microhetero - 
geneity will bedevil molecular weight determinations (Gottschalk, 
1971). This is obvious in the broad range of molecular weights obtained 
for sialidases, even within a specific group.
1.4.1 Size And Shape
1.4.1.1 Viral sialidases
In determining the molecular weights of viral sialidases, the added 
problem of harsh isolation techniques, employing proteolytic enzymes, 
detergents and mechanical methods, resulted in an enzyme that may have 
suffered unsuspected degradation.
The molecular weights differ for the various myxovirus sialidases. 
Their sizes range between 1 to 2.8 x 105daltons (Kendal et al., 1968; 
Maeno et al., 1970 and Allen et al., 1977), for the high molecular 
weight complex and 5 to 6 x 10* for the monomeric enzymes or subunits 
(Drzeniek, 1972).
Viral slalldase has been described as a square, box-shaped head with a 
long tall having a small knob at the end embedded in the viral coat
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(Laver & Valentine, 1969; Wrigley et al., 1973). Removal of the head 
from the tall via proteolytic enzymes has given the B/Lee virus a
5
molecular weight of 2.8 x 10 daltons, with four subunits of molecular 
weight 7.0 x 10* daltons each. Oxford (1973) and Lazdlns et al., 
(1972) obtained values of 6.3 x 104 daltons per subunit whereas Wrigley 
et al., (1973) obtained a molecular weight of 4.8 x 10 daltons after 
proteolytic digestion. Lazdins et al., (1972) observed further that 
if he treated his monomers with trypsin as well, a carbohydrate-rich 
fragment was released, thereby reducing the monomer weight to 5.6 x 10* 
daltons resulting in the loss of its ability to aggregate again.
A thorough investigation into the molecular weight of the N2 virus 
sialidase was carried out by Groome et al., (1977) in which all the 
possible effects of the carbohydrate side chains of the enzyme were 
considered. They found that the molecular weight of the enzyme wa 
between 1.47 to 1.55 x 1C? daltons as opposed to 2 x Ilf daltons (Kendal 
& Kiley, 1973). Their sequential breakdown of this enzyme, first using 
6M guanldine-HCl, halved the molecular weight to 66,000 (2 subunits)
then, after irreversible reduction and the blocking of sulphydryl 
groups, the molecular weight was halved again to 33,500 daltons (4 
subunits). They proposed the figure 1.6 below as a probable arrangement 
of the polypeptides in influenza sialidase.
I 1 Polypeptide ■ Stalk
Fig. 1. A The probable arrangement of polypeptides
in the Influenza sialidase (Groome et ol; 1977).
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1.4.1.2 Bacterial sialldases
Bacterial sialldases are so far considered to be single polypeptide 
chains and there is no existing evidence of subunit structure 
(Rosenberg & Schengrund, 1976). Compared to viral slalldases, the 
bacterial enzymes are smaller. Their molecular weights are spread
between 3.2 x lti* and 10 x 10* daltons. (Kabayo & Hutchinson, 1977
Myhill & Cook, 1972; von Nicolai et al., 1978; Balke & Drzeniek
1969; Tanenbaum & Sun, 1971; Flashner et al.r 1977 and Mohr <
Schramm, 1960). Whether this is attributable to de Novo synthesis, 
remains to be answered. Molecular weight discrepancies lie within 
subgroups, for example V. cholerae sialidase has a size between 6.8 x 
10* to 10 x 10 daltons (Mohr & Schramm, 1960 and Drzeniek, 1972). The 
differences may be due to analytical procedures, technique, different 
degrees of aggregation of the enzyme or microheterogeneity.
The existence of isoenzymes for bacterial sialidase as claimed by 
Tanenbaum & Sun (1971) and Nees et al., (1975) have raised doubts as 
to whether they are true isoenzymes or not. As it was shown that if the 
three "isoenzymes" isolated by Nees et al., (1975) were subjected to 
sodium dodecyl sulphate (SDS) or 8M urea, they migrated as a single 
band on polyacrylamide gels. The only evidence in favour of true 
isoenzymes was published by Ziegler et al., (1978). They found the 
two isoenzymes from V. cholerae showed differences in optimum pH and
catalytic activities. Uchlda et al., (1979) also reported two
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isoenzymes for a A. ureafaclens differing in size and catalytic 
activity only towards gangllosides. No molecular weights for mammalian 
sialidases have been registered thus far«
1.4.2 pH Optimum And Km
The pH optimum of sialidases varies within the range of 3.5 to 7.0, 
depending on the substrate used and the state of purification 
(Gottschalk & Drzeniek, 1972 and Drzenlek, 1973). Schnelr & Rafelson 
(1966) found that influenza virus Strain Ag/Japan 305/57 slalidase had 
a pH optimum of 4.5 with N-acetylneuraminosyl ( a , 2 — 6) lactose, 
whereas it was pH 6.5 for the action of the same enzyme on the isomeric 
substrate li-acetylneuramlnosyl (a,2 — 3) lactose as substrate Uchlda 
et al., (1979) observed a change of approximately 1.0 pH unit in 
going from IJ-acetylneuraminosyl- lactose to colomlnlc acid for 
sialida8e from a bacterial source. Whereas Thomas et al., (1979) and 
Sander et al., (1979) reported similar but less dramatic pH changes 
for mammalian sialidases using sialyl-oligosaccharides as substrates. 
Ada (1963) reported that the pH optimum shifted from 5.8 for the crude 
enzyme of chick embryo, to a lower pH optimum (4 - 5) for the purified 
enzyme.
Generally, the pH optimum ranges for viral and bacterial sialidases are 
6-7 and 4.5-6 respectively (Gottschalk & Drzeniek, 1972 and Drzenlek, 
1973) whereas the vertebrate sialidases exhibit two optimum pH ranges,
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4-5 for Che membrane bound enzymes (Ada, 1963; Mahadevan et al», 
1967; HorvaC & Touster, 1968; Tulslanl & Carubelll, 1970; Parker et 
al., 1979 and Schiller et al., 1979) and 5.2-5.8 ’for the soluble 
enzymes (Ada, 1963; Taha & Carubelli, 1967 and Tulsiani & Carubelll, 
1970).
The Mlchaells constants (Km) of sialldases, like most enzymes, are 
perturbed by the normal effectors of enzyme rates such as pH, 
temperature and ionic strength (Lipovac et al., 1973 and Barton et 
al., 1975).
When small substrates such as ti-acetylneuraminy 1-lactose are used, 
the Km's for viral, bacterial and mammalian sialldases range between 2 
x 103 to 2 x 10 (Gottschalk & Drzeniek, 1972). With larger molecular 
weight substrates such as glycoproteins and gangllosides, Km values of 
10~5 and 10"6 M have been obtained (Schengrund & Rosenberg, 1970 and 
Tallman & Brady, 1973) (see Table 1.3).
Ta b i. 1.3
pH Optimum And Michael is CanstontlKn) O f  Siaiideses 
D ire c t» «  Against Various Substrates
Source of SielldoM PMOptimum
Substrate
Km
M References
Influenza A:/Jap. 30V57 4 .5 ( a , 2  — X N A N l 1 2 .0 0  a 10"4 Schneir 4 Rofelson, 196c
Influenza A ,/ J a p .30V S 7 4 .5 ( a  ,2  —  6 > N A N l 1 .00  a  I0 * 3 Schneir 4  Safe Ison, 1964
N O V 5 .2  ‘ Fetuin 1 .00  a IO "4 »ro s tro -e t e l . ,  1471
Sendai virus 5 .1 Fetuin 1 .00  a  I0 " 4 3rostrom et o l . ,  1971
V .  cholera» 5 .4 ( 0 , 2  —  3 5 N A N I 1 .00  a I 0 " 3 A d a e t s l . .  1943
C .  perfringens 4 .5 ( « , 2  — 3 )N A N l 1.00  a I 0 " 3 Cassidy o r a l . .  1965. I ? M
Rat liv e r lysaeomes 4 .2 ( 0 , 2  — 3 )N A N l 1 . f S  a  I0 ~ 3 Harvot 4  Toustsr, 1963
C hicken  chorioallantoic 
membrane 4 .5 ( 0 , 2  —  3, N A N I 1.00  a I0 " 3 Ada 4  L ind , 1949
Fibroblast 4 .0 ( 0 , 2  — 35N A N L l . l  a  I 0 " 3 Frisch 4  N e u fe ld . 1979
FIbveble* 4 .2 Fetuin > .*  a l O " 4 Thomas et e l . ,  1979
' n a n i .  N - M . l y l m i « — l« v l - l » » o » «
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N-acetylneuramlnyl-lactose was at one stage frequently used as the 
test substrate for brain slalidases but it has now proved misleading. 
Since brain sialidase exhibits reduced activity towards 
N^-acetylneuraminosy 1-lactose, the substrates of choice nowadays are 
dl- and trisialogangliosides (monosialogangliosides and slaloglyco - 
proteins are normally not hydrolysed) (Llebovitz & Gatt, 1968). 
Gangliosides have been used as substrates for other slalidases as well 
and Km's vary from 9 x 106to 1 x 10'4(Tallman & Brady, 1973; Ohman et 
al., 1970; Schiller et al., 1979 and Parker et al., 1979.
1.4.3 Substrate Specificity
Slalidases are able to hydrolyse onlyo-0- ketosidically bound sialic 
acid (Kuhn and Brossmer, 1958 and Gottschalk, 1958), while the 
/9-anomers are not split (Meindel & Tuppy, 1966 a,b and Yu & Ledeen, 
1969). theo-SHcetosides, a -N ketosides and the naturally occurring 
compound cytidine-5-monophospho-N- acetylneuraminlc acid (CMP-NANA) 
are resistant to slalldases (Khorlin et al., 1970 and Comb et al., 
1959).
Three different types ofo-ketosldlc linkages have been found in sialic 
acid-containing substances. An ( a ,  2—»3) linkage was found in 
N-acetylneuraminosyl ( or ,2 —* 3)-D-lactose (Fig. 1.7(i)) (Kuhn & 
Brossmer, 1959) and in a number of gangliosides (Ulegandt, 1968). An 
Isomeric 6-sialyl-lactose (Fig. 1.7(11)), namely N-acetyl - 
neuramlnosyl (a,2-*6)-D-lactose, in which the neuraminic acid is joined
«
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to C-6 of the galactose molecules, was isolated from human milk (Kuhn & 
Brossmer, 1959).
F ig . '7 Isomeric sialyllactoses: i X-Acetylneuraminosyl (*. 2-»3)-D-lactose. 
ii X-Acetylneuraminosyl (i. 2-»6)-D-lactose
The (<*,2-»6) linkage between W-acetylneuraminic acid and 
11-acetylgalactosamine was found in the disaccharide isolated from 
bovine submaxillary glycoprotein (Gottschalk & Graham, 1959). Sialic 
acid is joined by an (a, 2-»8) linkage to an adjacent second sialic acid 
molecule in a number of gangliosides (Wiegandt, 1968) in colominic acid 
(McGuire & Binkley, 1964) and in disialy1-lactose
(N-acetylneuraminosyl ( a  , 2 —  8) -N-acetylneuraminosyl ( a ,2 
3)-D-lactose)(Fig. 1.8) (Kuhn & Gaughe, 1965).
Fig.H  Disialyllactose: N-acetylneuraminosyl (*, 2-»S)-N-acetylneuraminosyl 
(a. 2-*J)*D-lactose
-35-
An additional type of linkage, namely an (a, 2-»4) linkage between sialic 
acid and galactose in •, -acid glycoprotein has been reported (Jeanloz, 
1960).
Experiments with bacterial enzymes have shown that C. perfrlngens 
(Cassidy, et al., 1965) or V. cholerae sialidase (Drzeniek & Gauhe, 
1970) hydrolyse N-acetylneuraminosyl (“, 2-»3)-D-lactose twice as fast 
as H-acetylneuraminosyl ( “ , 2—• 6)-D-lactose. Great differences in the 
hydrolysis of these two isomers were found when viral enzymes were used 
(Schneir & Rafelson, 1966). At the optimum pH values for the enzyme 
obtained from influenza virus Strain A2 /Japan 305/57, the rate of 
hydrolysis for the 2—3-isomer was sixteen times faster than the 2- 
6-isoner.
Differences in the capacity to hydrolyse (e,2-»3), (e,2-»6) and («,2-»8) 
linkages by a number of viral sialidases were revealed by Drzeniek 
(1967 & 1970). The most specific viral sialidases tested were the
enzymes of fowl plague virus (FPV) resembling influenza A viruses and 
Newcastle disease virus (NDV), a representative of parainfluenza 
viruses. Under standard conditions as laid down by Drzeniek (1973), FPV 
and NDV sialidase easily hydrolysed the (■ ,2—>3) linkage of the 
N-acetylneuraminosyl ( « ,2—►3)-D-lactose, whereas from the (e,2-»6) 
isomer no more than I X of NANA was liberated.
FPV and NDV sialidases, though Indistinguishable in their action on 
(<*,2— *-6) linkages, showed marked differences when acting on the 
( a , 2— *8) linkage. It was found that the total amount of NANA could be
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removed from dlslaly1-lactose by brief Incubation with NDV slalldase. 
This substance was resistant to the action of fowl plague virus enzyme 
(Drzenlek & Gauhe, 1970). Since dlslaly1-lactose contains two 
differently linked NANA molecules, It Is evident that the (a,2-8) 
linkage Is resistant to the action of FPV sialidase. In this substance, 
however, the second (a,2—3) linkage Is not split off by this enzyme 
either. This behaviour demonstrates that viral sialidase is an 
exoenzyme, Incapable of liberating a non-terminal sialic acid molecule.
The above oligosaccharides were easily hydrolysed by V. cholerae 
sialidase. The substrate specificity of V. cholreae and both viral 
sialidases is compiled in Table 1.4.
Toblo 1.4
Substrate Specificity of Sialidases. Tha sensitivity (+) or resistance ( - )  of 
different types of a  -  ketosidic linkages of N-acetylneuraminic acid towards 
V ib rio  cholerae, Newcastle disease virus (N O V ) and fowl plague virus (FPV) 
sialidases a n  compared.
Type o f « Sìalìdas« of
R «f«r«n c«
linkage Vibrio cholerae N D V FPV
2 —  3 ♦ ♦ ♦ Drzaniek, 1967
2 — 4 ♦ - - Huang & 
O rllch , 1972
2 - 4 ♦ - - Drzenlek, 1967
2 — • ♦ ♦ * Drz«nf«k &  
G auh«, 1970
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For a compound Co be cleaved by sialldase, Che following crlcerla have
Co be mec (1) che carboxyl group of sialic acid muse noC be subscicuced
(Gottschalk, 1962 and Yu & Ledeen, 1969), (11) Che nlcrogen aCom of 
sialic acid muse noC be subscicuced by groups ocher Chan 11-aceCyl or 
N-Rlycolyl (Meindel & Tuppy, 1966 and Falllard, ec al., 1969), 
(111) che polyhydroxy side chain of sialic acid should noC be 
subscicuced wich bulky or negaclvely charged groups and 1C should noC 
be oxidized beyond C-8. (Schauer & Falllard, 1968, HolmquisC, 1975b and 
Suttajit, 1970)•
Slighc differences In caCalyClc selecCivlCy occur beCween bacterial and 
viral slalidases concerning subsCiCuCion aC C-4, C-6 and C-8. While 
viral (Influenza A2/Slngapore/57 virus) and bacCerlal [C. perfrlngens 
and V. cholerae] sialidases boCh cacalyse C-7 and C-8 O-acety—
laced sialic acid, only viral sialldase can cacalyse C-4 0-aceCy-
laCed sialic acid (Schauer & Falllard, 1968 and Pepper, 1968)»
Anocher facCor which could possibly be considered Co be a crlcerlon for 
Che hydrolysis of nacurally occurring subscraces such as gangllosldes, 
is chac Che vicinal carbon acorn, (normally C-4 of galacCose), of Che 
sugar parCner Co which sialic acid is linked, should noC be 
subscicuced. This subscicuclon sCerlcally hinders Che acCion of 
slalidase. Kuhn and Wiegandc (1963) have shown Chat the 
monoslaloganglloside (Fig. 1.9) as well as oligosaccharides derived 
therefrom are resistant to V. cholerae, chicken retina and calf brain
slalidase (Llebovitz Gate, 1968 and Pretl & Fiorilli, 1978). It is only 
after enzymic removal of galacCose (linkage a ) and
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N-acetylgalactosamine (linkage b) that slalidase will split the
ketosldic linkage c.
* ' •  I t  t u v n u c  « IrcM -b 'iM  o f m onoK alogonolM iolp I c . - t ' l  from  U o M : l o i  0 -« jl ,c to * i< l,a rI l b )  ¿.A '-o ro tv IcjU rro 'O Ji'in i 
«Lu». ««) i i i k i m  («Il /NgaLit-'osid.iar, imi <e)
However, the sialldase from A. ureafaclens has been shown to cleave
the sialic acid from G . without prior treatment with otherM 1
glycosidases (Sugano et al. , 1978, 1979).
Defined specificity will be discussed further in Chapter 4.
1.4.4 Activators And Inhibitors
Some metal ions are either activators or Inhibitors of enzymes. 
However, from the reviews of Gottschalk and Drzeniek (1972), Drzenlek 
(1972 & 1973), Rosenberg and Schengrund (1976), and Holmquist (1975), 
it appears that there Is no hard and fast rule about the effects of 
divalent or monovalent ions, especially the calcium ion on sialidases.
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Moat viral slalidases are activated by calcium iona which are often 
tightly bound to the enzyme- Bacterial slalidases on the other hand are
somewhat indifferent to the Influence of metal ions. Some are
activated, inhibited or unaffected, eg. the sialidases of V. cholerae,
D. pneumoniae and C. perfrlngens respectively (Mohr & Schramm, 
I960; Hughes & Jeanloz, 1964 and Cassidy et al», 1965, 1966),
Mammalian sialidases are generally unaffected by calcium ions 
(Kuratowska & KublcVca, 1967 and Schengrund & Nelson, 1973) but there 
are claims to the contrary Mahadevan et al», (1967) and Schengrund & 
Nelson (1975).
Though ethylenedlaminetetracetate (EDTA) inhibits most viral sialidases 
except the Sendai virus enzyme (Popa & Repanovlcl, 1977), the effect on 
bacterial sialidases is ambivalent in that it inhibits the V» 
cholerae and not the C. perfrlngens enzyme (Boschman & Jacobs, 1965 
and Popenoe & Drew, 1957). The EDTA inhibition could be overcome by the 
addition of calcium ions (Ada et al., 1961).
Viral sialidases are insensitive to heavy metal ions such as Pe*"*", Zn++
X Land Hg . The bacterial enzymes again portray diverse behaviour for 
example, S. grlseus enzyme is Inhibited whereas the A. ureafaciens 
enzyme is not inhibited by Hg ions. (Kunlmoto et al., 1974 and Uchida 
et al., 1979). Mammalian sialidases are generally inhibited by Hg"+ , 
Cu^and Zn^Tùlslanl & Carubelll, 1970 and Yohe & Rosenberg, 1978).
The chloride ion was shown to inhibit V. cholerae and C
- 4 0 -
perfrlngens slalldases (Brossmer et al., 1977 b, and Barton et
al. , 1975) whereas the annonlura ion inhibits the calf brain enzyme
(Pretl et al., 1974). Inhibitors of slalidases can be arbitrarily
classified as analogues and derivatives of sialic acid or as substances
with no direct resemblance to the substrate or product of the enzyme
Viral slalidases can be inhibited by the product of their reaction
namely NANA or by 2-deoxy-2,3 dehydro - sialic acids (dehydro-NANA)
(Fig. 1.10).
F ig .  1 . 1 0  2  - D c o x y -  2 , 3 -  d e h y d ro  - N -a c c t y ln r u r a m in i e  a c id .
The competitive inhibition constant (Ki) observed for the above is in 
the range of 5 x 103 M to 5 x 10^1. (Walop et al. , 1960; Drzenlek, 
1970 a£ and Meindl et al., 1971).
For the S-ketoslde, 2-Deoxy-2-£_-nitrophenylthio—N-acetyl- « -D-
neuraminic .acid and the 5 lactone, 3-Aza-2,3,4-trideoxy-4-oxo-D- 
arabino-octonic acid 5 -lactone, complete inhibition is obtained at a 
concentration of 103M (Khorlin et al., 1970).
For the perineal enigma, namely bacterial sialidases, it is reported 
that the V. cholera enzyme exhibits a similar profile to the viral
enzymes (Mohr & Schramm, 1962; Meindl & Tuppy, 1969 a,b, 1970 and
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Khorlin et al., 1970). C. perfrlngens and A. slalophllus show no 
inhibition by NANA or dehydro-NANA. Furthermore, dehydro-NANA methyl 
ester is an effective inhibitor of the A. slalophllus sialldase 
whereas the V. cholerae enzyme is insensitive to this analogue 
(Gottschalk & Drzeniek, 1972; Rosenberg & Schengrund, 1976 and Miller 
et al., 1978). The membrane bound mammalian enzymes of the brain,
heart and liver are inhibited by dehydro-NANA but uncertainty prevails 
as to whether or not NANA is an inhibitor (Sandhoff & Pallman, 1978; 
Parker et al., 1979 and Sander et al., 1979).
Inhibitors showing no structural analogy to sialic acid are either low 
molecular weight substances with different properties, or high 
molecular weight substances with polyanionic character. The action of 
these substances is not specific since they react not only with the 
sialldase molecule, but also with other proteins or substances often 
present in sialldase preparations.
The important examples of the low molecular weight substances are the 
glyoxals. The most active of these potent ^-substituted oxamic acids 
for both Influenza and V. cholerae sialidases, are phenyloxamic acid 
(Fig. 1.11(1)) N-(2-pyridyl) oxamic acid (Fig. l.l(ii) N-(2-thiazolyl) 
oxamic acid (Fig. l.ll(iii)) and thio-oxanilic acid (Fig. l.ll(iv)) 
(Edmond et al., 1966). Structurally, they all have similarities to 
phenylglyoxal (Fig. l.ll(v) (Brossmer et al., 1977 a) (Fig. 1.11).
(0 ( i i ) (Hi)
(iv) (v>
Fig. 1.11 N ^ u b lllv ltd  oxamic acid inhibitor! of sialldaM (Edmond et o l . ,  1966)
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How these compounds would react with the mammalian enzymes Is not 
known«
The high molecular weight substances with polyanlonlc properties are 
very potent Inhibitors (Drzenlek, 1966). Thus macromolecules such as 
dextran sulphate, ribonucleic acid (RNA), deoxyribonucleic acid (DNA) 
and heparin, which are all anionic In nature, will Inhibit most 
sialidases. This Inhibition can be reversed by the addition of 
polycationic substances such as poly-L-lysine or protamine sulphate. 
Comparing the action of the different polyanions, It was concluded that 
the anionic groups present in the molecules Inhibit in the following 
order: RS0“>RC00‘5R2P0J. Therefore the best inhibitor is expected to be 
dextran sulphate (Drzeniek 1970b , 1972). These effects have to be kept 
in mind when experiments are performed in the presence of polyanionic 
substances, eg. glycoproteins or nucleic acids.
A third type of inhibitor, Neuramlnln, for (Influenza and NDV) 
sialidases, which Is composed mainly of neutral sugar and lacks 
neuraminic acid, is still under study (Lin et al., 1977).
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CHAPTEK 2
ASSAY OF SIALIDASES
2.0 Introduction
One of Che major drawbacks in research involving sielldase has been Che 
lack of a standard assay procedure by which Che acClviCy of all 
slalldasea can be decernined. As a resulc ic has been dlfflculc to 
compare or meaningfully interpret Che observed properties of different 
slalldases. Thus, the amounts or properties determined may reflect the 
substrate specificity of the enzyme which varies, with either the 
number of different linkages in the same substrate (Table 2.0),
%  N A N A N -S v fc -
CeeSeet tlitulion
Srelyl-loclaM 433 49 N -A c e ty l
f T i j t lm ld i» I . M 23-30 N -A c e ty l
Cefeminic acid 10,000 90-100 N -A c e ty l
•,-seid glycoprstcM 44,100 12.1 N  Acetyl
feruim 40.400 0 .9
H - O l y - ^
csyl
i . t . i / 21
«•F*
O .  N - O I -  
ecciyl
CeflscaMIe awccM 9-1 3 O ,  N -O » -
Iff* i* -haM IM v
Reference
Iwchsr A  Pefeee I97S 
G merwch 1943 
K  bream 19Mb 
•wchev *  Pefcte 1973 
•wcber 4  M e ta  1979
•web« ft M s «  1973
the limitation in the detection system (for example, low sensitivity, 
Interference and reproducibility), or the differences in the purity of 
both the enzyme preparation and the substrates used.
Since slalideses hydrolyse substretes (eg. see Table 2.0) containing
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•-ketosidically bound sialic acids, It Is therefore possible to measure 
the activity of the enzyme by the decrease of bound sialic acid, by the 
increase of free sialic acid or by the determination of the free 
aglycone. The quantitive method used most frequently is the 
thiobarbituric acid (TBA) assay of Aminoff (1959, 1961) and Warren 
(1959, 1963), which allows the determination of free sialic acid in the 
presence of bound sialic acid* In this procedure free sialic acid is 
oxidized by sodium periodate to 0 -formylpyruvate (Paerels & Schut, 
1965) which, in turn, reacts with thiobarblturate to form a Chromophore 
with a molar extinction of 57,000 at 549 nm in cyclohexanone (Fig. 
2. 0) .
F i , .  2 .0  during rh* thiobarbitvric assay (Kuhn & lu tt , 1963)
For greater sensitivity Hammond and Papermaster (1976) modified the 
Warren method by extracting the chromophore in acidified butanol and 
reading the fluorescence at 550 nm. Free sialic acid can also be 
determined by using the coupled enzyme system of .N- acetylneuraminate 
aldolase (N-acetylneuraminate pyruvate-lyase)and
-45
lactate dehydrogenase (LDH) (Fig. 2.1).
N-ae»t»ln«ufaniln le  acid .........- -  ■ — »  N-ae.tylmanno«amln. t  P yrw ol.
Pyruvata + N A O H  ■ ^"> .......... ■ Lac tat* + NA D *
( I )  3 N-ocetylneurominate pyrvivata-lyaM 
(H ) 3 Loctato dohydrogenaso
Fig. 2 .1  Enzymic determination of free siolic acid
This enzymic method is based on the cleavage of NANA by If-acetyl- 
neuramlnate pyruvate-lyase to pyruvate and the corresponding
N-acetylmannosamlne • The reaction was coupled to the reduction of 
pyruvate by LDH and NADH, which drove the aldolase cleavage to
completion. The sialic a d d  concentration was estimated spectro- 
photometrlcally by either determining the initial rate of oxidation of 
NADH or the quantity of NADH oxidized at the end of the reaction (NADH 
is a function of sialic acid concentration) (Brunetti, et al., 1963 
and Comb & Roseman, 1962).
Sweeley and co-worlters (Sweeley & Walker, 1964 and Vance 4 Sweeley, 
1967) and Rauvala and Karkkalnen (1977) used gas-liquid chromato­
graphy (G-LC) in determining free sialic acid. In this procedure NANA 
and N-glycolylneuramlnic a d d  (NGNA) could be measured simultaneously 
(Tii 4 Ledeen, 1970).
Radioactive methods have been developed for detecting slalidase
activity at very low levels. A substrate,«,-acid glycoprotein, was 
labelled at the C-8 of sialic a d d  with tritium after periodate 
oxidation (Schauer et al., 1976). After incubating the radioactive 
substrate with slalidase, the radioactive 4- acetylanalogues
liberated were dialysed and the activity of the low molecular weight
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compounds counted* An Ingenious method developed by Petitou et al., 
(1977) employed lymphoblastoid cells grown in H-glucosamine (a 
precursor of sialic acid)* This resulted in membrane bound H-labelled 
sialic acid and was successfully used in the assay of membrane 
bound sialidase.
Determination of sialidase activity by measurement of the liberated 
aglycone was developed for the synthetic substrate methoxyphenyl 
neuraminic acid (2-(3-methoxyphenyl)-N-acetyl « -D-neuraminic acid) 
(Meindl & Tuppy, 1967) and for IJ-acetylneuraminosyl-lactose (NANL) 
(Holmquist, 1969). In the first procedure free phenol is determined by 
the folin-Ciocalteu (1927) reagent (Layne, 1957). Because this method 
cannot be used in the presence of high protein concentrations, an 
improved method was developed by Santer et al., (1978), using 
4-aminoantipyrine [Fig. 2.2(iv)] in the presence of an oxidizing agent 
which forms a coloured quinone [Fig. 2.2(v)] with para unsubstituted 
phenols.
•* nr "■
F ig .  2 .2  F .o c tio n , in v o lw d  in i f .  ou o y of . u U J i h  2 - ( 3 - M . l l w y p n . n y n - N -
acetyl- a  -O-neuro.-nin.’c acid (I) is hydrolyzed by e ie lia s s « to yield NeuAe 
(II) and merhonyphenol (I I I ).  Ill and amino-antipyrine (IV ) In buffer, pH 0 .5 , 
in the presence of an oxidizing agent, potassium terr¡cyanide, w ill yield a 
coloured quinone (V ).
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Another sialldase assay system based on measuring the aglycone moelty 
is that of Bhavanandan et al., (1975). In this method the 
N-acetylneuraminosyl («,2—3)-lactit[3H]ol, the tritiated borohydride 
reduction product of N-acetylneuramlnyl- lactose, is digested with 
slalidase after which the tritiated neutral aglycone is separated from 
the rest of the hydrolysate by ion exchange chromatography.
A method patented by Thomas and Folger (1976) describes the assay of 
sialidase in which a fluorescent aglycone, namely methyllumbelliferone 
is liberated from the substrate 2-0-4-methylumbelliferyl-ltf-acetyl- 
«—D—neuraminic acid and its intensity determined (Fig. 2.3).
F l f .  1 .1  S n c M  H »  D u a v i k  H h k M ,  J + 4  . « w w W ,  k M . tarllrlltan
It is clear from the number of assay methods available that no one 
method is ideal to meet all situations. For example the thiobarbituric 
assay Is subject to interference by a number of foreign substances in 
biological materials, such as 2-deoxyribose, sucrose and malonaldehyde 
(Warren, 1959; Aminoff, 1961; Horvat & Touster, 1968; Waravdekar & 
Saslaw, 1957 and Schneir, et al., 1970). Compounds that inhibit 
colour formation in Warren's procedure include L-fucose, acetaldehyde, 
DNA and nucleotides (Warren, 1959; Rosenberg & Einstein, 1972; Onodera 
et al., 1965 and Kuwahara, 1980). Further, free sialic acid exhibit 
different molar extinction coefficients (Aminoff, 1961 and Schauer & 
Faillard, 1968) in the thlobarblturate procedure and ferrous ions at
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concentratlons of 30 to 10 ■ Molar decrease Che colour yield In the 
Warren assay by 35 - 55Z (Hartree & Brown, 1970).
The coupled enzymic system has Its limitations In that the NANA and 
NGNA must not be 0-acetylated and the system should be free of NASH 
oxidase activity.
As no one assay is suitable, being either tedious, Insensitive, 
expensive or unreliable, we decided upon two assay systems; the Warren 
assay and a radioactive assay using a,-acld glycoprotein as the 
substrate. The Warren assay proved suitable for moderate enzyme 
quantities In a fairly pure state. It was most unsuccessful when 
assaying for sialidase activity In the culture fluid or solutions 
containing chromophores that Interfered with the absorbance reading at 
549 nm. The assay using tritlated «-acid glycoprotein yielded 
unreprodudble results though It could have been effective under 
conditions In which the Warren assay failed.
It was for these reasons we attempted an Improvement of the radio­
active assay and Investigated the possibility of a radioimmunoassay 
(RIA) as It has long been known, though with scepticism (Bergman et 
al., 1962 and Barry, 1958), that sialic acid Is an immunodetsrminant 
sugar (Rule, 1965; Prat & Comoglio, 1976; POgonowska- Goldhar et al., 
1967; Apicela, 1976; Baker & Kasper, 1976; Egan et al., 1977 and Sela 
et al., 1975).
The techniques of RIA have expanded over the last two decades to 
Include the detection of many biological substances. The reasons for 
such wide application of this technique are derived from its high 
sensitivity, specificity and precision compared to other analytical
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methods . In a typical RIA, tha antibodies (Ab) to the biological 
•ubstanca of interest (Antigen» Ag) are prepared and used to determine 
the concentration of the antigen, following observations in which the 
radlolabelled antigen (Ag*) molecules compete with the unlabelled 
antigen (Ag) molecules for a limited number of binding sites on the 
antibodies* Fig. 2.4 summarises the reactions involved in RIA (Berson & 
Yalow, 1968).
The mixture of Ab, Ag and Ag*, in which there is a fixed amount of Ab 
but a relative excess of Ag, is incubated to allow establishment of an 
equilibrium before the antigen-antibody complexes (Ag-Ab & Ag*-Ab) are 
separated from free unbound Ag* and Ab. The radioactivity of complexed 
or free Ag* or both are measured. When Increasing amounts of unlabelled 
antigen are added to the assay, the limited binding sites of the 
antibody can bind less of the radlolabelled antigen (Ag*). A diminished 
binding of labelled antigen offers evidence for the presence of 
unlabelled antigen. The concentration of the unlabelled sample antigen 
can then be obtained by comparing the observed inhibition of labelled 
antigen binding with that obtained by standard solutions containing 
known amounts of unlabelled antigen.
Any compound can be measured by the RIA technique provided that (a) it 
can be made immunogenic, (b) it is available in a pure form, (c) it can 
be radloactlvely labelled and (d) there is a technique available to 
separate antibody-antigen complex from tha free compound. Though both
Ffg. 2.4 Summary of fho principles of a RIA
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labelled and unlabelled NANA are available commercially and sialic acid 
is an ImmunodetermlnanC sugar, (on Its own It cannot raise antibodies), 
neither antibodies to sialic acid nor attempts to design a RIA for its 
determination have been reported.
2.1 Experimental Procedure 
Definition of a slalldase enzyme unlt:-
One unit, (u), of enzyme activity is defined as the amount that 
releases 1 pMol of NANA per minute under the reaction conditions used. 
The specific activity, (SA),is defined as units/mg.
2.1.0 Warren Assay
The enzyme (0,02-0,6 u) was incubated with lOOjil of the substrate, 
fetuin or a, acid glycoprotein (19 mg/ml) in a total volume of 500/tl in 
0.05M sodium acetate buffer (pH 5.3 for S. grlseus, pH 4.5 for C. 
perfrlngens ' and pH 5.1 for the V. cholerae slalidases). After 1 hr 
at 37°, the reaction mixture (200/ul) was removed and dispensed into 
centrifuge tubes at 4* containing lOO/il 10Z phosphotungstlc acid (in 
12.5Z H2S04 ) (PTA) this was rapidly mixed and the precipitated protein 
removed by centrifugation (10,000 x g for 5 min .)• The clear 
supernatant (S/N) was then used to determine the released sialic acid 
by the method of Warren (1959), except where otherwise stated.
2.1.1 Radioactive assay
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2.1.1.0 Preparation of the radioactive substrate (Schauer et al., 
1976)
Fetuin (10 mg) was dissolved in 4.0 ml of 0.1M sodium acetate buffer pH
5.6, containing 0.15M sodium chloride. To this solution cooled in ice,
was added sodium metaperiodate (0.4 ml, 4.8/iMol) and allowed to react
in the dark. After exactly 8 min , (determined by trial
experimentation), 200jil of 50Z ethylene glycol was added. Ten minutes
later the solution was dialysed against 0.15M sodium chloride in 0.05
sodium phosphate buffer pH 7.4 ( 2 x 5  Its) for 36 hr . To the dialysis
residue was added 330n 1 of sodium boro-['hi]-hydride in 0.01M sodium
•
hydroxide (661 m Cl/mMol). This was allowed to react for 30 mins at 21 
2 ml of unlabelled sodium borohydrlde (4 mg in 2.0 ml 0.01M NaOH) was 
added and the mixture was left to react for a further 30 min at the 
same temperature. The solution was then dialysed extensively against 
the following buffers 0,005m  sodium phosphate, pH 7.4 (48 hr, 2 x 5  
Its) and 0.001M sodium phosphate, pH 7.4 (120 hr , 5 x 5 Its). The 
non-diffusable material was lyophylized and thereafter resuspended in
1.0 ml, 0.001M sodium phosphate buffer, pH 7.4 and the specific 
activities of the trltlated fetuin and the trltlated sialic acid deter­
mined.
2.1.1.1 Determination of the specific activity of the trltlated sialic 
acid analogue by acid hydrolysis (100Z)
Trltiated fetuin (50 pi) was hydrolysed in 450 pi of 0.01M ^  S04 for one 
hr at 80*• The protein was then precipitated with 10Z phosphotungstic 
acid and centrifuged as previously described. The released sialic acid 
present in the S/N was determined by the Warren method and the 
radioactivity was determined by counting aliquots of the S/N using
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Triton X-100 butyl PBD as the sclntillant (Table 2.1).
2.1.2.2 Determination of the specific activity of the trltlated sialic 
acid analogue by enzymic hydrolysis
Trltlated fetuln (50 pi) was added to 0.005m sodium acetate buffer pH
5.1 (150 pi) containing V. cholerae slalldase (10 pi, 0.8 u). This
was allowed to react for 1 hr at 37* . The reaction was stopped with 10Z 
PTA as above and the free sialic acid and the radioactivity in the 
supernatant was determined as above (Table 2.1).
2.1. 1. 3 Trial application of the radioactive assay V.
V. cholerae sialidase (5 /ul 0.002 u ) was incubated at 37* with 
substrate, [3H]fetuin, at varying concentrations (legend of Fig. 2.5) 
in 0.05M sodium acetate buffer, pH 5.1. 50 pi of reaction solution was 
removed at 15 min intervals and dispensed into centrifuge tubes at 4 
containing 100 pi of 10Z PTA. This was rapidly mixed, centrifuged and 
the radioactivity of the supernatant determined as previously described 
(Fig. 2.5). This assay procedure has been used where Interfering 
chromophores hampered the Warren assay.
2.1.2 Radioimmunoassay (RIA)
2.1.2.0 Purification of colomlnlc acid
The further purification of the commercially available colomlnlc acid 
(see Fig. 2.11 for structure) was an adaptation of the methods of Barry
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(1958), Kimura (1966a), Uchlda (1973)and Alhadeef (1978), The colomlnlc 
acid (1 gm) was dissolved In 8.0 ml bicine buffer, (8.0 ml) pH 8.0 
containing 0.1M magnesium chloride, and to this was added rlbonuclease 
A (0.8 ml, lmg/0.lml) and allowed to react for 12 hr at 21 . This was 
followed by the addition of deoxyribonuclease 1 (lmg/ml) and allowed to 
react as above. Pronase was then added after 12 hr and the digestion
tallowed to proceed for a further 16 hr at 37 . The solution was then 
made 90Z with ammonium sulphate at pH 8.0 and left for 6 hr at 21 . 
This was then centrifuged for 2 hr at 15,000 rpm x g, the supernatant 
carefully removed and then dialysed, in spectrapor membrane tubing with 
a mol. wt cut off of 6,000-8,000, against 0.001M sodium phosphate 
buffer, pH 7.4 (6 x 5 Its), after which the non-diffusible material was 
lyophilized. The freeze dried material was made up to a concentration 
of 30Z (w/v) in 0.02M sodium acetate buffer, pH 4.0, and then 
fractionated with ethanol at -10* (0-75Z fractionation) and allowed to 
stand for 2 hr at -2(? . The solution was centrifuged as above at -20* 
and the resulting precipitate extensively dialysed against 0.001M 
sodium phosphate buffer pH 7.4 and the dialysis residue lyophilized. 
Yield - 33%.
2.1.2.1 Sizing of colomlnlc acid (generation of the hapten)
Purified colomlnlc a d d  (250 mg) was dissolved in 16.0 ml of 0.05M NaOH 
and left overnight at 21 (Kimura 1966b). This was followed by dialysis 
as previously described and lyophilized.
The colominic a d d  was dissolved in 9.0 ml water to which was added 1.8 
gm Dowex 50 - x 8[H'tl and allowed to hydrolyse for 16 hr at 5cf . The 
hydrolysate was spun clear and freeze dried. The material was
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resuspended In 300 pi 0.001M sodium phophate buffer, pH 7.4 and applied 
Co a column (1.2 x 45 cm) containing Bio-Gel P-2 (fractionation range 
100-1,800) pre-equilibrated with the same buffer. Fractions containing 
the colomlnlc acid polymers of mol. wt 100-1,800 namely the VI (VI - 
Internal volume within the gel particles) fractions were collected, 
these were freeze dried and applied to a Sephadex G-10 column (1.2 x 45 
cm) and the fractions containing the polymer size of 700-1,800 the (Vo 
fractions, Vo « void volume surrounding the gel particles) were 
collected and freeze dried. This fraction, the hapten, now having a 
chain length of 3 - 4 NANA units long, was conjugated to bovine serum 
albumin (BSA).
The time of 16 hr for the hydrolysis was determined from a trial
experiment In which samples were removed at hourly Intervals for 24 hr
and subjected to the above procedure. The Vo fractions from the
Sephadex G-10 column was split and one half subjected to 0.01M H2S04 
ahydrolysis at 80 and the NANA determined In both. It was found that 
at 16 hr 70Z of the colominlc a d d  had hydrolysed Into chain lengths 
of 3 - 4 NANA units and that 16Z was single NANA units, whereas at 24 
hr 58% was single NANA units.
2.1.2.2 Conjugation of the hapten to BSA (formation of the BSA-NANA 
conjugate)
The methods of Erlanger and Beiser (1964) and Butler and Chen (1967) 
were used with slight modifications.
The hapten (15 mg) was dissolved in 0.9 ml, 0.05M sodium acetate 
buffer, pH 5.0, to which was added 0.9 ml (75 pMole) sodium meta 
periodate and allowed to react In the dark at 21 (and 200pl samples
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were removed for Che trial experiment at 0 - 9 hr)« After 1.8 hr the 
reaction waa stopped by the addition of 4 pi 1.0M ethylene glycol« 30
was added and the pH adjusted to 9-9.5 and stirred for 1 hr. Sodium 
borohydrida (273jil. 15 mg/ml ) was added and set aside for 18 hr. The pH
BSA-hapten conjugate was precipitated with saturated ammonium sulphate 
In phosphate buffer« pH 8.0 (0-70Z fractionation) and left overnight at
precipitate dialysed extensively against 0.001M sodium phosphate buffer 
pH 7.4 and freeze dried. The oxidation and conjugation times of 1.8 and
1.0 hr respectively giving the maximum attachment of hapten onto the 
BSA, 392« was achieved by trial experimentation which was performed as 
above but with proportionately reduced samples (Fig. 2.6).
min later 0.273 ml BSA (28 mg/ml at pH 9-9.5 adjusted with 5Z K2 >
was readjusted to 8*5 with 1M NH40H and stirred for another hour. The
4* • This solution was centrifuged at 15,000 rpm x g for 30 min and the
70
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were removed for Che Crlel experiment it 0 - 9 hr)» After 1.8 hr the 
reaction was stopped by the addition of 4 pi 1.0H ethylene glycol, 30
was added and the pH adjusted to 9-9.5 and stirred for 1 hr. Sodium 
borohydrlde (273jil, 15 mg/ml) was added and set aside for 18 hr. The pH
BSA-hapten conjugate was precipitated with saturated ammonium sulphate 
In phosphate buffer, pH 8.0 (0-70Z fractionation) and left overnight at
precipitate dialysed extensively against 0.001M sodium phosphate buffer 
pH 7.4 and freeze dried. The oxidation and conjugation times of 1.8 and
1.0 hr respectively giving the maximum attachment of hapten onto the 
BSA, 39Z, was achieved by trial experimentation which was performed as 
above but with proportionately reduced samples (Fig. 2.6).
min later 0.273 ml BSA (28 mg/ml at pH 9-9.5 adjusted with 5Z *2 C0? )
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2. 1.2. 3 Imnunizatlon
A sheep was Injected over a three month period with a total of 2.0 mg 
BSA-(NANA) conjugate, suspended in phosphate buffer and emulsified in 
Freunds Complete Adjuvant to a total concentration of 1 mg/ml. Fifteen 
days after the primary Intramuscular injection, the sheep was boosted 
with 200 pi of antigen in complete Freund Adjuvant at multiple sites. 
Seven days thereafter a trial bleed was obtained. Injections were 
repeated every two weeks and bleedings obtained at Intervals of seven 
days. A control bleed was obtained before the primary injection. Blood 
collected from the challenged sheep was allowed to clot overnight, the 
serum decanted and centrifuged (15,000 rpm x g) for 30 min at 5 . The 
antiserum obtained was subjected to various immunological tests.
2.1.2.4 Immunodiffusion
The double diffusion technique of Ouchterlony (1953) and Milford-Hard 
(1977) was carried out on glass slides, 8 x 8  cm, coated with 9.6 ml 1Z 
agar (electrophoresis grade) in phosphate buffer pH 7.1. The wells were 
loaded as described in the legend of Fig. 2.7 and allowed to develop at 
21 in a moist chamber for 36 hr • After this the gels were washed, 
dried, stained and destained as described (Ouchterlony & Nilsson, 
1979). The precipitation lines produced by these secondary reactions 
appeared only between 70 and 90 days after the first immunization.
2.1.2.5 Equilibrium dialysis
Prior to equilibrium dialysis, the antibody (Ab) was purified by the
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methoda of Hold* and Schwlck, (1979) and Allanat al., (1977), and 
lta purity Judged by PACE. A a sail amount of IgA vaa found In the major 
IgG active fraction.
The equilibrium dlalyals was carried out In an apparatile alnilar to 
that deacrlbed by Neuhoff and Klehl (1969) (Pig. 2.8).
f l f .  I  t  . Section through the maim body of tko 
«poilikrioa cioljrsio appproto».
Compartmenta A A B each with a capacity of 450 pi were separated by a 
dlalyals membrane. The exact constituents of these compartmenta are 
described below, but the compartment A will elwaya contain the hapten 
(labelled or unlabelled) or the ensyme while compartment B will always 
contain the antibody except where equilibration tine controla are run. 
Controla, as each point In the following experiments were set up la 
triplicate, with 10 pi of labelled*^ NANA (245 a  Cl/nM diluted 1/100 ) 
but without Ab's la compartment B. The radioactivity of each 
compartment was determined by counting the contents of both 
compartments using Triton X-100 butyl PBD as scintillant.
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2.2.5.0 The determination of the binding capacity of the antibody by 
equilibrium dialysis
Each compartment A (1-16) contained 10 pi of labelled'4C NANA plus 445 
pi of PBS. Compartments B contained 0-300 pi of antibody (lmg/ml) In a 
final volume of 450 m Is PBS. This was allowed to equilibrate while 
rotating at 4 for 44 hr (total equilibration time) after which the 
radioactivity of each compartment was determined as previously 
described (Fig. 2.9).
2.1.2.5.1 The competition assay for sialic acid with the aid of 
equilibrium dialysis (development of a diagnostic plot for the 
slalldase activity)
Compartments A (1-16) contained 10 pi labelled 4C NANA and varying 
concentrations of unlabelled NANA (0-50nMoles) while compartment B 
contained 250 pi of the Ab solution. The differences in volume were 
made up to 450 pi with PBS. This was allowed to equilibrate and the 
activity determined as above (Fig. 2.10).
A similar assay was set up with the following sugars, N-acetylgalacto- 
samine, N-acetylglucosamine, D- mannose and 0-glucose In place of the 
unlabelled NANA.
2.1.2.5. 2 The radioimmunoassay for slalldase
Slalldase of unknown activity was incubated at 37 in the appropriate 
assay buffer with the substrate fetuln (ca 400nM). At set Intervals 
(0-24 hrs) 10 pi was dispensed into compartment A containing 10 pi of
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14C NANA and 430 pi of PBS while compartment B contained 250 pi Ab and 
200 pi PBS. This was allowed to equilibrate and the radioactivity 
determined as above. The decrease in the amount of radioactivity bound 
to the Ab is equivalent to the amount of unlabelled NANA released from 
fetuin by sialidase. and this amount is determined from the diagnostic 
plot as previously set up (Fig. 2.10) which is then converted to enzyme 
units.
2.1.3 The Determination Of Bound Sialic Acid (with the use of 
equilibrium dialysis and sialidase)
In this procedure (experimental detail see legend of Fig. 2.11), the 
sialic acid containing macromolecules are allowed to incubate at 21° for 
2 hr with the sialidase (specific activity 47u,50 pi) in compartment A 
and then allowed to equilibrate for 30 hr with Ab, before 5 pi of14C 
NANA is added and allowed to equilibrate for a further 44 hr and then 
the radioactivity determined as previously described (Fig. 2.11).
2.2 Results And Discussion
The Radioactive Assay For Sialidase
By controlling the periodate oxidation time during the synthesis of the 
tritiated fetuin substrate for the radioactive assay, we were able to 
achieve maximum labelling (104Z) at C—8 of the NANA unit in fetuin 
Instead of the C-7 NANA analogue which is not hydrolysed by sialidase 
(Suttajit, 1970). The 104Z labelling at C-8 indicating no labelling at 
C-7 is questionable as the periodate oxidation is probably not 
sequential (Table 2.1).
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Toble 2.1
Determination O f  Spacific Activities O f  Hydrolysis Product (N A N A ) V lo A cid And Encymlc Released From
TKs Substrata»
Specific Activities O f  Substrate» And Product (N A N A )
Substrate, Product Specific A ctivity  (Ci/mMol)
Fetuin(s) 332
3H N A N A  (Acid hydrolysis) 24
N A N A  (Enzymic hydrolysis) 23
However, this substrate proved reliable in that a proportional linear 
response in the release of product over a period of time (0-60 min ) at 
various substrated concentrations and fixed enzyme concentration was 
achieved (Fig. 2.5).
I n >  m y in s C M M M t a .  d  M lh M  h u l a  m C
o — —  O , 90 p molwj A— — A  , 180 p moI«V
'  360 p mol«;
.TJOpmUmv
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Fur Char» w  could detect enzyme activities as low as 2 x 10 units and 
reproduce this result and results within the range of ? x 10*to 16 x 10* 
in a linear fashion. This assay methodt rapid and inexpensive. Is very 
much more sensitive than the Warren assay and is not hampered by 
chromophorlc substances, commonly associated with the Impure enzyme 
solution, which Interferes with the spectrophotometric method. It also 
does away with the unneceaary, time-consuming chromatographic and 
dialysis procedures normally accompanying radioactive assays
(Bhavanandan et al., 1975 and Schauer, et al., 1976). Thus this 
assay fits the criteria of a good enzyme assay In that it can detect 
enzyme activity at low concentrations and accurately reproduce these 
results, a hallmark not attained by many of the radioactive assays for 
sialldase.
The Radioimmunoassay For Slalldase .
The authenticity and specificity of the BSA-NANA antiserum was tested 
by primary (equilibrium dialysis) and secondary (immunodiffusion) reac­
tions.
Iomu nod if fusion carried out with the antiserum cross reacted with sia­
lic a d d  containing macromolecules such as spec Id glycoprotein, fetuln 
and mucin but once these sialic adds were enzymically removed from 
these macromolecules, this phenomenon disappeared, indicating the 
existence of antibodies specific for sialic a d d  (Fig. 2.7).
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F ig . 2 .7  ( I )  Immunodiffusion of italic acid containing moctomolcculcc
and B A
( I I )  Immunodlfhieian of destalyilatad mocramolaculcc (from 
above) and IS A .
W all A  contained Iho B S A -N A N A  anH tanim (30 p i)
W a lk  I A  5  contained B A  (10 pi of a SmgAnl solution)
W all 2 contained ftiu in (10 pi of 20tngAnl solution)
W a lls  contained e  -a c id  glycoprotein (10 pi of 20mg/ml solution)
W a l l «  contained fetuin (10 pi o l 20m ^m 0+ N A N A  SO pg)
W ell 6 contained destalyilated feluln (20tag^ml)
W ell 7 contained destalyllatad a, acid glycoprotein (20ta^m l)
W ell • contained dmtalyllated fetuin (10 pi of 20n®'nsl) ♦ N A N A  SO ug
Destalyllatlon was carried out by Incubating each sialic acid-containing macro- 
molecule (lOOtng) with V .  choleroe siolidoso (10 O) In amay buffer for 24 hr at 
4° . This war then extensively dialysed, lyaphiltzed and retuipendod in PtS 
(2an^ ml)
Definitive evidence for the presence of NANA specific antibodies was 
obtained by equilibrium dialyls.
»1#.*.*  The btedUg of she fcoptse, *^ C NANS ly  mtytng esmsmsattae W entlta# srfviico .«■ etaWWta. «M yth. h pmtacmel 4n*i
In mi
6F ig . 2 .7  (I ) Immunodiffusion of  siollc acid contoining mocromolaculas
and BSA
(U ) Immunodiffusion of dosfalyilatod mocromolaculas (front 
abovo) and BSA.
W all A  contoinad tfaa BS A -N A  N A  anH larum (30 p l)
Walls I & S contoinad BSA (10 yl of a Sm&'ml solution)
W all 2 contoinad fatuin (10 pl of 20m ^m l solution)
W all 3 contoinad ^  -o c id  glycoprota in (10 pl of 20m ^m l solution)
W all 4 contoinad fatuin (10 pl of 20m ^m l)+ N A  N A  50 p g )
W all 6 contoinad doslalyl latod fatuin (20m ^m l)
W all 7 contoinad dosialyllotod a, ocid glycoprotaln (20m ^m l)
W all 8 contoinad dosiolyllatad fatuin (10 pl of 20tng^ml) ♦ N A  N A  50 pg
D os ialyl lotion was carriad out by incuboting a oc K siollc acid-containing mocro- 
molacula (lOOtng) with V .  choleroa sîolidosa (10 U ) in assay buffar for 24 hr ot 
4 . TMs was than axtcnsivaly dialysad, lyopbilizad and rasuspondod in PBS 
(20m^ ml)
Definitive evidence for the presence of NANA specific antibodies was 
obtained by equllibrlua dialyls.
Fig. 2.9 shows that with increasing antibody concentration, Increasing 
radlolabelled14C-NANA is bound. This strong binding capacity was not 
present in the preimmunizatlon serum; it was a .property of the 
immunoglobulin fraction of the antiserum. This specificity was further 
confirmed by observing a decrease in the amount of la belled*^-NANA 
bound to the antibody with increasing concentrations of unlabelled NANA 
(Fig. 2.10).
F r a «  « 5 . 0  « M  raAjtràn of ra%lob.lU 0 N A N A  o l t o o l t  (0 -  10  p i) .rara  d h p .nra d  Ira »  Camprafnrara A  «0  Ih*  ««*11 Ibrfcra 
dlolvM s r a . . M  . A i d .  . I r a  c o o n lira d  IO  p i o l " c  N A N A  (1/100 d ilu tlo » ) <rad Ora « r a d  « I r a »  <0 P K  H  g ira  .  
total volumo o f 4 5 0 p i .  Comportino»* • conlolnod 250 p i o f A b  «olution and 200 p i P K .  Ibis syslem wee ellowed le  
e quilibrale  far 44 hr « b i le  rototin g  a l 4 °  after uditali I t a  rodlooctlvity af die  «oluttans la  eacfc camporbu o a l «me d eter- 
m ined ae de t r ib ed la  die  «e o i.
The inhibition of binding by unlabelled NANA has formed the basis of 
the radioimmunoassay for slalidase, the enzyme releasing the sialic 
a d d  which competes with the C-NANA for the limiting binding sites on 
the BSA-NANA antibodies. With this assay unlabelled NANA In the pico
molar range could be detected and with the aid of the diagnostic plot,
_2It was possible to determine enzyme activities at l i 10 units (Fig.
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2.10).
No inhibition of labelled hapten binding was observed in the 
presence of the sugars tested. This inhibition was the major 
disadvantage of our previous attempt (Kabayo, 1978) and also 
that of Smith and Ginsburg (1980). The reason for the success 
of eliminating this inhibition, we think, lies in the fact that 
the NANA units were linked directly to the BSA molecule, there­
by excluding the intermediate polysaccharide chain which normally 
binds the NANA molecule to the protein backbone as seen in 
the structures of fetuin ¿Fig. 2.11 (v)_/ and the sialyl-
lactose ¿Fig. 2.11 (i\J used by Kabayo (1978) and Smith and 
Ginsburg (1980), or the antibodies could be heterologous in 
nature. There is, however, a disadvantage associated with 
our method, which is its low titre. Although it is known that 
sialic acid generates a poor immune response (Simons & Rios,
1971; Simons et al,, 1971 and Hinzler, 1970), we suspect that 
by binding the N A N A  unit through the polyhydroxy side chain, we 
possibly reduced the response even further as the polyhydroxy 
side chaip could be one of the antigenic determinant sites on 
the N A N A  molecule (Lisowka a Roelcke, 1973).
One bonus to develop from the basis of this assay is its 
capability to determine the mole to mole ratio of the number 
of NANA units per sialic acid containing macromolecule 
as was done for fetuin and a^-acid glycoprotein (Fig. 2.12).
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F ig . 2 .1 2  Kodloimmunoomoy (D iognotfic p lo t) for H w  do lunwinotion o f Iho number of moloo o f N A N A  per molo of sialyl compound v ia  e q u ili­
brium dialysis.
O f  a  0 .7  p M  solution of e xtensively dialysed fetuin o r q  -a c id  glycoprotein in  PBS, 0 ,  5 ,  7 J  and 10 pis were dispensed into Compartment A  
of the equilibrium  dialysis u nit to  w hich was added lO p I  (0 .6  U u t f o f  V .  choleroo siolidoso. Comportment • contained either 30 . 75 or 
100 pi antiserum in  P B .  The final volume in  each comportment was 450 p i .  A fter 30 h r , 5  p i of 1/100 **C N A N A  was added to C a n p a rt -  
ment A  and the system allow ed to  oquilibrate far 44 h r and the radioactiv ity  determined In each compartment. Control comportments contained 
PBS and * C  N A N A  o n ly .
0 — 0  in  ohsonco o f unlabelled N A N A
a — a  i .  |m m .  W a l M  “ C  N A N A  mmd » I M M  N A N A .  A --------------- A  b  I t »  adduct of I t »  hound “ C  N A N A  (d p o . O --------- O )
In d u r a  of u n lo M lo d  N A N A  * Gabon) I t »  « a u n t  o f bound " C  N A N A  In  ^oconco o f c o ld  N A N A  (  Q  ■ )
With greeter cere,increased controls and sialldase of high specific 
activity the nole to mole ratio of NANA bound by fetuin was determined
to within 5-10Z of the reported value (Bucher & Palese, 1975) while
that of a,-acld glycoprotein was with 15-25Z (Bucher & Palese, 1975). 
Therefore with this method the mole to mole ratio can also be
determined for biologically important molecules, such as interferon 
which, if pure, is available in only very small amounts (Morser et
al., 1978).
In view of the increasing number of diseases associated with slall- 
dases (Chapter 1). an assay as effective as the radlolmaunoassay system 
is long overdue. Our RIA. though effective down to 10"* units, requires 
an improvement in the specific activity of the radlolabelled^C NANA and
t
Che antibody Citre as well as a reduction in the assay time. However, 
despite these difficulties, the accuracy (delivered by equilibrium 
dialysis) in determining low levels of sialidase activity in plasma and 
biological fluids in close contact with diseased and/or infected organs 
and in which sialidase plays an primary role, is still possible with
this radioimmunoassay
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CHAPTER 3
PURIFICATION OF SIALIDASES
3.0 Introduction
The purification of bacterial sialidases has followed the time 
honoured, standard lines of approach for protein purification; thus, 
with the exception of affinity chromatography, very little change has 
occurred in the basic methodology in recent years, as can be gathered 
from table 3.0.
Because the majority of bacterial sialidases are extracellular enzymes,
inducible and stable for long periods at the purification temperatures
• ,[ 4 - 8 ] ,  (Ada & French, 1959 and Ada et al., 1961), it would appear 
to be the easiest to purify and should, theoretically, yield a pure, 
stable enzyme as opposed to the unstable and often impure preparations 
of viral or maimiallan enzymes which are normally membrane associated.
After removing the cells, the basic procedure in purifying soluble 
proteins such as the bacterial sallldases normally follows the pattern 
described below in which each step exploits a certain protein 
characteristic.
The first stage in purifying these enzymes involves concentrating the 
large volumes of culture filtrate. The most common method Involves salt 
fractionation (ammonium sulphate), which has been used by Rosenberg ■et 
al., (1960), Cassidy et al.. (1965, 1966), Balke and Drzeniek (1969) 
and Schramm and Moore (1959) for the concentration of the culture
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flltrate containing tha slalldase. Ultrafiltration, a fairly recant 
technique In large scale preparation of proteins, has' now become the 
method of choice over salt fractionation as a concentration procedure« 
Uchlda et al. (1977) have been the only group so far to use 
ultrafiltration as a concentration step for culture filtrate containing 
slalldase.
The second stage In the purification of soluble proteins normally 
Involves Ion exchange chromatography. The principle feature /underlying 
this form of chromatography la represented In fig. 3.0 and 3.1.
i •  he separate* ^ C r a M S i M
Fig. 3.0 FrineipU*#
In tha purification of slalldaees, Ion exchange chromatography has been 
a popular choice by the researchera listed In table 3.0t It has been
70-
best exploited by Kunimoto et el. (1975) (Fig. 3.2) In the 
purification of S. grlaeus slalldase because this enzyme has a very 
high pi (7.9-8.0), which Is far above that of most proteins.
F ig  3l2 H u  n»t chare« of S . a r liw i ilolld—  ai a h n c t lw  r f  
p H . 1 h  pH rang** In which Hw onzymo It bound to 
anion and cation axchangon (Kunlmoto at a l . t 1973).
The latter stage Is often followed by gel permeation chromatography. 
The principle la founded on the separation of molecules on the basis of 
their molecular size and shape and It utilizes the molecular sieve 
properties of a variety of poroua materials. The popular choice of gel 
for slalldase purification la Sephadex G-100, which has a fractionation 
range (molecular weight) of 4,000 to 150,000, within the molecular 
weight range of the bacterial slalldasea. This procedure was used as a 
final purification step by Vertlev and Ezepchuk (1972), von Nicolai and 
Zillken (1972) and Kunlmoto et al. (1975).
Some authors chose affinity chromatography (Fig. 3.3) as a final step 
In the purification of the ensyme. The purification of a macromolecule 
by affinity chromatography exploits Its most unique property, namely 
biological specificity. In the case of an enzyme. Its three- 
dimensional structure Is such that the active site and regulatory
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slte(s) arc accessible to only a snail number of compounds (ligands) 
which say be either substrates or effectors of a reversible or 
Irreversible type« It Is this specific recognition of these sites which 
foras the basis for affinity chromatography of ensymes. Purification Is 
possible provided that the affinity of the site for the ligand Is high, 
that the binding Is reversible, and that at the experimental condltlona 
chosen no reaction occurs after the ligand Is attached to the site.
F ig .  3 .3  Diogram m otic Illustration of the principle  c f  afR u ily  
chromatography
Three strands o f tho cross! Inked polymer matrix ere shawm. The 
spacer asm is showm in bold , attaching tho lig a ra  (she sea) to  tho 
polym er m atrix . Various ro ughly globular protein m oiaculas era 
shewn diffusing between tho strands of tho poly—e r bu t o n ly  tho 
enzym e molecules (shaded) have a  binding silo far tho lig an d . 
O n e  enzyme m olecule is shown actually binding to tho immobi­
liz e d  lig an d . N o te  that the attachment o f If  send to  tho spacer 
ana is mode a t  o  point wharo there is no interaction w ith  tho e n ­
zym e.
Basically, Che technique conelsta of covalently attaching the ligand, 
(which la normally a reversible competitive Inhibitor or substrate), to 
a suitable Insoluble matrix In such a way that Its potential for 
combination with the enzyme Is not Impaired (Fig. 3.4).
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F ig .  3 .4  Sown possible synthetic routes for the ottochment of the 
lig a n d  to  a g o ra #  o r Sopharose. R Is the lig an d  to  w hich  the m a e - 
rom olecule w ill b ind and W S C  Is e  w ater-soluble  ccrboalim ide.
F o r  s im p lic ity , reaction a t o n ly  one of the h yd ro e yl groups is indi­
ca te d .
A solution of the impure enzyme is then applied to a column of the 
liganded-matrlx immersed in the correct buffer medium and the enzyme is 
selectively retained. Impurities which are not bound are eluted and the 
enzyme is subsequently displaced by elution with a solution of the 
substrate, or any compound which haa a higher affinity for the enzyme 
than the ligand, in a medium of different pH and/or ionic strength.
Affinity chromatography applied to the purification of bactorlal 
alalidasea haa seen the use of substrates, such as «¡-acid glycoprotein 
(Gelsow. 197S). colomlnic acid (Uchlda at al. 1977) and fatuin 
(Kabayo & ftitchlnson. 1977), the product NANA (Holmquist & Ostman, 
1975) and inhibitors of no structural resemblance to the substrate or 
product, such as N-(p-aminophenyl) oxamic acid (Cuatrecasas & 
Illiano, 1971) and N-(A-oltropheayl) oxamic acid (Brossmer at al, 
1977), as ligands attached to a solid support. Spacer arms wars used 
whan NANA and the inhibitors warm used as ligands. Most of these
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afflnity columns have displayed specific adsorption except that of 
Cuatrecasas and Illiano (1971), in which contaminating proteins also 
adhered»
Many unsettling reports have appeared in the literature questioning the 
purity of the bacterial alalidases as prepared by the aforegoing 
procedures. For example, immunologically distinct sialldase and the 
toxin of Corynebacterlum dlptheria have been found by Moriyama and 
Barksdale (1967) to move together on CM-cellulose and, presumably, to 
have similar molecular weights. Commercial preparations of sialldase, 
made according to methods similar to those described above, have been 
further purified by ion-exchange chromatography (Hatton & Regoeczl, 
1973) to remove proteases, and an earlier study has described (Kraemer, 
1968) the presence of cytotoxic, haemolytic and phospholipase (White & 
Mellanby, 1969) activities still remaining in commercial preparations 
of slalidase from C. perfrlngens prepared ostensibly by a method 
similar to that described by Cassidy et al., (1965). Rood and 
Wilkinson (1974), Huang and Amlnoff (1974) and Den et al., (1975) 
pointed out that the enzyme preparation purified from the culture 
filtrate of C. perfrlngens by means of Cuatrecasas's affinity column 
still contained a number of other enzymes and toxins.
As our research centred on the comparison of the active site of 
pathogenic and non-pathogenlc sialidasea, it was essential that the 
enzymes, to be compared, were completely free of contaminating proteins 
or polysaccharides.
Our Initial method of purification was that of Kunlmoto et al., 
(1975). We found that this procedure yielded small amounts of Impure 
enzyme and was therefore still unsatisfactory. By including an affinity
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sCep using either the ■ -acid glycoprotein or fetuin-bound matrix, the 
resultant enzyme solution displayed new low molecular weight protein 
bands on SDS- polyacrylamide gel electrophoresis (PAGE). We suspected 
that low levels of contaminating proteases in the still impure 
slalidase solution were digesting the protein ligand. When we used the 
N-(4-nitrophenyl) oxamlc acid affinity column of Brossmer et al., 
(1977) we achieved an improvement in the purity of the enzyme but still 
more than one protein band was present in the analytical polyacrylamide 
gels.
Because of the above reasons, a new method of purification was 
investigated to improve not only the purity but the yield and rate of 
purification. Conditions selected were of such a nature that it could 
be used for all three enzymes, namely S. grlseus, C. perfrlngens 
and V. cholerae sialldases.
3.1 Experimental Procedure
Calcium phosphate gel was prepared by the method of Kellin and Hartree 
(1938). The Amicon Matrex Blue A and Red A were activated by washing 
with 4 bed volumes of 8M urea, 0.5M sodium hydroxide followed by 40 bed 
volumes of loading buffer, namely 0.05M sodium acetate buffer pH 5.0. 
The preparation of the N_-(4- nltrophenyl) oxamlc acid coupled via 1,6 
dlaminohexane to Sepharose 4B (NNP0A-AHS4B) was prepared by the methods 
of Aschan (1885), Marcus and Balbinder (1972), Cuatrecasas (1970) and 
Brossmer et al., (1977). Fetuin was purified from foetal calf serum
via the method of Spiro (1960)
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3.1.0 Isolation Of Slalldase From The Cell Culture (S. grlseus)
S. griaeus MB395-A5 (obtained from The American Culture Collection) 
wa8 agitated under aerobic conditions as previously described by 
Augustus (1977) and Kabayo (1978). The culture fluid containing the 
slalidase was separated from the cells after 72 hr , by filtration 
under vacuum through a buffer-washed Cellte 545 bed on an 18.5 cm 
Greens Hyduro filter paper. After filtration, the bed was washed with 
0.01M sodium phosphate buffer pH 7.0 and 0.025M potassium chloride. The 
cell free culture filtrate was adjusted to pH 7.0 with l.GM sodium 
phosphate buffer and EDTA was added to a concentration of 0.05 Molar.
3.1.1 Ultrafiltration (UF)
Selective ultrafiltration was carried out in a ChemLab C2L (which had 
been modified to a 10 litre capacity), stirred ultrafiltration cell 
fitted with an Amicon XM50 ( 50,000 mol. wt cut off) ultrafiltration 
membrane. Ten litres were introduced into the cell and the system 
pressurized with air (50 p.s.i.). After concentrating the first 10
litres, the remaining 7.0 litres were concentrated and finally washed 
with 1.0 litre 0.001M sodium phosphate buffer pH 7.0. The
non-diffusible material, precipitate A, was assayed and discarded while 
the filtrate 1 was reintroduced into the ultrafiltration cell, this 
time fitted with a G10T (10,000 mol. wt cut off membrane). The 
resultant eluate 11 was assayed and discarded, while the precipitate B, 
retained in the cell, was resuspended in 1.0 litre of 0.001M sodium 
phosphate buffer pH 8.0 and dlaflltratlon (DF) was carried out with a 
further 5.0 litres of the latter buffer [Fig. 3.4(1)].
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Culture mediom
1
Filtrate
Ultrafiltration 3
Preclpotote A 
(Discarded)
Eluate II 
(Discarded)
Eluate 1
»
Ultrafiltration 4
Precipitate B
I 5
1 Culture medium was filtered 
through a buffered Celite 
545 bad.
2 Adjusted to 0.01 M sodium phos­
phate buffer, pH 7.0 and 0.025M 
KCI
3 Using a 50.000 m.wt. cut off 
membrane
p .s.i. * 50, flow rats/h * 800 ml
4 Using a 10.000 m.wt. cut off 
membrane. The concentrate 
was washed extensively with 
0.001M sodium phosphate buffer 
pH 7.0.
p .s .i. -  50, flow rat^h 3 600 ml
5 Lyophilized, resuspended in 0.001M 
sodium phosphate buffer, pH 8.0 and 
adsorbed to calcium phosphate
Fig 3.4(i) The initial steps in purification of S. grise us sialidase by ultrafiltration through a 
series of graded ultrafiltration membranes
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3.1.2 Calcium Phosphate Gel Treatment
The precipitate B, resulting from the concentration-dlaflltration 
procedure, was dissolved in 0,001M sodium phosphate buffer, pH 8.0 and 
stirred with calcium phosphate gel (ratio of wet gel to protein, 50:1). 
After 1.0 hr stirring at 4* , the suspension was spun for 10 minutes at
10,000 x g and the gel precipitate retained. This was then suspended in 
20 ml 0.05M sodium phosphate buffer pH 8.0, allowed to stir for 30 min 
then centrifuged as above. The supernatant was discarded (for S. 
grlseus slalldase preparation only) and the gel precipitate
9resuspended in 0.4M sodium phosphate buffer at 21 and stirred for 30 
min after which it was spun again. The supernatant was retained. (The 
trial experiment of adsorbtlon and desorbtion is elaborated upon in the 
legend of fig. 3.5). The supernatant from the above was diafiltered 
with 0.05M sodium acetate buffer, pH 5.0 in an Amicon ultrafiltration 
cell 52 fitted with an Amicon PM10 (10,000 mol. wt cut off membrane).
3.1.3 Affinity Chromatography On Amicon Mat rex Blue A: (Affinity 
Column 1)
Prior to the use of the Matrex Blue A as an affinity column, inhibition 
studies were carried out with the ligand namely F3GA (reactive blue). 
(See legend of fig* 3.7 for method and fig. 3.6(1) for F3GA structure).
The concentrate from the previous step (Ca3(P04^ step) in 0.05M sodium 
acetate buffer, was applied at a flow rate of 0.3 ml per minute to a 
chromatographic column (1 x 14 cm) containing the Amicon Matrex Blue A 
equilibrated with the same acetate buffer. After the sample was applied 
and allowed to equilibrate at cero flow for 1 hr , the column was 
washed with the loading buffer until a xero absorbance reading was
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obtained at 280nm. The affinity column was then charged with a stepwise 
gradient, of l.Ot sodium chloride in acetate buffer, followed by a 1.5M 
sodium chloride acetate buffer« The enzyme containing fractions were 
diafiltered as above with 0,05M sodium acetate buffer pH 5.0. The trial 
experiments with Blue A and Red A are expressed in the legends of fig. 
3.8.
3.1.4 Affinity Chromatography 11 On NNP0A-AHS4B
As in the case of Matrex Blue inhibition studies were carried out with 
NNPOA (see legend of fig. 3.10 for method).
The diafiltered concentrate from the above stage was applied to the 
NNPOA-AHS4B affinity column (3 x 22 cm) previously equilibrated in
0,05M sodium acetate buffer, pH 5.0. The flow rate and the washing
procedure was similar to the Matrex blue affinity column. After
achieving zero absorbance at 280nm a stepwise gradient was applied
using 1.CM sodium chloride in acetate buffer. (See legend of fig. 3.9). 
The enzyme containing fractions was extensively dialysed against 0,001M 
sodium phosphate buffer pH 6.8 and then concentrated.
Hydroxylapatlte Column Chromatography
The enzyme solution was loaded onto an hydroxylapatlte column (1.4 x 26 
cm) and washed until zero adsorbance at 280nm was achieved and then 
eluted with a linear gradient of 0.05M to 0.8M sodium phosphate pH 6.8 
(Table 3.1).
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The commercial preparation of C. perfringens was further purified via 
Calcium phosphate gel, Amlcon Hatrex Blue A, NNP0A-AHS4B affinity and 
hydroxylapatlte column chromatography. The elution of C. perfringens 
sialldase from calcium phosphate occurred in one step using 0.3M sodium 
phosphate and the elution from the Amlcon Matrex Blue A was with 1.0M 
sodium chloride In acetate buffer (see figures and legends of Fig. 3.5,
3.8 and 3.10).
The V. cholerae slalldase obtained from Burroughs Welcome was further 
purified via Amlcon Matrex Blue A, NNP0A-AHS4B affinity and 
hydroxylapatlte column chromatography (Fig. 3.11). The elution of the
V. cholerae from NNPOA--AHS4B was a two step elution of 0. 8M NaCl and
1.2M NaCl, which gave rise to V. cholerae sialidase 1 and V«_
cholerae sialidase 11. The 1 and 11 enzyme fractions were loaded
separately onto the hydroxylapatite column as described previously and 
eluted via a stepwise gradient of 0.4M and 0.5M sodium phosphate, pH
6.8 (Fig. 3.11).
3.1.6 Molecular Weight Determination
3.1.6.0 By Polyacrylamide gel electrophoresis (PAGE)
The molecular weights of the slalldases were determined by SDS- 
polyacrylamide (10Z) gel electrophoresis using the method of Weber and 
Os borne (1969): 15pg - 100 pg of enzyme was loaded per gel. The BDH 
molecular weight markers compromising a mixture of oligomers ’of 
molecular weights in the range 14,300-85,000 were used as described by 
the manufacturers (BDH handbook 1979). After electrophoresis the gels
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were stained with Coomassle blue and destained by diffusion (Weber & 
Osborne, 1969) [Fig. 3.12 (i + ii) and Table 3.2].
3.1.6.1 By gel permeation chromtography
The molecular weight of the sialldases were also determined by gel 
filtration on a Sephadex G-100 column (2.2 x 50 cm) following the 
procedure of Andrews (1965). The column was calibrated with five 
proteins of known molecular weight. Two milligrams of each of these
9
proteins (0.5 mg slalldase) was dissolved in 2.0 ml 0.1Z dextran and 
the solution eluted (40ml/hr) from the column with 0.2M phosphate 
buffer, pH 7.0, containing 0.05M potassium chloride, 4.0 ml fractions 
were collected. The elution volume of each protein was determined by 
monitoring the absorbance of the eluted fraction at 280nm. The elution 
peak of the slalidases were identified by its enzyme activity (fig. 
3.13).
3.1.7 Determination Of Enzyme Purity
The purity of the enzyme was determined by the method outlined for 
SOS—PAGE (Weber & Osborne, 1969), the only difference being that 15 fig 
aa well as 100 fig enzyme loads were run per gel (Fig. 3.121).
Assay of sialldase activity is discussed in Chapter 1.
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3.1.8 Assay Of Protease Activity
The protease activity was assayed according to the method of Sekine et 
al., (1969). The reaction mixture, containing enzyme preparation, 
distilled water and 1.5Z casein In Mcllvaine buffer, pH 6.0, was 
incubated at 37 for 10 min . The reaction was stopped by adding 3.0 ml 
of 0.44M trichloroacetic acid (TCA). The amount of TCA soluble material 
showing a positive reaction to the Folln reagent was determined 
colorlmetrically (Lowry et al., 1951).
3.1.9 Assay Of Other Enzyme Activities
The N-acetylneuramlnlc acid aldolase aclvity was assayed according to 
the method described by Comb and Roseman (1962). For the assay of phos­
pholipase C, the reaction conditions described by Pastan et al., 
(1968) were employed with egg phosphatidyl choline as substrate (Rood & 
Wilkinson, 1974) and phosphoryl choline liberated by this reaction was 
determined by the method of Lowry and Tinsley (1974).
Glycosidases were assayed according to the methods of Uchida et al. 
(1977).
Haemolyaln activity was determined as described by Geisow (1975).
3. 2.10 Protein Determination
Protein concentration was determined by the method of lowry et al., 
(1951) with bovine serum albumin (BSA) as a standard.
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3.2.11 Glycoprotein Detection
Gels fixed overnight in an aqueous solution, 40Z ethanol, 5Z glacial acetic 
acid (v/v) were oxidised with 0. 7Z periodic acid at roots temperature 
for 2 hr. The gels were rinsed with distilled water and treated with 
0.5Z sodium metabisulphite in SZ aqueous acetic acid for 1 - 1.5 hr. 
until colourless in order to destroy excess periodic acid, the gels 
were rinsed and to each tube was added an equal volume of acidic 
dimethyl sulphoxlde solution (0.60 ml cone. HC1/1 CMSO) and freshly 
prepared dansylhydrazlne solution (2 mg/ml DMSO). The tubes were 
stoppered, mixed and Incubated for 2 hr at 60 . The dansylhydrazine 
solution was poured off and a solution of NaBH4in DMSO (5 ml, 0.2 mg 
NaBH^ /ml DMSO was added to each tube and Incubated at room temperature 
for 30 minutes. The gels were then rinsed with distilled water and 
destained overnight in 1Z glacial acetic acid (v/v) with several 
changes (Eckhardt et al., 1976).
After destainlng, the fluorescent-labelled glycoproteins can be 
visualised with long range ultraviolet light.
A fetuln sample was tested in parallel with enzyme as a check on
procedures and, in certain cases, the gels were sliced longitudinally 
and stained simultaneously for protein and glycoprotein.
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3. 2 Results And Discussion
During the large scale preparation of this enzyme we endeavoured to 
improve the enzyme yield over the first concentration step, which 
originally involved an ammonium sulphate fractionation step which 
proved to be costly not only in expense but also in manhours; the 
batchwise technique appeared the most suitable. However, our attempts 
with various adsorbents such as DEAE-, CM-cellulose and C-G 30 ion 
exchange resins as well as calcium phosphate gel, showed no significant 
adsorbtion of the enzyme. With the advent of relatively cheap 
ultrafiltration cells which could be modified, we have been successful 
in not only concentrating and diafiltering the enzyme solution but also 
in removing 97Z of the contaminating protein with a loss of only 16Z of 
slalidase (Table 3,1), This has proved to be the most effective step in 
the entire large scale purification of S, grlseus sialidase.
When calcium phosphate gel was added to the concentrated enzyme, (S. 
grlseus), as well as the commercial C. perfrlngens enzyme solution 
in 0,001M sodium phosphate buffer, pH 8,0, we obtained a positive 
adsorbtion of the enzyme as opposed to the expected negative adsorbtion 
(Colowlck, 1955), It was found that this step proved essential for the 
removal of viscous material associated with S. grlseus sialidase 
which could not be removed as easily by our previous purification 
methods (Kunimoto et al,, 1974 and Kabayo, 1978) , Further, we could 
selectively remove contaminating protein with a lower affinity for 
calcium phosphate with 0,05M sodium phosphate, whereas the S. grlseus 
sialidase could be removed with 0,4M sodium phosphate. This same 
selective desorbtion could not be achieved with C. perfrlngens
sialidase, although the adsorbtion was selective. However, a 9-fold
Tabi* 3.1
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purification was achieved for the latter enzyme over that step (Table 
3. 1 and Fig. 3.5).
I
i
Moloriry sodium phosphate buffer, pH 8 .0
Fig. 3.5 The elution profile of S. emeus ( ) and C . ocr*ri-?cns ( — - — ) siolidcse from calcium
phosphate gel with increasing socium pncsphofe buffer concentration. Protein concentration (O — O ) ,  
specific activity ( ) ond co octivity <•‘— — '3
Residue B resulting from the S. oriscus culture filtróte, ofter UF and OF (see Table 3.1 for charge) wos 
suspended in 23 ml 0.001M sodium pnoschote buffer, pH 8 .0 , to this wos added cole turn phosphate eel 
(ratio of gel to protein, 50:1). The suspension, otter stirring for 1 hr ot 49 , was centrifuged ot the some 
femperoture ot 10,030 x g for 10 mins. The supernotont (S/N) w «  retained while the precipitated gel 
wos suspended in 20 ml 0.025M sodium phosehote buffer, pH 8 .0 . stirred for 30 mins, and centrifuged os 
above. Tiie S/N was ogoin Wept ond the precipitate resuspended in 0.05M buffer, stirred for 30 mins at 
4° and then centrifuged. This procedure of resusrension cf the precipitated gel in increasing concentra* 
lions of sodium phosphate, stirrinq, centrifuging ond retaining the S/N» and gel precipitates was contin­
ued up to concentration of 1.0M  sodium phosphate. The resultant S/Ns were diol>*sed against tlie essay 
buffer before determining tl>c eniyme specific octivity. T'*e some procedure wos adopted for t!*e further 
purification of the commercial preparation of C ■ perfringens sioiidase.
Since polyanionic substances such as sulphonated dyes inhibit siali- 
dases (Drzeniek, 1966), it was in our interest to investigate the 
cheap, commercially available Matrex Blue A and Red A which possess 
immobilized polycationic ligands Cibacron blue F3GA and Procion red 
HE3B [Fig. 3.6(1) and (11)] respectively, as a possible affinity column 
for sialldases. Inhibition studies carried out on V. cholerae 
sialidase with the ligand F3CA, revealed that it was a non-competitive 
inhibitor (Ki ■ 1.125 x 103M). (Fig. 3.7). When used as a purification
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step, the Metres Blue A wee as effective as Red A but required e lower 
salt concentration to remove the ensyne (Fig. 3.8).
i  buffer appJi«4 to • chremefogrophie
*• MW. T*: "^Jr*-1**M u  M  #M l*««l |M* (Ajjj €**■ »* .*U,"i wl"*•
3rrt crtl
iijnfmT ife  appropriate n y  buffer bafero dntecnwning m
»*<««•
I r a )  M a  A .  Mortal M * 11«  M  C .  rtM W a . h a  hah A a l w
Mart.«haA * —  oatortA A-— a .
Metres Blue A  cannot be labelled as a true affinity column for 
slalldaae since the ligand, being a non-competitive Inhibitor in that 
it interacts with the binding site, does not have any influence on the 
affinity of the ensyne for the substrate (Mahler A Cordes. 1971).
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Nevertheless, 1C has proved Co be a very effective step In Che 
purification of the three slalldases Increasing the purification 1 - 6  
fold (Table 3.1).
NNP0A-AHS4B was shown to be a specific adsorbent for all three slall­
dases. Although no Increased purification was observed for the C. 
perfrlngens sialidase, the column still adsorbed the enzyme and could 
be eluted with 1M sodium chloride, whereas 6Z of the total S. grlseus 
sialidase activity was found In the breakthrough (fig. 3.9) (no 
adsorbtlon occurred when this 6Z was reloaded on a new NNP0A-AHS4B 
column).
F I « .  3 . »  n »  ^ W I I .  g h w  h — N N F O A -a > 8 4 «  W lW tr M l— .  FtaM * C M « M l a  (O — O )
and swiyiss  activity (a  a ) .
D a  coluaa» wm  r t a p i  and « Iw M  (atrow) as described In tfw laxt. Fractions (13 n i )  «ara  cal facial and dlalysad again# 
lia  oppraprlsia assay b u lla  bafara anryme actlvltlas «ata deterU d nad . A  similar procadyra «as wsad lor C .  parfrlnpsns 
sfaU dasa «tiara as lbs V .  cKolaraa anxyma was alvtad with O .tM a n d  1.1M  todlym d d otlda la buflw.
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In Che case of Che V. cholerae enzyme, cwo enzyme peaks were 
observed, one ac eluclon wlch 0.8M and Che ocher ac 1.2M sodium 
chloride concencracions (Table 3.1). NNPOA was shown Co be a 
compeCiCive lnhibicor of sialidase from S. grlseus, C« perfrIngens 
and V. cholerae (Brossmer, 1977 a) wich Ki's of 2.48 x , 
3.15 x 10UJVand 2.3 x 10 respecCively (Fig. 3.10). This, and Che high 
molaricy of sale required Co remove Che enzyme from Che column, 
illuscraces Che acrong adsorbeion of Che sialidases. The column was 
effecCive in removing ll-acetylneuramlnate pyruvace lyase (EC4.1.3.3), 
a NANA requiring enzyme, from Che procein soluCion as well by passing 
Chrough Che column wiehouC adsorbing Co Che affinlcy gel.
The use of hydroxylapaclce as a final seep in Che purlficacion of all 
Chree sialidases proved crucial Co our purposes because of Che 
following reasons: (i) Ic improved Che purlficacion, (ii) 1C separated 
Che Cwo forms of S, griseus and V. cholerae sialldase (fig. 3.11) 
and (ill) 1C removed conCaminaClng sugars ChaC leached from Che 
previous affinlcy column, a common source of concamlnatlng sugars which 
affeces sCrucCural studies, one of Che themes of this thesis. These 
preparations have been adjudged free of Che contaminating enzyme 
activities tested for.
With this newly developed method, we were able to Increase the S. 
grlseus sialidase yield by a .  three-fold (6.3 mg) over our previous 
method, though still less than Kunlmoto'a et al., (1975), but with an 
increased specific activity. The yield of the V. cholerae sialidase 
prepared by our method could not be compared but Che highest specific 
activity so far reported is 133 (Ada et al., 1961). We were able to
improve on this with Che aid of the NNP0A-AHS4B affinity gel and 
hydroxylapatlte. Further, with Che aid of the latter two
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chromatographic steps, we were also able to separate the two 
Isoenzymes. The determination of the molecular weights of glycoproteins 
Is no almple problem as these compounds are known to behave In an 
anomalous manner under most techniques uaed for Its mol« wt estimation 
(Segrest et al., 1971 and Hughes 1976). It Is for this reason that a 
combination of methods were used to eatlmate the mol. wts of the 
slalidasea. By our methods (SDS-PAGE, 10Z) fig« 3.12 (1 + 11) and table
3.2 and gel filtration chromatography, fig. 3.13, we were able to 
approximate the molecular weights of the slalldases within 1,000—2,000 
mol. wt units. The molecular weights obtained, 32,000 (S. grlseus 1)
57,000 (C. perfrIngens) and 69,000 (V. choleras 1), were those used 
throughout the forthcoming experiments.
r%. i n
Iy  n t lra r iw  ,
S .  «m3. « * .  eshS far S a  » a r ia ,, ,1, 
(3 - y h —  t| . 37.1001C. i r f i la w a l . 
JT.OOO ( V .  « W w r  10
32.300
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Mobil ìty mpm wd m m %  w ftm d  1«  Hwl of hrawoplwncl  blu«
FI*. 3.12 (n )
Flg. 3.12 (i & il) Tabi* 3.2 Determination of Ih* molecular wtlghb 
of Ih* «¡alidore* by  SDS-PAGE (10%).
Th* calibrar ton Un* flg. 3.12 (10 far Ih* mol. wt. maritar* (molecular 
wetghr ranga 14,300 -  71,500, flg. 3.12 (0 X ) woa obtained a* de*- 
cribed In Ihe lext. H e  %  electrophoretic mobility obraIned from 
flg. 3.12 Q) far thè appropriale fialide*** are Ihted in fobie 3.2
Tfco Molgcular W ti^ l Dote noi nailon Off ilo  S laild oai 
I»  SOS-^aly cnflomlig  Col EloelroobnraUo
JUej*)
tUemeimlIc•mkUliriet
lnm|*aMl Un»
di
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m
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». mkmm tlmtUma I 
{¿jgjMrMMe. N
14.300 4 .1SS3
30.400 4 .4344
42.900 4.4329
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71*300. 4 .0343
03*000 4.9339
31.700 4 .9 1 9
N 4 N i
34*300 4 .791
70*000 4 .034
40*000 4 .4 M
0 .4 100.00
7 J 09.00
4 .4 94.90
3 .0 3 9 .0 0
2 .0 21.42
1 .3 19.73
t . t 11.00
4 .1 7 40.30
N é N i
l . M 34.40
1 .4 * 14.30
1 .37 39.10
Mobility expressed as o % referred to that of bromophenof blue
F !» . J . l  K D  FI*. 3. 12 (II)
Fig. 3.12 (i & ii) Table 3.2 Determination of the molecular weights 
of the sialidoMt by SDS-PAGE (10%).
The calibration line fig. 3.12 (ii) for the mol. wt. markets (molecular 
weight range 14,300 -  71,500, fig. 3.12 (i) X) was obtained as des­
cribed in the text. The %  electrophoretic mobility obtained from 
fig. 3.12 (i) far the appropriate sialidases are listed in table 3.2
TmLIc 3.1
The Molecular Weight Determination O f The SiolIJ swt 
By SDS-Polyocrylamida G al Electrophoresis
Bond
In ardor of decreasing mobility Molecular weight
Molecular weight 
^  I0>
Distance of band 
from start (cm)
Electrophoretic 
mobility (%)
Bramo pbonal blue (reference) 0 .4 100.00
Monomer 14,300 4.1553 7 .3 05.00
Dimer 20,400 4.4544 4 .4 54.90
Trlmer 42,900 4.4325 3 .0 35.00
To m 57,200 4.7574 2 .0 23.42
71,500 4.0543 1.3 15.73
Ms lower 05,000 4.9335 f.O 11.00
« i S . f  news sielidme 1 32,700 4 .515 4 .1 7 40.50
m 5 . grneus siolldose II Nd Nd Nd Nd
(31 C . tfc lw M m 54,500 4 .752 3 .1 « 24.40
(41 V. choleras siolidaeo 1 70,000 4.034 1.40 14.20
(5) V . dialerae sielidaee N 40.000 4 .402 3 .37 39.10
Nd Not determined
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As the aim of our project was not to characterize the various sub-forms 
of slalldases per bacteria, we however determined the molecular weight 
of the V. cholerae 11 sialldase; it was found to be approximately 
40,000. We suspect it is the isoenzyme described by Ziegler et al., 
(1978) in which no molecular weights are given. The mol. wt of the 
second S. grlseus enzyme was not determined.
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CHAPTtt 4
ACTIVE SITE STUDIES ON SIALIDASES' 
(CHEMICAL MODIFICATION - ENZYME MECHANISM)
4.0 Introduction
Whether we consider enzymes or Immune-, transport-, receptor- and 
contractile-proteins, the key step In their biological function Is the 
specific recognition and binding of a ligand (substrate, antigen, 
hapten, transported ligand, hormone, regulatory substance, etc.). A 
small and well defined portion of the total protein surface Is presumed 
to be Involved In this selective, high affinity Interaction with the 
specific ligand, and is referred to as the binding site. The binding 
site (or active site in an enzyme), is taken to include those side 
chains and peptide bonds which are In direct physical contact with the 
substrate (perhaps through Intervening water molecules) and other side 
chains or peptide bonds that, although not In direct contact with the 
substrate, perform a direct function in the catalytic process.
The complete understanding of how enzymes carry out their catalytic 
function requires a detailed knowledge of how this active site is 
constituted, and this then has become the key problem In the area of 
enzyme (protein) structure-function analysis.
The central question In the study of reaction mechanisms concerns the 
structure of the transition state and the nature of the Intermediates 
for the reaction under consideration. In the case of enzyme-catalysed
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reactions, a knowledge of the structure of the transition state 
Involves not only an understanding of the geometry of the substrate 
molecule but also the three dimensional conformation of the enzyme. The 
high catalytic efficiency and marked specificity exhibited by enzymic 
reactions imply the participation of several distinct functional groups 
of the enzyme In the catalytic process. This Implication has been fully 
borne out by, for example, the X-ray diffraction studies of lysozyme 
(Imoto et al., 1972), chymotrypsln (Kraut, 1971) and carboxypeptldase 
(Hartsuck & Lipscomb, 1971), which established the involvement of 
several groups, usually distant from one another, along the polypeptide 
backbone but near one another In space In the associated catalytic 
processes. This fact, together with structural complexities Inherent In 
the chemistry of molecules of the size of proteins, suffices to 
Indicate that a precise definition of the transition-state, structure 
for enzymic reactions is a formidable task. Nevertheless, the mutually 
supportive investigations concerning protein structure and the various 
facets of enzyme activity have, in several cases, including the three 
enzymes mentioned above, brought the goal within reach. For the great 
preponderance of proteins for which the three-dimensional structure is 
unknown, one must be content to work towards less sophisticated goals.
The immediate goals in the study of the mechanism of enzyme-catalysed 
reactions may be formulated as follows: (1) the elucidation of the 
pathway for enzyme-catalysed reactions, (li) the identification of the 
amino adds Involved in substrate binding and in bond making and bond 
breaking reactions, (ill) determination of their approximate 
arrangement in space and (iv) development of a rationale, through 
assigning specific catalytic roles to the groups involved, that 
explains the velocity of enzyme catalysed reactions to within an order 
of magnitude. It is within the context of this approach (especially
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(11) and (lv)), Chat Che succeeding part of the chapter la couched.
The Identification of the amino acids present In the active site of 
enzymes Is clearly of major Importance for the understanding of the 
basic facets of the mechanism of enzyme-catalysed reactions. Several 
methods, of varying utility, have been employed in attempts to Identify 
at least some of the residues that constitute these active sites. Some 
of these methods Involve (1) chemical modification of specific groups 
on the substrate molecule and determining whether they are essential 
for enzymic activity and, by so doing, It can be deduced which amino 
a d d  groups in the enzyme would be likely to react with the essential 
group on the substrate. (11) Chemical modification of the enzyme with 
group specific reagents (ill) affinity labelling (lv) X-ray diffraction 
studies on enzyme-substrate or enzyme-inhibitor complexes.
Besides deducing which amino acids are involved in the active site with 
the aid of the substrate. Important information can also be obtained 
regarding the action of the enzyme (Chapter I).
4.0.1 Chemical Modification
With a few exceptions, most of the advances made In the field of 
chemical modification of protein structure during the last twenty 
years, have resulted from Increased reagent specificity and selec­
tivity. Carefully designed reagents could be used to probe details of 
reaction mechanisms and to detect the changes In protein conformation 
which accompany function. Some of the types of reactions that are used 
for amino a d d  modification are given In table 4.0
■ M c lfk  iig rB iin ti«  Igual of cpUmlen not of»«« aeMowoi Ii* proclks; group-** lecHve dncriboi moro «ecwroM y A o reality 
ulchsmlcatnTodlflc sf Ion of «  i W «  typo of M » H » " « I **+ »«• • *• t«»ol « f  •***- *•Tka tana«
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Toblo 4.0
»«octlons For Modlflcotlon O f  FuncHonol Group» In Proteins
FuncHonol Group Reactions
Amino of lysine Acylation, alkylation, arylation, reaction with 
carbonyls
Guonidtnium of orgintno Condensation with dicarbonyls
Carboxyl of apartIc and glutamic acids Esterification, amide formation with carfaodii- 
mides, reduction
Thiol of cystoino Oxidation, arylation, alkylation, 
^-elim ination, heavy metal derivatives
Imidaxola of hlstldlno Alkylation, diazonium coupling, iodlnotlon, 
oxidation, photooxidation
Thioothor of mothionino Oxidation, alkylation
Phanol of tyrosine Acylation, alkylation, iodinatlon, nitration 
oxidation, diazonium coupling
Indolo of tryptophan Alkylation, formylation, oxidation, ozanlysis
Hydroxyl of sarin« and threonine Esterification, phosphorylation, alkylation.
Most of these reactions are non-specific; they occur with more than a 
single residue or even a single type of residue. Fortunately» certain 
residues» because of their alcroenvlronment within the three- 
dimensional structure of the protein» may exhibit reactivities 
different from those expected on the basis of studies with model 
systems. They often participate in biological function and» in fact» 
the structural features generating function are closely related to 
those giving rise to unusual chemical reactivity. Because of this 
unique reactivity they can be modified selectively, thereby 
facilitating structure-function correlation studies.
Moreover» it became possible to employ a variety of reagents to modify 
the same residue. With tyrosine» for example, reactions can ba carried 
out either on the phenolic oxygen or at the 3- position of the aromatic
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ring (Rlordan & Sokolovsky, 1971). Structural circumstances that 
activate one of these sites usually activate the other as well. 
Depending on the nature of the 3- position substituent, the pK of the 
phenolic hydroxyl group can vary over several units. This provides a 
means to explore the pH dependence of function as it relates to degree 
of ionization of the specific tyrosine in question.
Hartley (1960) identified the "seryl proteases" by virtue of the fact 
that they all were inactivated by diisopropylphosphofluoridate (DFP), a 
reagent that phosphorylates a specific seryl residue at the active site 
of these enzymes. DFP cannot be called a seryl reagent, however, since 
it does not react with seryl residues in general but only with those 
having a neighbouring histidine residue at the active site of certain 
enzymes. On the other hand, a large number of reagents has been used to 
identify the "sulphydryl enzymes". These enzymes are inactivated by 
heavy metal ions such as Ag*” and Hg^  + , p-mercuribenzoate (PMB), 
N-ethylmaleimide (HEM) and iodoacetate among others. However, in many 
of these instances, loss of activity is not due to the selective 
modification of an active site cysteine residue but rather to effects 
on structure (Vallee & Rlordan, 1969). Thus, classification of proteins 
based on functional site residues is operationally convenient but can 
be mechanistically misleading. Therefore, with all protein chemical 
modifications, it is important to understand the specificity of the 
reagent employed and its effects on protein structure before making 
functional deductions.
The chemical modifications discussed below are the systems of choice 
used in our investigations. Group-specific reagents have been used 
extensively for site specific modification of native proteins. For such 
a purpose, the modification is performed on the native protein (or in a
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solvent which does not Irreversibly alter the conformation of the 
protein). The concentrations of the modifying reagents are generally 
considerably lower than those used for the total modification of a 
given side-chain and the conditions of reaction are suitably chosen, 
bearing in mind the stability characteristics of the protein under 
study.
In the attempt to ascertain which amino acids participate in the 
binding or catalysis in the active site of sialidases, group selective 
reagents of varying specificity have been used over the years with 
controversial results (Table 4.1).
It is yet to be established whether the apparent disagreement in the 
results of these studies reflect on differences in the (i) mechanisms 
of action for sialidases of various origins, (ii) limitations of the 
techniques employed for chemical modification, (namely, side
reactions, effectiveness of the modification reactions and
interferences in the determination of enzyme activity),
(iii) structures of the enzymes, (iv) substrates used for enzyme 
assays.
Preliminary studies inclined towards the resolution of these queries 
have been carried out in our laboratory by Kabayo (1978) on S. 
griseus slalidase and Groundwater (1979) on V. cholerae sialldase.
This thesis reports on the comparative studies, by chemical
modification and amino acid analysis, carried out on the active sites 
of sialidases obtained from pathogenic (V. cholerae and C»
perfrlngens) and non-pathogenic (S. griseus) sources under 
Identical conditions (namely, temperature, time, pH substrates and 
chemical modification reagents) and the precursory investigation into
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the function of the carbohydrate moieties of these glycoproteins«
4.0.1.0 Modification of sulphydryl groups
Of the long list of sulphydryl reagents N-ethylmalelmide (NEM) (Rlordan 
& Vallee 1972) and 5,5-dlthlobls-(2-nitrobenzolc acid) (DTNB) (Janatova 
et al., 1968 and Ellman, 19S9) were the reagents of choice (Fig. 4.0 1
(1) and (11).
(t0 5* S' -dithiobls-(2 nltrobenzoic octd). (R, represent! the protein group).
NEM, besides being specific. Is known to form a stable adduct with the 
thiol group, whereas thiol groups from the derivatives of 
organomercurlals such as p-chloromercurlbensoate (p-CMB) (Bradbury 6 
Smyth, 1973) are readily regenerated. With the use of DTNB we were also 
aware that Incomplete conversion of protein sulphydryl groups to - the 
mixed disulphide leaves open the possibility of Intramolecular 
reactions leading to the formation of disulphide bonds.
01
CH,SM
R -N -C H -C O O -  ♦I
N
CM C H j-C O
R-NH COOT
S_ («hylsucanimidol-CY**'»
R -S - .C
Fig. 4 .0  (I) & (10 Reaction of protein Ihlol group* with (I) N-elhylmalelmide ond
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4.0« 1.1 Modification of amino groups
Lysyl residues may be converted Co Che homoarginine derlvaclve by 
treatment of proteins with 0-methylisourea at alkaline pH (Hughes et 
•1., 1949) [Fig. 4.1 (1)]. At high pH values, (eg. pH 10.5), the 
guanldatlon of primary amino groups takes precedence over the 
S-methylation of thiols (Banks & Shafer, 1972). Another advantage of 
this method is the a-amino groups react much more slowly with this 
reagent than do «-amino groups (Plapp et al., 1971). 
2,4,6-Trlnltrobenzenesulphonate (TNBS) [Fig. 4.1 (il)] Initially used 
by us, (although its reaction in alkaline conditions is restricted to 
and «-amino acids in proteins), also reacts with sulphydryl groups 
forming unstable thiol derivatives (Fields 1972).
OCHj
> 9 9 -  r —n h —c
/
\
NH,
NH,
♦ CHjOH
R—NH, ♦ OjN NO, ♦HSOi'
Fig. 4.1 (I) & (10 Reactions of protein amine groups with (I) O-me thy I isourea and 
(ii) 2,4,6-trinitrobenzanesulphonate. (R, represents the protein).
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4.0.1.2 Modification of guanldlum groups
Procedures for Che modification of arginine residues In proteins, under 
■lid conditions, are based on their reaction with 1,2- or 
1,3-dlcarbonyl compounds (Cohen,1968, Means & Feeney, 1971, Yankeelov, 
1972 and Riordan, 1979).
Fig. 4 .2  (0  & (11) Reaction of protein guanidinium group! with (1) 2,3 butane dtone and 
(II) phenylglyaxal yielding the alternative structures far the phenylglyOKol-argtnlne 
odduct. (R, represents the protein).
/ H N  HCM* !l
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Following the procedures outlined by Rlordan (1973) and Daemen and
Riordan (1974) the specific modification of arginine residues is
achieved when using 2,3-butanedlone [Fig. 4.2 (i)]. Phenylglyoxal (PG), 
first introduced as an arglnyl reagent by Takahashl in 1968, reacts 
with these residues under mild conditions to give a product that
contains two phenylglyoxal moieties per guanldlno group [Fig. 4.2(11)].
This product is stable at acid pH's and dissociates to regenerate 
arginine only on prolonged incubation in neutral and alkaline media. 
Besides this reagent being specific for arginine at pH 5.5 and 7.0 as
described by Takahashl (1968, 1977a,b), it can also be made
14radioactive, and the C-phenylglyoxal (Riley & Gray, 1947) can be 
obtained commercially. Thus the reagent offers the advantage of direct 
quantitation of the total number of arginyl residues in the protein or, 
by differential labelling, determine the presence of binding or 
catalytic arginine residues in the active site.
4.0» 1.3 Modification of carboxyl groups
The raction most exploited for the modification of these residues 
involves the coupling of nucleophiles, such as glycine methyl ester to 
the carboxyl groups in the presence of water soluble carbodiimlde eg. 
l-ethyl-3-(3 - dimethylamlnopropyl) carbodiimlde (Carraway & Koshland, 
1972).
The activation reaction is performed with the carbodiimide in the 
presence of high concentrations of nucleophiles. The latter displaces 
the carbodiimide group from the initially formed carbodiimide-carboxyl 
adduct, as shown in Fig. 4.3
*- J 0 6 -
R — ^ — X  ♦  R — NH— 2 - NH— R'
nucleophile
H Z
R -C O O R  ♦  R 'M — C - N R ' - ^ r- ^ / hr.
N H R*
O -A c jlU o u rta
I rurrancem rat
R— C — NHR*
N H R '
y - A c y k u a
Fig 4.3 Reaction of protein carboxyl groups with ccrbodilmide followed by (I)  a nucleophilic 
attack (HX) or (10 rearrangement. (R, represents the protein, R* and R" represent alkyl 
groups)
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Water and other added nudeophilea compete with the intramolecular 
rearrangement of the O-acylisourea to il-acylurea. Attack by water 
regenerates the carboxyl group, whereas attack by other nucleophiles 
leads to an acyl nucleophile derivative of the carboxyl group. At pH 
4.8 and high nucleophile concentrations in the presence of excess 
carbodilmlde, the formation of the acyl nucleophile is essentially 
quantitative (Hoare & Koshland, 1967; Carraway & Koshland, 1972).
It should be noted that the carbodilmide reacts with both sulphydryl 
and tyrosyl OH groups as well as with carboxyl groups (Carraway 6 
Triplett, 1970 and Carraway & Koshland, 1968). Tyrosine can be 
regenerated by treatment with hydroxylamine but successful regenera­
tion of thiol groups has not been reported.
4.0.1.4 Hodlflcatlon of tryptophan residues
Oxidative bromlnatlon by N-bromosucdnimide (NBS) has been widely used 
for the modification of tryptophan residues giving rise to an oxlndole 
moiety [Fig. 4.4 ].
H
NBS
M
indole oxindolei
Fig. 4 .4  Reaction of protein tryptaphanal residue with N-bromosucclnlmide (NBS)
(R, protein).
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As NBS Is an extremely reactive reagent, side reactions with tyrosine, 
methionine, cysteine and sugars as well as peptide bond cleavage Is 
possible If conditions are not stringently controlled (Spande & Wltkop, 
1967).
At low reagent to protein tryptophan ratios, In 50Z aqueous acetic 
acid, it was found that 2-(2-nltrophenylsulphenyl)-3-methyl-3-bromo- 
indolenlne (BNPS-skatole) reacts selectively with tryptophan residues 
converting these also to oxindole derivatives. Methionine Is con­
comitantly converted to the sulphoxlde and at high concentrations of 
reagent, selective cleavage of ptptide bonds can occur (Fontana, 1972).
A.0.1.5 Modification of carbohydrate groups
The chemical modification pursued was not only confined to amino acid 
side chains but included carbohydrate side chains of sialidases as well 
because it Is apparent that the carbohydrate moiety In glycoproteins 
play two important roles. The first Is of a physicochemical order and 
concerns protein protection against proteases, the movement of Ions and 
small molecules in tissues In the membrane regions. The second Is of a 
biological order, the basis of which is essentially the notion of 
recognition of signals brought by the carbohydrate groups and 
consequently the notion of specific structure of these groups 
(Wlnterburn & Phelps, 1972; Montreuil, 1975; Hughes & Sharon, 1978).
The removal of carbohydrate moieties from most glycoenzymes (enzymes 
having carbohydrate residues covalently linked In their molecular 
structure (Pazur et al., 1969)), have been shown to have no effect on
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Chelr catalytic activities (Pazur et al., 1963; Lee & Hager, 1970; 
Yasuda et al., 1970) whereas a few have either displayed an Increase 
or decrease In enzyme activity (Eomelot & Bos, 1965; Dzlembor et al., 
1970; Varute & Patll, 1971).
The principle linkages found between the carbohydrate and protein 
components of glycoenzymes are of the N-glycosyl and the 0-glycosyl 
types (Pazur & Aronson, 1972). The components of the former linkage are 
normally asparagine covalently bound to N-acetylglucosamlne and the 
latter Involves either serine or threonine, linked either to 
N-acetylgalactosamine, mannose or glucose (Marshall, 1974). The mild 
procedures normally employed to investigate the significance of these 
residues Involve the use of either glycosidases, periodate oxidations 
or f) -elimination reactions (Fig. 4.5) (Spiro 1972; LI & Li, 1977; 
Zlnn et al., 1977).
S-NMH
0
SM-C-« OH* «-NM-Ç-S-R * * ° r ^-NH—CM—c—a.
(
1
Send
fgtyceuOs
5h,
♦
t(o-
CM,SOi 
Cysts «  acid
Fig. 4 .5  Reaction of a teryl glycoside with alkali ( ^-elimination) In the presence 
of sulphite. ( t ,  represents the protein; R’ , represents the carbohydrate moiety).
A fairly recent procedure for deglycosylatlng glycoproteins la the use 
of anhydrous hydrogen fluoride. According to Mort and Lamport (1977), 
It la possible to cleave all the linkages of neutral and addle sugars 
or the O-glycosldlc linkages leaving the N-glycosldlc linkage and 
peptide bonds Intact.
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For the purpose of confirming that the chemical modification was 
absolutely specific, amino acid analysis is normally carried out on the 
protein before and after treatment. In the event of this not being 
possible for reasons such as (1) insufficient protein sample, (11) the 
lack of the formation of an acid stable adduct with the group selective 
reagent or, (ill) the protein Is a glycoprotein, (Eastoe, 1972; Niall, 
1973 and Niall et al., 1973) cross checking of the results with 
different group selective reagents Is essential and, where peptide bond 
cleavage Is suspected, gel or paper electrophoresis would be an 
essential step.
Although it has been suggested that the ultimate procedure In deter­
mining the mechanism of enzyme catalysis, by chemical means, would be 
by affinity labelling (Glazer et al., 1975) the chemical modifica­
tion process using group selective reagents still accounts for most of 
the papers published in this area. This is because of several rea­
sons: firstly, minimal commitment of resources is necessary to initiate 
such studies and secondly, most of these site specific reagents are 
readily available and finally, affinity labels usually have to be 
synthesized - often by difficult routes. Although a successful site 
specific modification with these reagents is significantly less likely 
than with well defined affinity labels, many more experiments with 
these compounds are attempted and the results cross checked with other
group selective reagents
4.1 Experimental Procedure
4.1.0 Synthesis Of [2- 3H] Acetophenone (the starting material for 
phenyl[2-3H]glyoxal)
To anhydrous tetrahydrofuran (2.S ml) and dllsopropylamine (0.49g,
4.9mMol) under an argon atmosphere was added'1.9 ml of 2.SM-n-butyl-
lithium (standardized by the method of Kofron & Baclawslci, 1976) in
hexane and the mixture stirred for 30 min below 0* . Acetophenone
(0.27g, 2.25mMol) and tetrahydrofuran (1 ml) were then added and the
omixture stirred for a further 15 min. below 0 after which hexamethyl-
phosphoramide (0.9 ml, 5mMol), was added. After 20 min , trlfluoro [^H]
acetic acid (0.273 ml, 2.4mMol), prepared by treating3H20 (5 Ci/ml; sp.
radioactivity approx. lOOmCi/mMol) with an equimolar amount of
trlfluoroacetic anhydride, was added and the reaction stirred for 2 hr
at 21* . The reaction mixture was then acidified with 1M-HC1 at 0* and
the aqueous solution extracted with 3 x 20 ml of light petroleum (b.p. 
• •
40-60 ). The organic extracts were combined, washed with 5 x 10 ml of 
IM-HC1, dried and- evaporated in vacuo to give [2-3H] acetophenone 
(0.27g), which was not purified further but was oxidized lmsedlately.
4.1.1 Synthesis Of Phenyl [2-3H]glyoxal
To a solution of sublimed Se(^(0,27g, 2.4mMol) in dioxan (0.84 ml) and 
water (4.5 1) at 5cf was added [2-3H]acetophenone (0,27g, 2.25mMol) and 
dioxan (0.5 ml). The mixture was heated at 80 for 6 hr and filtered 
through cotton wool, which was then washed with dioxan (20 ml). The
filtrate and washings were evaporated In vacuo and dry ethanol (2 ml)
was added to the resulting oily residue* After being left for 2 days at 
5 , the supernatant was carefully removed from the red precipitate that 
had formed and was evaporated In vacuo. The oily residue was 
dissolved in ethyl acetate (0.5 ml) and the phenyl[3H]glyoxal purified 
by preparative t.l.c* with petrol/ethylacetate (1.1, v/v) as solvent.
3
The phenyl[ HJglyoxal was eluted from the silica with ethylacetate (50 
ml), which was then concentrated in vacuo to 0.5 ml. The
phenyl[ Hjglyoxal was rechromatographed as described earlier and the 
ethylacetate removed in vacuo to leave an oily residue. Final traces 
of ethylacetate were removed by repeated (5x) dissolution of the 
residue in ethanol (50 ml) and evaporation in vacuo. Ifalabelled 
phenylglyoxal was synthesized in a similar manner.
4.1.2 Trial Experiments With The Phenyl[2-3H]glyoxal
(1) Inactivation: The alkaline phosphatases and lactate dehydrogenase 
(LDH) were treated at 25 with various amounts of a solution of 
unlabelled phenylglyoxal hydrate (16 mg) in ethanol (100 pi) as des­
cribed in table 4.2. Care was taken to use the same buffers for the 
inactivation as were for the assay. Samples were removed after fixed 
times and assayed. After inactivation, the modified enzymes were 
dialysed at 4* for 36 hr against the buffers indicated ( 3 x 5  litres), 
after which portions were removed and assayed.
(li) Protection by substrate: The three enzymes in the presence of 
their substrates were treated with unlabelled phenylglyoxal hydrate as 
described in table 4.3 and then dialysed against buffer. The modified 
enzymes were then treated with 100-fold molar excess of phenyl[2-3H]- 
glyoxal for 2 hr, the protein was precipitated on glassflbre discs with
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trichloroacetlc acid (Yang & Schwert, 1972) and their 3H content 
determined.
A.1.3 Modification Of Amino Acid Residues In Sialidases
A.1.3.0 Active site protection and experimental conditions
In these experiments the sialidases were incubated with N-acetyl- 
neuramlnic acid (NANA, 170 mg/ml) (S. grlseus and V. cholerae
enzymes) or sialyl-lactose (NL, A80 mg/ml) (C. perfrlngens enzyme) at 
molar ratios given in table A.5 for 1.0 min in the specific buffers 
before treatment with the group specific reagents. In all cases, 
controls (Including non-protective reactions), were set up as described 
under specific headings with omission of either the group specific 
reagent or enzyme. All the reactions were carried out at 37 .
A. 1.3.1 Modification of arginine residues
A. 1.3.1.0 (a) By phenylglyoxal
This was carried out on the three sialidases as described in the 
legends of fig. A.8 (i) and (11) for both the unprotected active centre 
and protected active centre.
A. 1.3.1.1 By phenyl[2-3H]glyoxal (Augustus & Hutchinson, 1979).
The active sites of the three sialidases were protected as described
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above before the enzymes were treated with excess phenylglyoxal. The 
total volume of the reaction mixture was 150 pi. The excess unreacted 
phenylglyoxal and active site protector were removed by dialysis and 
the enzymes were treated with 100-fold molar excess of phenyl[2- 3HJ- 
glyoxal. After 2 hr the 3H content of the protein was determined as 
previously described.
4.1.3,1.2 By 2,4, butanedlone (Riordan & Scandurra, 1975)
The three slalidases from S. grlseus, C. perfrlngens and V. 
cholerae (50, 20 and 25pg respectively), were Incubated In 0.125M 
sodium borate buffer pH 7.5 in the dark, containing butanedione (8.6 
mg/100 pi) at molar ratios listed in table 4.4, the final volume being 
adjusted to 150 pi. After 1 hr the reaction mixture was diluted (lOx) 
and the enzyme activity determined by the method of Warren (1959).
4.1.3.2 Modification of carboxyl residues *1
The methods of Carraway and Koshland (1972) and Braun et al., (1977) 
were used. The reagents and reaction conditions for both the unpro­
tected and protected modification are stated in the legenda of fig. 4.9
(1) and (11) and tables 4.4 and 4.5.
4.1.3.3 Modification of tryptophan residues
4.1.3.3.0 By M-bromosucclnlmlde (Spande & Wltkop, 1967)
Solutions of the three slalidases in sodium acetate buffer (2.0 ml, pH
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4.0) were Created with N-bromosuccinimlde (NBS concentrations Table 
4.4). The reaction was dialysed after 1 hr against the appropriate 
assay buffer and the specific activities determined. Aliquots of the 
non-diffusable material were subject to polyacrylamide (10%) gel 
electrophoresis.
The protection of the active sites of the enzymes were carried out with 
sialyl-lactose in all three sialidases at concentrations listed in 
table 4.5.
4.1.3. 3.1 By 2-hydroxy-5-nltrobenzylbromide (Fehske et al., 1978)
2-hydroxy-5-nltrobenzylbromide was added to the three enzymes (molar 
ratios given in table 4.4) in sodium acetate buffer (1.0 ml 0.1M pH
4.0) and the solutions incubated with shaking for 2 hr. The Insoluble
products were removed by centrifugation and the supernatants dialysed 
against the appropriate assay buffer after which the specific
activities were determined. As above, aliquots were also subjected to 
polyacrylamide gel electrophoresis.
4.1.3.4 Modification of sulphydryl groups (Rlordan & Vallee, 1972)
The three sialidases were incubated with N-ethylmalelmide (NEM) in 
sodium phosphate buffer (1.0 ml, 0.1M pH 7.0) for 1.5 hr. (Table 4.4). 
Aliquots were removed at various time intervals and the reaction 
stopped by the addition of 2-mercaptoethanol at twice the molar excess 
of NEM. The samples were dialysed against phosphate buffer before 
determining the specific activities.
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4.1.3.5 Modification of lysine residues
4.1.3.5.0 By 2,4,6-trlnltrobenzenesulphonlc acid (Fields, 1972)
To solutions of the three enzymes In 0.1M sodium phosphate buffer (2.0 
ml, pH 7.0) were added recrystallized 2,4,6 trlnltrobenzenesulphonic 
acid at various concentrations (molar ratios Table 4.4). Samples of the 
reaction mixture were removed at fixed time intervals and the reaction 
was stopped by the addition of excess lysine. These were dialysed 
before determining the specific activity.
The modification was carried out in the presence of NANA and NL as 
previously described (molar ratios are represented in Table 4.5).
4.1.3.5.1 By &-methylisourea (Habeeb, 1972)
To solutions of the sialidases in 0.2M glycine NaOH buffer (2.5 ml, pH
10.5) was added a freshly prepared aqueous 0-methylisourea (0.6M, pH
10.5) . The molar ratios are given in table 4.4. The solutions were
oincubated fot 24 hr at 6 during which time aliquots were removed, 
dialysed against sodium phosphate buffer pH 8.5 for 36 hr. They were 
then assayed for sialidase activity.
4» 1.3.6 Isolation of the active site peptide
The overall strategy adopted for the isolation of the active site 
peptide of the three sialidases is illustrated in figure 4.6.
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Enzym m
1
2
Modified Enzyme (active site unmodified)
3
4
^H-Lobelled Active Site Enzyme
5
6
Peptide Mixture
7
8
^ -la b e lle d  Active Site Peptide
1 Protect the active site of the 
enzyme, modify peripheral 
arginines with unlabelled phenyl-  
glyaxol
2 Chromatograph, dialyse and lyo­
phil ize
3 Label the octive site with phenyl-  
/ ? -3jj7fllyoxal
4 Chromatograph, dialyse and lyo­
phil ize
5 Hydrolyse with C N B r
6 Dilute and lyophilize
7 Label with fluorescamine
8 Separate peptides by gel 
electrophoresis (4  -  16%)
9 9 Excise fluorescent peptide bands 
and determine rodiooctfve counts
10 10 Elute active site peptide from the gel
I I 11
Purified Active Site Peptide (still 
containing phenyl/2-^t^jlyoxol & fluo­
ro scarnine
Amino A c d Analysis
Control consisted of Insulin 8 chain, 
naturaland modified with phenylglyoxol 
and fluoresc amine.
F ig . 4 .4  Strato«, adapted for the isolation. Identification and purification of the active site 
peptides In S. jlseus,  C .  perfrlngem and V .  chol.ro . slalldoses
18-
Dtfferentlal labelling with phenylglyoxal (unlabelled and labelled)
Differential labelling of the enzymes (500/ig each) was carried out as 
described previously under the heading, "modification of arginine 
residues", the only difference being that the excess reagent was 
removed by gel-chromatography (Sephadex G-25, column dimension 1.2 x 45 
cm), followed by dialysis and lyophilizatlon.
Cynogenbromide (CNBr) cleavage of the modified enzymes
The modified enzymes were suspended in 70Z formic acid (400 pi) to 
which solid CNBr was added (molar excess of 300). Half the required 
CNBr was added at zero time and the remainder after 12 hr and the 
reaction was allowed to proceed for 24 hr at 21 (Kuroslty et al., 
1976, Gross, 1967 and Augustus, 1977). The reaction was then diluted 
(10 x) with distilled water and lyophillzed.
Detection and purification of peptides
The CNBr-peptldes were dissolved in 0.05M borate buffer, pH 8.1, 
containing 50Z (v/v) glycerol (100 pi) and freshly prepared fluoresca- 
mlne (5 pi, 30 mg/ml acetone) was added while shaking vigorously on a 
vortex mixer. The reaction mixture was allowed to stand at 21 for 10 
min (Kosemblait et al., 1975) and applied to a polyacrylamide gel 
(discontinuous 4-12-16Z). Electrophoresis was carried out in the dark 
as described earlier. The peptides were visualized under longwave 
ultraviolet light. The fluorescent peptides were excised and samples 
counted to determine the radioactivity. The radioactive peptide was
-119-
oextracted from the macerated gel by diffusion at 37 , In 0.005M sodium 
bicarbonate buffer containing 0.OSZ SDS and a bacterlostat. After 24 hr 
the acrylamide fragments were removed by centrifugation and the 
supernatant lyphollzed (Weiner et al., 1972). The peptides were 
subjected to gel permeation chromatography (Sephadex G-10 and Bio-Gel 
P-2) In 35Z formic acid. The peptide containing fractions were further 
purified by descending paper chromatography (Whatman 54) the solvent 
being butanol-acetic acid water (5:2:3 v/v). After locating the 
peptide, eluting and lyophillzlng it, it was subjected to amino acid 
analysis. The controls consisted of (i) phenylglyoxal modified 
arginine, (ii) fluorescamine modified lysine, (ill) natural insulin B 
chain and (iv) phenylglyoxal and fluorescamine modified insulin B chain.
4.1.3.7 Modification of carbohydrate residues in slalidases
Periodate oxidation of C. perfrlngens slalldase (and its action on 
different substrates) (Steward et al., 1977)
The reagents and methods are described in the legend of figure 4.17 (i) 
and (11).
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4. 1.3.7.0 Periodate oxidation of the three slalldases 
For the method see the legends of figure 4.17 and 4.16 (1 + 11). 
Periodate oxidation of V. cholerae slalldase for polyacrylamide gel *V.
V. cholerae slalldase (1 mg) was allowed to react with 0.1M sodium 
metaperiodate (450 pi) In 0.1M sodium acetate buffer» pH 4.5 at 4° in 
the dark for 24 hr. The reaction was stopped by the addition of 50% 
ethandlol (50% v/v). This was mixed very rapidly and continued to react 
for 30 min. and then dialysed against 0.001M sodium phosphate buffer» 
pH 7.0 (48 hr» 2 x 5  Its). The retentate was lyophilized and subjected 
to SDS-polyacrylamide (10%) gel electrophoresis, after which the gel 
was halved longitudinally and stained for protein and carbohydrate as 
described in Chapter 3. The control contained no periodate.
4.1.3.7.1 g-ellnlnatlon on V. cholerae slalldase for polyacrylamide 
gel electrophoresis (Simpson et al., 1972; Birken & Canfield, 1977)
V. cholerae sialidases (1 mg) was reacted with 0.2M sodium sulphite 
in 0.1M NaOH (500pi) for 24 hr. A control containing slalldase (0.5 mg)
In the absence of sodium sulphite was set up. The reactions were 
stopped by the addition of glacial acetic ad d  (10 pi) and dialysed, 
lyophillzed, electrophoresed and stained as above. The reaction 
was carried out at 25°.
^-elimination with [35S} sodium sulphite on V. cholerae slalldase 
(Simpson et al., 1972; Birken & Canfield, 1977)
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V. cholerae slalldase (6.9 g, 10 pi) suspended In 0.1M NaOH (90 ul) 
containing I^S] sodium sulphite (10 pi, specific radioactivity 0.8 Ci/ 
Mole, prepared by the method of Tanase & Shlkata,(1976) was allowed to 
react for 10 hr at 2^ . The reaction was stopped by the addition of 
glacial acetic acid (10 pi). The solution was lyophillzed resuspended 
in 20Z trichloroacetic acid (TCA) (10 pi) and deposited on Whatman GCF 
discs and washed in vacuo with 20Z TCA (500 ml) and the radioactivity 
associated with the disc determined.
4.2 Results And Discussion
Synthesis of phenyl[2- * 3H]glyoxal
is unsatisfactory as the
14of [1- Cjacetophenone, is 
expensive and comparatively difficult to synthesize. (Dauben et al.,
31950). The synthesis of [2- HJacetophenone was achieved by a 
development of a method introduced for the alkylation of aliphatic 
carboxylic acids (Pfeffer & Sllbert, 1970). In our synthesis, the3H 
originates from3H20 which is easily converted into [3H]CF3 COOH, thereby 
considerably decreasing the cost of lsotopically labelled acetophenone. 
Under our labelling conditions, few side reactions occur and hence the 
[2- 3H]acetophenone can be obtained in almost quantitative yield. The 
position of isotopic exchange was confirmed by 'H n.m.r. spectroscopy 
with (2-ZHJ acetophenone prepared in an analogous manner from trifluoro 
[ ^1 acetic acid. The signal due to the acetyl group at 2.6 p.p.m. was 
greatly diminished as it is now deuterated.
The synthesis of phenyl[1- ^*fc]glyoxal 
material which is prepared by the oxidation
- 1 2 2 -
The [2— 3H ] acetophenone was oxidized by SeC>2 to yield phenyl[2- 3H]~ 
glyoxal (76Z, basedon E 250nniof 9000 litre mor'era''in ethanol) with 
specific radioactivity 12.2 mCi/mMol. The phenylglyoxal ran as a single 
U.V.-absorbing spot on silica t.l.c. with petrol/ethyl acetate (1:1, 
v/v) as developing solvent with the same mobility as authentic 
phenylglyoxal. The 'H n.ra.r. phenyl[2-3H]glyoxal was Identical with that 
of authentic material with a singlet at 9.55 p.p.ra. due to the 
aldehydic proton. This singlet was absent in the n.m.r. spectrum of 
phenyl[2- H]glyoxal, prepared as described above from [2- HJaceto- 
phenone, confirming the position of isotopic substitution. The
phenyl[2-3H]glyoxal decomposed slowly (30Z in 3 months) when stored as
oa 1M solution in dry ethanol at 4 . Little decomposition occurred when
the phenylglyoxal was stored as an oil or as the hydrate. The latter
compound could be obtained by crystallization from a concentrated 
oaqueous solution at 4 .
The oxidation of acetophenone by Se02proceeds via the formation of an 
enol selenite ester that rearranges and then decomposes to phenylgly- 
glyoxal, two protons being lost during the reaction sequence (Fig. 4.7) 
Corey & Schafer, 1960).
C Ji,C O C H ,> H  +  SeO,
OSeOjH
I
C ,H ,C -C H » HI
C .H ,CO C *H O
OSeOH
I
C .H ,C O C H * H
F i g .  4 . 7  Reaction sequence during the synthesis of phenylglyoxal
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In the synthesis of phenyl[2- *H]glyoxal, the retention of 3H may be 
assisted by favourable Isotope effects operating In the two 
proton-abstraction steps.
Trial use of phenyl[2- 3H]glyoxal
3The phenyl[2- H]glyoxal was used to determine the number of arginine 
residues in the active centres of two alkaline phosphatases and lactate 
dehydrogenase. The interaction of the enzymes with unlabelled 
phenylglyoxal was investigated over a molar range (phenylglyoxal/ 
enzyme) of 0.7 x 103 — 1C? (Table 4.2), assaying at fixed time intervals 
until the inactivation was constant. The enzymes were then dialysed and 
reassayed and in all cases the inactivation was irreversible with molar 
ratios of 3 x 103 or greater. The rate of inactivation was less at pH
5.3 than at 7.5. Once the conditions for rapid inactivation had been
determined, the inactivation was carried out on the enzymes in the 
presence of substrates. The concentrations of the latter substrates 
derived from the turnover number for each enzyme and were chosen so as 
to provide maximum protection of the active site. After 5 min the 
substrates and excess phenylglyoxal were removed by dialysis and the 
enzymes were treated with phenyl[2- HJglyoxal (Table 4.3). The number
3
of molecules of phenyl[2- H]glyoxal that bound to each enzyme
molecule was then determined. This value is twice the number of
arginine residues modified (Takahashi, 1968) and hence the number of 
arginine residues at or near the active centres of the enzymes can be 
calculated. The values obtained for calf intestinal (1.8) and E. coll 
(2.1) alkaline phosphatases and lactate dehydrogenase (3.3) are dose 
to that (2) determined by Daemen and Riordan (1974) for E. coll
alkaline phosphatase and 3 for beef heart lactate dehydrogenase as
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Toble 4.2
Inactivation of enzymes with phanylglyoxal
Slow inoctivation Rapid Inactivation |
Enzyme Buffer Molar ratio of 
phenylglyoxal 
to protein
Time for 75% 
inactivation 
(min)
Molar ratio of 
phenylglyoxal 
to protein
Time for 100<* 
inoctivation 
(min)
E . coll alkaline phosphatase' 
(mol .w t. 89,000)
0 .125M-NaHCO, 
(pH 7.5)
1 x 103 256 3.3 x 103 60
Calf intestine alkaline phos­
phatase! (mol. wt. 140,000)
0 .125M-NaHCO, 
(pH 7.5)
1 x 103 240 3.3 x 103 60
C. perfrlngens sialidase 
(mol.wt. 66,000)
0. lM-Sodium 
acetate (pH 5.3)
6 x 10* 180 1 .6 x 105 96
Beef heart lactate dehy- 
drogenasd* (mol.wt. 
144,000)
0. IM-Sodlum phos­
phate (pH 7.4)
7 x  101 2 53 5.0 x 103 18
1 Assayed by the method of Ghosh & Fishman (1968)
2 Assayed by the method of Reeves & Fimognari (1963)
Table 4.3
Protection of active sites of enzymes during rapid labelling by phenylglyoxal followed by /""^H^phenyl-
glyaxal
The buffets used were the same as in Table 4.2
Enzyme Substrate
Molar ratio of 
phenylglyaxal 
to enzyme
Molar ratio of 
substrate 
to enzyme
Time for 
reaction 
(min)
Molar ratio of 
p h e n y ^ f ^  -  
glyaxal bound 
to enzyme
Number of 
arginine resi- 
duev'active 
site
Alkaline phosphatase' Phenyl phosphate 1 x IO 5 105 5 4.23 2.12
(E. coll)
Alkaline phosphatase' Phenyl phosphate 1 xIO 5 105 5 3.56 1.80
(calf intestine)
Lactate dehydro­
genase*
Sodium pyruvate 2 x  104 7 x 104 1 6.62 3.31
1 In the presence of M gClj (5 mol/mmol enzyme)
2 In the presence of NADH (20 m oi/m m ol enzyme)
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determined by Yang and Schwert (1974).
Modification Of The Amino Acid Residues In Slalldases
The effect of group specific chemical modification reagents on the 
three sialidses are listed In table 4.4 and illustrated In figures 4.8 
(1) and 4.9 (1), while table 4.5 and figures 4.8 (11) and 4.9 (11) 
respectively, list and illustrate effects of the same reagents on the 
three sialldases In the presence of the active site protecting agents.
Treatment of the three slalldases with N-ethylmalelmide did not cause 
any significant diminution of enzymic activity, suggesting that 
sulphydryl groups are not catalytlcally Important. These findings are 
In agreement with those of Mohr (1960) and Holmquist (1975a ) for the 
V. cholerae sialidase, Bachmayer (1972) for C. perfrlngens 
sialidase, and Wang et al., (1978) and Uchida (1979) for both 
Arthrobacter species. However, Kunimoto et al., 1974 have shown that 
while sulphydryl groups are not catalytlcally important for the S. 
grlseus sialidase, the C. perfrlngens enzyme is inactivated by 
p-chloromercurlbenzoate - also known to react with other amino acids 
(Riordan & Vallee, 1972). We therefore conclude that sulphydryl groups 
are not essential for catalytic activity.
Previously, Kabayo and Hutchinson (1977) have observed that the 
sialidase from S. grlseus Is unaffected by the lysine modifying 
reagent trlnltrobenzene sulphonlc add. We now observe that partial 
Inactivation does occur when the slalldases of C. perfrlngens (25Z) 
and V. cholerae (20Z) are treated with this reagent whereas Wang et_
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T d b le  4 .4
Effect O f  G f M f  Specific R w g w H  O n  Sielidetet
Enzym e Reagent M eier Rat la  
Reogen^Enzym e Tim a
K R e u 'd u o l
A c t iv ity
s * f lw n y lg ly a a l l . l a l f • 1 14
c * Pbenylglyonel 1 . 0 a  Iff* 1 29
V Pfeenylglyenol 2 . 1 a 10* 1 •
s Butondiane 0 .0  a  1« ? 1 29
V Butondiane 0 .0  a  I « 1 1 19
c Butendiene 0 .0  a  10* 
I . O a l t *
1 39
c E D C  ♦ g lycln a  attar 1 . 0 a  id 4 4 9
V E O C  ♦ glycin e  ester 1 .0  a  I0 4 4 17
s N K 2 4 0 1 .0 2 .4
c N B 90 1 .0 10
V N B 6 0 1 .0 30
s H N I 1 9 . 0  a  10* 2 .0 20
c M N § 9 . 0  a  10? 2 .0 10
V M N t 9 . 0 a \f 2 .0 3
s N t M * 1 .0  a  10? 1 .9 100
c N E M 1 . 0 . 10* 1 .9 100
V N E M 1 . 0 a 10* 1 .9 100
s I N K * 1 . 0 a  1«* 2 .0 100
c T N B 2 . 0 a 10* 2 .0 79
V T N B I . O a l O * 2 .0 80
s M i l / 1 .0  a  10* 24 99
c M il l I . O a l O * 24 100
V M il l 1 . 0 a 10* 24 100
a  S . g r h m  liolidoee m ol. w t.  « 3 2 ,0 0 0  
b  C .  perfringero tiofldote m ol. « t .  «  9 6 ,0 0 0 3  5 -h yd ro K y -5 nitre  benzyl bromide
■ a  m ol. e t .  * 6 9 .0 0 0 4  N -e th y lm o le imide
Table  4 .9
Effect O f  G r a f  Specific Reagents Ola S ie lido M i Wilfc A ctive  Site Protection
E ia y a a
_  ___.  Malm Kotin
ftoauant te e g e n V In e yin e Protect! ng Agent
Molar Ratio
Protecting A g en^Eneym e
Time t W A r iA c t iv ity
S 1 . 1  • in 3 N A N A 1 1 . 9 .  10* 1.0 88
c B n . , l ^ , . i a >  1 . 9  a  I« 1 N l * 1 . 1  a  1« ? 1.0 94
filB 1 1.1 a  i t *  
1 .0  a  I0 4s c o c 1 . 0 a  i t * N A N A 4 .0 88
V E O C I . O a l O 4 . N L 4 . 0 a  1C? 4 .0 84
c E O C 1 .0  a  I0 4 N A N A 9 .1  a  if 4 . 0 74
s N B 4 0 N L 1 . 4 . 1 0 * 1 .0 6 7
y N B 9 0 N L 1 .4  a  i t * 1.0 79
c N B 6 0 N L 1 .4  a  i t * 1 .0 97
c I N K 2 . 0 a  10 * N L 2 .4  a 10* 2 .0 69
V I N K 9 . 0 a  10* N L 1 . 0  a  i t * 2  0 82
> Sialyl-lee toee
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al*» (1978) observed only 11Z Inactivation for the Arthrobacter 
enzyme. If the modification of the C. perfrlngens and V. cholerae 
sialidase is modified by trlnltrobenzenesulphonlc a d d  in the presence 
of substrate, approximately the same percentage of inactivation is 
achieved as in the absence of protecting agent (substrate). This 
suggests that this could be because of a change in the tertiary 
structure of these enzymes due to the modification of non-specific 
lysine residues. Further, when the modification is carried out with 
O-methylisourea, virtually no loss of enzyme activity is observed for 
the three enzymes. Since O-methylisourea reacts only with <-amino 
groups of lysine residues at pH 10.5, (Habeed, 1972) and not with 
N-terminal amino groups, we therefore concluded that lysine residues 
are not important in the catalytic function.
The most pronounced inactivation of all three sialidases was obtained 
with reagents which modify arginine, carboxylic and tryptophan amino 
acid residues.
In order to ascertain the location, function and number of catalyti- 
cally active or binding amino a d d  residues in or near the active sites 
of these enzymes, the modification reactions were carried out in the 
presence of a competitive inhibitor or a substrate of the enzymes as 
these should protect the vicinity of the active site.
The enzymic activities of all three aialidases were maintained if we 
preincubated the enzymes with an inhibitor or substrate before treat­
ment with phenylglyoxal (Fig. 4.8 (ii)), suggesting that arginine 
residues are in or near the active sites of the sialidases. This was. in 
agreement with De Brock's (1957) results, in which influenza sialidase 
was inhibited by dlols.
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«  Rm Mm I Activity « t o r  1 .0  hr
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These result« were further substantiated by u«ing phenyl[2- H]glyoxal 
(Augustus & Hutchinson, 1979) when it was shown that two arginine 
residues In the C. perfrlngens slalldase were 'protected against 
modification by unlabelled phenylglyoxal In the presence of 
sialyl-lactose (followed by dialysis and reacting with trltlated 
phenylglyoxal, differential labelling). In addition to this. It was 
shown that for the slalldases from S. grlseus and V. cholerae. one 
arginine residue Is protected in each case (Table 4.6).
3
Total. 4 . «
L d b .il in f  O f  TV . A c r i . .  S i i »  O f  Sitai ¡ 4 M  W tlll f V .n y l / 7 -3i / , l r . . d
Enzyme M ure#
%  Enzym ic activity 
after dialysis
M olar ra tio  o f 
p h o n y l/ ï -3H 7 -  
glyoxoi bound 
to enzym e
Num ber of a rg i-  
n ¡ne/Residues
S . grisou* 83 1.90 0 .8 3 (1 )
C .  perfringen* 83 3 .7 4 1 .15 (2 )
V .  choleras 70 1.60 O .K X D
1 mol* of arginino combinas w ith  2 molas of phonylglyoxal (Takahashi. 1968). The number* in brockets 
indicate the number of arginines labelled corrected to the nearest w hole number.
All three slalidases were Inactivated by treatment with glycine ethyl 
ester hydrochloride and l-ethyl-3-(3-dlmethylamlnopropyl)carbodlimide 
(Fig. 4.9(1)). However, only Incomplete protection was afforded by 
preincubation with It-acetylneuraminlc acid (sialidases from S. 
grlseus and V. cholerae) or sialyl-lactose (slalldase from C. 
perfrlngens) (Fig. 4.9 (11)). As most of the amino a d d s  In these 
ensymes are acidic amino a d d  residues, (Kabayo & Hutchinson, 1977; 
Wang et al., 1978 and Geisow, private communication). This loss of 
activity may be due to modification of carboxyl groups remote from the 
active site which would cause changes to the tertiary structure of the 
enxymes. The very large molar excess of modifying reagents required l o r  
Inactivation suggests that many carboxyl groups may be Involved In the 
activation process. Support for the requirement for Intact carboxyl
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«  Activity
%  I m M m I  Activity
groups for full activity in V. cholerae slalidase is provided by 
Holmqulst (1975b), who completely inactivated the enzyme using ethyl 
diazoacetate even in the presence of acetic acid which suggests that 
some carboxyl groups in this enzyme must be very reactive*
When the sialidases from S. griseus and C. perfrlngens were 
incubated with an active site agent (substrate sialyl-lactose in both 
cases — Table 4.5) prior to treatment with N--bromosuccinimlde, their 
enzymic activities were decreased by 27Z and 30Z respectively. However 
preincubation with N^-acetylneuraminic acid did not protect the V. 
cholerae sialidase from JJ-bromosuccinimide (70Z loss of activity) 
(Groundwater, 1978) but, in the presence of sialyl-lactose, the loss of 
activity was reduced to 37Z. As N-acetylneuraminic acid is capable of 
completely protecting an essential arginine in the active site of V. 
cholerae sialidase, the failure to protect the enzyme from 
inactivation by a tryptophan-modifying reagent suggests that the 
crucial tryptophan(s) do not occur near the active site or are in 
relatively exposed positions on the edge of the active site, namely at 
a position where it probably binds with the aglycone moiety. The 
inactivation of the three sialidases in the absence of protecting agent 
was also observed when using 2-hydroxy-5-nitrobenzyl bromide (Table 
4.4). The inactivation by 11-bromosucclnimide of sialidases from C. 
perfrlngens (Bachmayer, 1972) and A. sialophllus (Wang et al., 
1978) In the absence of active site protecting agents has been reported 
and we confirm these observations with the sialidases from S. 
griseus, C. perfrlngens and V. cholerae.
The results of the modification studies described here for sialidase 
obtained from pathogenic and non-pathogenic sources indicate that these 
three enzymes have common amino acid residues necessary for their
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activity i namely arginine, tryptophan and carboxylic amino acid 
residues.
Amino Acid Analysis
The amino acid analysis was performed on the peptides modified by 
phenylglyoxal, on the three enzymes, obtained by the procedure out­
lined in figure 4.6.
In our initial attempt at characterizing the CNBr-peptides obtained 
from S. griseus slalidase by polyacrylamide gel electrophoresis, 
problems were encountered, the major problems being insolubility of 
some of these peptides and the loss of others by diffusion during the 
staining and destalnlng of the gels. This indicated the presence of 
small peptides. Further, these peptides could not be detected by the 
ultraviolet spectroscopic method available for ion exchange and 
permeation chromatography, because of low peptide yields and the low 
ultraviolet absorbance of the peptide.
Because the primary aim was to sequence the active site peptide manu­
ally, it was decided to bypass the characterization step and label the 
active site directly via the method outlined in figure 4.6, but without 
the fluorescamine tag. Oily one major radioactive peak was revealed by 
subjecting the 2 mm gel slices to radioactive counting. When this peak 
was checked for peptide purity by subjecting it to descending paper 
chromatography, two nlnhydrln spots were observed, Indicating either an 
impurity or a very closely accompanying peptide in the vicinity of the 
radioactive peptide in the gel. The latter was confirmed by following 
the procedure outlined in figure 4.6 but with the Inclusion of the
fluoreacamlne label» The gels further revealed that the molecular 
weights of the active site peptides of the three slalldases were 
similar (smaller than 670 as they were migrating ahead of the 
bromophenol blue marker» mol» wt» 670) (Fig. 4.10).
Fig. 4.10 U M 4 k i g M M l « 4 * i l
CD C . m.  ( » )  w i  V . cM i w  (
Similar modification experiments were performed on the insulin B chain 
(as It has only one arginine and one lysine) (Fig. 4.11).
H -rU v d -A a < jb -H g -L i»C > i-G ly -]v  h 1- L«»-Val-Gta-AJa-Un-Tyr-Lcu-Val-Cj»- 
<%-Gln-A>a-Gly-PI»-Ftw-T»i-Thr-Pra-Ly«-'nr-OH
Fig. 4.TI Amino acid sequence oF the Insulin B chain m i
Hence we were able to determine the effect of the phenyl[2- 3 H]glyoaal 
modification In the vicinity of the active site but were unable to 
pursue the sequence analysis because of the fluorescamine blocked
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N-terminal residue and secondly, the results of histidine and glycine 
were suspect because of the presence of unknown contaminants.
Nevertheless, the results in table 4.7 confirmed the presence of
arginine being Involved in the active site of the three slalidases•
Further, the number of arginines in the active site of S. grlseus and 
V. cholerae slalldase verified our previous labelling experiments but 
not that of C. perfringens slalldase where we determined two
arginines by labelling and one by amino acid analysis. The reason for
the latter is unknown and open to speculation.
The amino acid analysis of these active sites further revealed the 
presence of glutamic acid the other probable amino acid involved in the 
catalytic mechanism (the phenomenon of protein folding is not 
overlooked). It does not, however, reveal the presence of the third 
type of amino acid involved in the active site, namely tryptophan, as 
this was not determined.
Table 4.7
Amino Acid Analysis O f The Active Site Peptides Obtained From 
S. gfiseus, C . perfringens A V .  choletoe siolidases
Amino Acfd s“ Cb V*
Threonin« 0.66(1) 0.80(1) 0.50(1)
Serin« 0.50(1) 0.58(1) 0.54(1)
Glutamic acid 1.40(1) 1.30(1) 0.80(1)
Prolin« 0 0.50(1) 0
Glycine N d Nd Nd
Histidin« 0.60(1) Nd Nd
Arginine 0.70(1) 0.90(1) 1.20(1)
N  •terminal Nd Nd Nd
1 Ami no K id  .nolyrii M  por t b y  Or J  t  t o . ,  Mw fd w c b w le  Analysis S s n k s ,  Birmingham Univanily.
• S. griseus sialidase 
b C . perfrinqens sialidase 
c V . choleroe slalldase
Nd Not determined (refer to tent)
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Thus, before any function Is assigned to these essential active site 
residues, (viz, arginine, tryptophan and carboxylic acid), two major 
dictates (by the enzyme) have to be fulfilled by the substrate: (i) 
the terminal carboxyl group must be free (Brossmer & Holmquist, 1971 
and Holmquist & Brossmer 1972) and (ii) the polyhydroxy side chain must 
be Intact and unsubstituted for maximum enzyme activity (Schauer & 
Faillard, 1968), Because of these requirements, two different types of 
binding residues appear to be required, one of which offers an 
electrostatic interaction to the anionic substrate (Brossmer et al., 
1974), the other offering a hydrophobic Interaction, From our 
investigations, the only positively charged residue which can bind 
electrostatically to the free carboxyl group of the substrate is 
arginine. This is highly favourable as there are many enzymes acting in 
this manner on negatively charged substrates, of which the prime 
example would be carboxypeptidase A (Lipscomb et al,, 1968), The 
hydrophobic interaction on the other hand, can be afforded by the 
tryptophan residues as it has been shown that these tryptophans can 
participate in the carbohydrate-protein binding interaction in some 
carbohydrate-protein binding proteins eg, lysozyme (Blake et al., 
1967),a -mannosidase (Paus, 1978) and lectin (Privat et al., 1976), 
Thus it is possible that a hydrophobic side chain such as tryptophan 
could interact with the polyhydroxy side chain of the substrate and, 
further to this, a reduction of the polyhydroxy side chain by periodate 
oxidation to C-8 leads to a decrease in enzyme activity and further 
oxidation to C-7 leads to total loss of enzyme activity (Suttajit, 
1970), indicating that the loss of the polyhydroxy side chain of the 
substrate diminishes the stabilizing hydrophobic interaction with 
tryptophan.
The unassigned function of the carboxylic amino acid residue leads
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us to speculate on its role as a catalytic residue as opposed to a 
binding residue« Factors favouring this catalytic role of the 
carboxylic amino acid residues are based on the following observations 
that (1) thea-ketosidlc bond In the substrate can be cleaved by an acid 
catalysed reaction. (11) The pH (4.5 - 6) dependence of the enzyme 
catalysed reaction Infers the presence of a dissociable group in the 
protonated form to act as a proton donating species. As histidine (pKa 
6.0) has been ruled out as a catalytic site residue (Kabayo, 1978 and 
Groundwater, 1978), the only other group within that pKa range are the 
carboxylic amino acid residues. (Hi) The polyhydroxy side chain of 
NANA a-ketosldes modified with anionic groups are neither substrates 
nor inhibitors of the enzyme, inferring the presence of free carboxyl 
groups in the active centre of slalldase as well as the presence of an 
active site pocket and the line of approach of the substrate (Fig. 
4.12) (Holmquist, 1975b). (iv) Besides our report showing that carboxyl 
groups are Involved in the active site, Holmquist (1975a) and Gelsow 
(private communication), have shown by experimentation that carboxyl 
residues play an essential role in the active site of sialldases. 
(v) The catalytic mechanism of glycosldases such as lysozyme (Blake 
et al., 1967), sucrose-isomaltase (Braun et al., 1977) and 
Aspergillus wentllg-glucosldase (Bause & Legler, 1973) proceeds via 
the action of carboxylic amino acid residues.
The most convincing evidence which would support the involvement of 
carboxylic amino a d d  residues in the active site of slalidases has to 
meet the criteria established by Cordes and Bull (1974) l.e. that the 
a d d  catalysed hydrolysis of glycosidlc and ketosldlc bonds, a 
unlmolecular reaction involving the fission of the carbonyl-carbon- 
oxygen bond, must generate the cyclic carbonlum of oxocarbonlum ion as 
an intermediate. Melndl and Tuppy (1969b) have reported such a compound
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Chat resembles the oxocarbonlum intermediate (Fig. 4.13 (i)) namely 
2,3- dehydro-2-deoxy-t^-acetylneurarainic acid (Fig. 4.13 (ii))t which 
inhibits V. cholerae sialldase very strongly thus functioning as a 
model of a possible transition state structure.
Because of this strong evidence and those stated above (i — v), one can 
propose that the carbonyl-carbon-oxygen cleavage goes via the initial 
steps outlined by (A) Cordes and Bull (1974) [(i) protonation of the 
oxygen atom, followed by the rate determining formation of an 
oxocarbonium ion (specific acid catalysis) (ii) concerted proton 
transfer and cleavage of the carbonyl-carbon-oxygen bond with the 
formation of an oxocarboniun ion (general acid catalysis), (iii) attach 
by nucleophiles], (B) a further formulation of the above for a stepwise 
catalytic sequence for sialidases via the cyclic oxocarbonium ion by 
Holmqulst (1975b)(Fig. 4.14) and (C) the conclusion by Miller et al., 
(1978) that whatever the mechanism, the geometry at the C-2 of NANA
(•>
( i i )
P '9 - ( - 0  (•*) Structure of the 2 - D e o .y -2 , 3 d c h y d ro -N  occtylncuroniinic ocid
must pass through planarity
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during Che course of the reaction (substrate distortion).
E ♦ 5 . ■ E —  P, + P.2 E ~ 'P ,  —  OH
P.2 E + P, _ OH + Pj ♦ HjO*
Fig. 4.14 Reaction sequence as formulated by Holmquiit 1975b 
P| represents the cyclic oxacarbonium ion, Pj -  OH the free N - 
ocetylneurominic acid, P2 the released aglycane, E the enzyme, 
and S the substrate.
Thus a precedent for the proposed mechanism involving the above steps 
can be found in one of the proposed mechanisms of lysozyme (Imoto et 
al., 1972) which involves a distortion of the saccharide moiety to 
its unstable half chain conformation, general acid catalysis and a 
charge-charge stability interaction. Therefore in the case of these 
three sialldases, the mechanism could possibly proceed as outlined in 
figure 4.15 (i - iv) in which the C-l (carboxyl group) of the substrate 
binds to the arginine electrostatically producing a substrate 
distortion which facilitates the hydrolysis by a carboxylic amino acid 
residue which acts as a general acid catalyst by transferring a proton 
to the oxygen bridge. The formation of the positively charged oxygen 
bridge facilitates the rupture of the C-2 to oxygen linkage with the 
resultant formation of the C-2 carbonium ion in the sialic acid. The 
transition state for the formation of this carbonium ion should be 
stabilized by the proximity of a charged carboxylate group. The 
hydrolysis is completed by the replacement of the leaving group by a 
water molecule, a reversal of the first step, to give the products. The 
release of the free sialic acid is affected by the rapid anomerization 
to its f} -anomer (Friebolin et al., 1980).
(1*1
Fig. 4.15 (i -  iv) Repretenh o tchemollc propotai oí a catalytic reaction sequence explained 
the text ( enzyme).
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The SN 1 mechanism which we have proposed (fig. 4.15) is based 
solely on our chemical modification studies and supporting evi­
dence reported in the literature. However, one has to be cog­
nizant of the other possible mechanisms akin to that of lyso­
zyme, illustrated in figures 4.15A (i) - (iv) (Fig. 4.15A iii
is similar to our proposed mechanism). Therefore, in view of 
these possible mechanisms and the fact that no experiments,
(other than the chemical modification reactions), have been 
carried out by us which were directed purely at the enzyme 
mechanism, it would be naive to conclude that figure 4.15 
represents the true mechanism.
Future experiments would therefore have to be carried out to 
ascertain whether or not our proposed mechanism (fig. 4.15),or 
those represented in figure 4.15A or a yet undiscovered mecha­
nism is the proper set of catalytic events for sialidase.
These experiments could possibly employ the following techniques 
and ideas,'some of which have been previously applied to lyso­
zyme (Imoto et a l ., 1972).
(1) NMR to show whether or nots- (a) an inversion of configura­
tion occurs at the anomeric carbon atom during hydrolysis. If 
this does not occur, it then eliminates mechanism i of figure 
4.15A. (b) The binding is a function of pH. (c) A chemical
shift of the acetamido methyl protons occurs during the catalytic 
mechanism. If no change occurs, it then eliminates mechanism
Asp 99
(ii)
01» 99
(iii)
01» 99
Fig. 4.I5A Four proposals for the catalytic mechanism of lysozyme 
which could fit the catalytic spectrum for sialidase (Imoto et al.. 
1972).
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iv of figure 4.15A. (d) A distortion of the ring occurs,
employing the relationship between the coupling constant and 
the dihedral angle at C2. If distortion does occur, it 
would favour mechanism iii of figure 4.15A.
(ii) Affinity labelling, whereby the ligand could be covalently 
attached to the proton donating species, further confirming the 
active amino acid(s).
(iii) Secondary isotopic effects to ascertain whether or not
the k / k „  ratio is 1.33 or 1.03, the former favouring mechanism H D
iii i.e. S^l reaction and the latter mechanism ii, i.e. an 
S^2 reaction.
(iv) A trapping system to determine whether or not a covalent 
ES complex is formed. If so, it would favour the SN 2 mechanism
(v) X-ray crystallography and model building studies of the 
enzyme, enzyme-substrate and enzyme-inhibitor complexes to 
confirm the constellation of the active site residues.
With the aid of the above experiments and the aforegoing results 
it should be possible to conclude the catalytic mechanism of
sialidase
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Modlflcatlon of the carbohydrate moieties
The effect of periodate oxidation on the enzyme activity of the three 
sialidases as represented if figure 4.16 shows an overall loss In 
activity (S. grlseus, 1002; C. perfrlngens, 902; V. cholerae, 452 
when the substrate fetuln is used [Fig. 4.16 (i)]) but in an irregular 
manner. When the substrate a,-acid glycoprotein is used, a total loss 
of enzyme activity is observed [Fig. 4.16 (ii)] in a similar fashion to 
that quoted above. This irregularity was further investigated on C. 
perfrlngens slalldase, using substrates of varying molecular weights, 
carbohydrate content and sialic acid content, as well as types of 
ai -glycosidic linkages (Table 2.0, page 43).They all showed an overall 
drop in enzyme activity with a similar irregular profile (Fig. 4.17), 
except for colominic acid and sialyl-lactose in which, after 7 hr, 
there was a rise after an initial loss in enzyme activity. Further, 
substrates having a sialic acid content of greater than 202 showed an 
increase (greater than 10 0 2), in enzyme activity within the first 
half-hour of periodate oxidation.
Although the' result, (loss of activity), is contrary to the majority of 
results published for glycoenzymes showing no loss of enzyme activity 
on removal of carbohydrate units, the only other explanation (other 
than the protection against proteases or side reactions as periodate can 
modify amino acids (Clamp & Hough, 1965 and Spies & Chambers, 1949), is 
that the carbohydrate units participate in the maintenance of the 
three-dimensional structure of the enzyme. This, however, leads us to 
suspect that, because the drop in enzyme activity proceeds in a 
sequential fashion, the collapse in the three-dimensional structure 
therefore also proceeds via the same sequential fashion. Thus, the 
first stage in the collapse could block the approach or make the active
1 4 2 -
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I
Hours
Fip . 4 .1 7  T U  « l l « c t  a# i l lu d a ti o n id iw d C .  pw fcw gw i «lolidano a n o y t^  «ttb  vartaua m b ilro lt i.  O — O ,  ^ «< c W  pipe opratali»
IO M^ml; »-■■ o Bovina m b n o tlllo y  mucto W " i  0 — 0  col amiate « M  IO mq/ml; f — f  Fatato 10 mg/mi; * — -& »W yT-lactBM  
3 .0  mg/mi.
C .  porfrlogota i M M m  (0 .3  mg) Io 0 .1 M  n d K m  acetato W f t »  pH 4 .9  (90 p i) «aa allo— d ta roact « I d i  lodlum — taporiodato 
(490 p J, molar t a t o  af 1C^ : o w p o  (1470:1 lo H o  d aA  ot 4°. Aliquota (90 p i) «toro ramo «od at flood timo Iota tool» and oddod 
ta 4 0 pi af otKandtal (9 0 %  V * ) >  T M i « a i  vtgaromly miood far 30 to c . and tben a/bfoctad ta d ialjo li ogolrwt d o  appropriata 
aaov buffar. Diana a liquota «oro ibon aaqiod far onoymo activltp uoing difforont tutatratoa. Control« «oro tot wp in a  «bollar
but lo Iba
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site less acceslble to large molecular weight or bulky substrates than 
to that of a smaller molecular weight or less bulky substrate, such as 
sialyl-lactose.
When the 0 -elimination was performed on the V. cholerae slalidase, 
there followed a rapid loss of enzyme activity. This tends to favour 
the idea that the carbohydrate moieties participate in the 
three-dimensional structure of the enzyme. When the 0 -elimination was 
carried out with ]-Na,SOj , [35S] was incorporated, revealing the 
presence of O-glycosldic linkages to serine or threonine and from the 
amount of radioactivity bound, the presence of four such linkages could 
be deduced, which indicates that there exists the possibility of either 
a ser(thr)-f^-acetylgalatosamine, ser (thr)-mannose or a ser(thr)- 
glucose linkage, (Marshall, 1974).
Gel electrophoresis of the enzyme subjected to 0 -elimination revealed 
by carbohydrate staining sugar moieties still attached to the enzyme. 
This suggests that besides O^glysldic linkages there probably exist 
N-glycosidlc linkages as well or it could infer that the
0 -elimination reaction was incomplete. Further gel electrophoresis of 
the alkali and periodate modified enzyme revealed a decrease in the 
molecular weight of the enzyme (Fig. 4.18) and on carbohydrate staining 
it also disclosed the presence of carbohydrate moieties still attached 
to the protein backbone. Thus it is apparent that the two methods, i.e. 
periodate oxidation and 0 -elimination do not remove all the 
carbohydrate moieties from the V. cholerae
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slalidase but those moieties which are modified or removed affect the 
activity and molecular weight of the enzyme«
F I , .  4 . I t  i.li.iooH c f pr . i— of I t »  p o lro c ry W i. got oloclro»»»«o«l» of V .  ch o lo w  . IoII4 m o  wfcjoclod to  (10 porlofoM 
oxidation and (in) ^-o lim in o tlo n . C ontrol (I)
In summary, our reaults reveal that:
(1) the synthesis of phenyl[3H]glyoxal with a specific activity much
grlaeua and V. choleras slalldase both have one arginine present 
whereas C. perfrlngena sialidaae has two«
(ill) that the active sites of all three enzymes require arginine, 
tryptophan and carboxylic acid amino acid residues for full enzymic 
activity«
5-0
4-8
II 4 4 '
4 0*-
( I ) (H)
higher than that of commercial phenylglyoxal, is possible:
(11) with the aid of the phenylP HJglyoxal the active sites of S.
(lv) The arginine and tryptophan residues appear to be Involved in
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binding of Che substrate whereas the carboxylic amino acid residues 
participate in the catalytic reaction possibly via acid catalysis 
involving the generation of an oxocarbonium ion as an intermediate.
(v) By amino acid analysis, the presence of arginine in the active 
site is confirmed.
(vi) By preliminary investigation that the carbohydrate moieties are 
more likely to be involved in maintaining the three-dimensional struc­
ture of the enzyme as opposed to being catalytically Involved
(vii) That there exists £-glycosidic protein-carbohydrate bonds in 
the V. cholerae sialidase.
(viii) That removal of these carbohydrate moieties affect the catalytic
and molecular weight of the enzymes.
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APPENDIX I
Sources of Materials
N-acetylgalactosamine Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
N-acetylglucosamine Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
N-acetylneuraminlc acid Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
tl-acetyl [4,5,6,7 1 8 ,9-11+C ]neuraminic acid The Radiochemical 
Centre, Amersham, 
Buckinghamshire, U.K.
a-acid glycoprotein Scottish National 
Blood Transfusion 
Association,
Edinburgh, U.K.
Alkaline phosphatase (E. coll) Sigma (London)
Chemical Co., Poole, 
Dorset
Alkaline phosphatase (Bovine) Boerhlnger, Mannheim, 
G.F.R.
Bio-Cel P-2 Bio-Rad Laboratories, 
Bromley, Kent, U.K.
Bovine serum albumin Miles Laboratories, 
Maidenhead, 
Buckinghamshire, U.K.
N-bromosuccinlmlde Pierce and Warriner 
(UK) Ltd., Chester, 
Cheshire, U.K.
2, 3-Butanedlone Aldrich Chemical 
Company, Gillingham, 
Dorset, U.K.
n Butyl-lithium Ventron Alpha 
Products, Beverley, 
MA., U.S.A.
Carboxymethyl cellulose Whatman Ltd., 
Maidstone, Kent, U.K.
Colomlnlc acid, sodium salt Koch Light 
Laboratories, 
Colnbrook,
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Buckinghamshire , U.K.
Cyanogen bromide Eastman Kodak 
Rochester, New 
U.S.A.
Co ., 
York,
Dansylhydrazine Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
DE1AE-cellulose Whatman Ltd., 
Maidstone, Kent , U.K.
Deoxyribonuclease 1 Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
Dl-lsopro pylamlne Aldrich Chemical 
Company, Gillingham, 
Dorset, U.K.
Dowex 50 - X8 (H+ J Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
l-ethyl-3-(3-dlmethylaminopropyl)carbodllmide Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
N-ethylmalelmide Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
N-ethylmorphollne B.D.H. Chemicals Ltd., 
Poole, Dorset, U.K.
Fluorescamlne Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
Glycine echylester hydrochloride Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
V The Radiochemical Centre, Amersham, 
Buckinghamshire, U.K.
He xame t hy1phos phoramide Aldrich Chemical Co., 
Gillingham, Dorset, 
U.K.
Hydroxylamine hydrochloride B.D.H. Chemicals Ltd., 
Poole, Dorset, U.K.
2 Hydroxy-5-nltrobenrylbromlde Sigma (London) 
Chemical Co., 
Dorset, U.K.
Poole,
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Lactate Dehydrogenase Boerhinger, Mannheim, 
G.F.R.
Matrex Blue A & Red A Amicon Corporation, 
Lexington, MA., U.S.A.
O-Methylisourea Aldrich Chemical 
Co., Gillingham, 
Dorset, U.K.
Molecular weight markers B.D.H. Chemicals Ltd., 
Poole, Dorset, U.K.
Mucin Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
Phenylglyoxal Koch Light 
Laboratories,
CoInbrook,
Buckinghamshire, U.K.
Phosphatidyl choline Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
PM-10 membranes Amicon Corporation, 
Lexington, MA., U.S.A.
Ribonucléase A Boerhinger, Mannheim, 
G.F.R.
Sephadex G— 10 Pharmacia Fine 
Chemicals, Uppsala, 
Sweden
Sephadex G— 25 Pharmacia Fine 
Chemicals, Uppsala, 
Sweden
Sephadex G-100 Pharmacia Fine 
Chemicals, Uppsala, 
Sweden
Sepharose 4B Pharmacia Fine 
Chemicals, Uppsala, 
Sweden
Sialldase from C. perfrlngens Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
Sialyl-lac tose Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
Sodium borohydrlde Hopkins and Williams 
Romford, Essex
- 1 5 0 -
Sodium-[ HJ-borohydride The Radiochemical 
Centre, Amersham, 
Buckinghamshire, U.K.
Spectrapor membrane tubing Spectrum Medical 
Industries, Terminal
Annex, L.A., U.S.A.
[35S] Sulphur The Radiochemical 
Centre, Amersham, 
Buckinghamshire, U.K.
Thiobarbituric acid Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
2,4,6-trinitrobenzenesulphonic acid (TNBS) Sigma (London)
Chemical Co., Poole, 
Dorset, U.K.
XM-50 Membranes ChemLab, Hornchurch, 
Essex, U.K.
*
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The Synthesis of Phenyl|2-3H]glyoxal
By BRIAN W. AUGUSTUS and DAVID W. HUTCHINSON 
Department o f  C hem istry and M olecular Sciences, U niversity o f  W arwick, C oventry C V 4 7A L , U J(.
(R eceived  16 O ctober 1978)
A simple inexpensive method has been developed for the synthesis of [2-3H]acetophenone, 
which has been converted into phenyl[2-3H]glyoxal. The latter compound has been used to 
modify arginine residues in alkaline phosphatase from two sources, and also a sialidase.
Phenylglyoxal will selectively modify arginine 
residues in proteins (Takahashi, 1968) and the sites 
of modification can be studied by using phenyl- 
[l-‘*C]glyoxal (Armstrong e t a!., 1976), which can be 
prepared by the oxidation o f [l-'*CJacetophenone 
by SeOj (Riley & Gray, 1947). However, [1-“ CJ- 
acetophenone is expensive to purchase and is 
comparatively difficult to synthesize (Dauben e t al., 
1950). We have synthesized [2-3H]acetophenone by a 
development of a method introduced for the alkyla­
tion of aliphatic carboxylic acids (Pfeffer St Silbert, 
1970). In our synthesis the 3H originates from 3H20, 
considerably decreasing the cost of the isotopically 
labelled acetophenone. Moreover, under our labelling 
conditions few side reactions occur and hence the 
[2-3H]acetophenone can be obtained in high yield. 
Oxidation of the latter compound with Se02 leads to 
the formation of phenyl[2-3H]glyoxal and we have 
demonstrated the use of this reagent in the modifi­
cation of arginine residues in some model enzymes.
Materials and Methods
n-Butyl-lithium was obtained from Ventron Alpha 
Products, Beverly, MA, U.S.A. and standardized by 
the method of Kofron & Baclawski (1976). Di-isopro­
pylamine and hexamethylphosphoramide were ob­
tained from Aldrich Chemical Company, Gillingham, 
Dorset, U.K. Phenylglyoxal was obtained from Koch- 
Light Laboratories, Colnbrook, Bucks., U. K . Alkaline 
phosphatase (EC 3.1.3.1) from Escherichia coli, and 
sialidase (EC 3.2.1.18) from Clostridium perfringens 
were obtained from Sigma (London) Chemical Co., 
Kingston upon Thames, Surrey, U.K. The latter was 
purified by affinity chromatography by the method 
of Brossmer et al. (1977), followed by the method of 
Geisow (1975). Calf intestinal alkaline phosphatase 
was obtained from the Boehringer Corporation 
(London) Ltd., Lewes, East Sussex, U.K.
Synthesis o f[2 -3H]acetophenone
To anhydrous tetrahydrofuran (2.5 ml) and di­
isopropylamine (0.49g, 4.9mmol) under an Ar
Vol. 177
atmosphere was added 1.9ml of 2.5M-n-butyl- 
lithium in hexane and the mixture stirred for 30min 
below 0°C. Acetophenone (0.27 g, 2.25 mmol) and 
tetrahydrofuran ( 1 ml) were then added and the 
mixture stirred for a further 15 min below 0°C after 
which hexamethylphosphoramide (0.9ml, 5mmol) 
was added. After 20min, trifluoro[3H]acetic acid 
(0.273 ml, 2.4mmol), prepared by treating 3H20  
(5Ci/ml; sp. radioactivity approx. 100 mCi/mmol) with 
an equimolar amount of trifluoroacetic anhydride, 
was added and the reaction stirred for 2 h at room 
temperature (21 °C). The reaction mixture was then 
acidified with 1 m-HCI at 0°C and the aqueous solution 
extracted with 3 x 20 ml of light petroleum (b.p. 
40-60°C). The organic extracts were combined, 
washed with 5 x 10 ml o f 1 m-HCI, dried and evapora­
ted in vacuo to  give [2-3H]acetophenone (0.27g), 
which was not purified further, but was oxidized 
immediately. The position of isotope exchange 
was confirmed by ‘ H n.m.r. spectroscopy with 
[2-3H]acetophenone prepared in an analogous 
manner from trifluoro[2H]acetic acid. The signal due 
to the acetyl group at 2 .6 p.p.m. was greatly dimin­
ished.
Synthesis o f  pheny[[2-i H ]ylyoxa l
To a solution of sublimed Se02 (0.27g, 2.4mmol) 
in dioxan (0.84ml) and water (4.5/d) at 50°C was 
added [2-3H]acetophenone (0.27 g, 2.25 mmol) and 
dioxan (0.5 ml). The mixture was heated at 80°C for 
6 h and filtered through cottonwool, which was then 
washed with dioxan (20 ml). The filtrate and washings 
were evaporated in vacuo  and dry ethanol (2  ml) was 
added to the resulting oily residue. After being left 
for 2 days at 5°C, the supernatant was carefully 
removed from the red precipitate that had formed 
and was evaporated in  vacuo. The oily residue was 
dissolved in ethyl acetate (0.5 ml) and the phenyl- 
(3H]glyoxal purified by preparative silica t.I.c. with 
petrol/ethyl acetate (1:1, v/v) as solvent. The phenyl- 
[3H]glyoxal was eluted from the silica with ethyl acet­
ate (50 ml), which was then concentrated in vacuo to 
0.5 ml. The phenyl[3H]glyoxal was rechromato-
• ■ V-
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graphed as described above and the ethyl acetate 
removed in vacuo  to leave an oily residue. Final 
traces of ethyl acetate were removed by repeated (5 x) 
dissolution of the residue in ethanol (50ml) and 
evaporation in vacuo. Yield of phenyl[2-3H]glyoxal 
was0.23g (76%, based on c250nm of 9000 litre mol-1  • 
cm- 1  in ethanol) with sp. radioactivity 12.2mCi/ 
mmol. The phenylglyoxal ran as a single u.v.- 
absorbing spot on silica t.I.c. with petrol/ethyl 
acetate (1 :1 , v/v) as developing solvent with the same 
mobility as authentic phenylglyoxal (R F = 0.33). 
The ‘ H n.m.r. phenyl[2-3H]glyoxal was identical 
with that of authentic material with a singlet at 
9.55 p.p.m. due to the aldehydic proton. This singlet 
was absent in the n.m.r. spectrum of phenyl[2-2HJ- 
glyoxal, prepared as described above from [2-2H]- 
acetophenone, confirming the position of isotopic 
substitution. The phenyl[2-3H]glyoxal decomposed 
slowly (30% in 3 months) when stored as a 1 m  
solution in dry ethanol at 4°C. Little decomposition 
occurred when the phenylglyoxal was stored as an 
oil or as the hydrate. The latter compound could be 
obtained by crystallization from a concentrated 
aqueous solution at 4°C.
Reaction o f  phenylg lyoxa l with enzym es
(а ) Inactivation. The alkaline phosphatases and 
sialidase were treated at 25°C with various amounts 
of a solution of phenylglyoxal hydrate (16 mg) in 
ethanol (100/il) as described in Table 1. Care was 
taken to use the same buffers for the inactivation as 
were used for the assay. Samples were removed after 
fixed times and assayed. After inactivation, the 
modified enzymes were dialysed at 4°C for 36 h 
against the buffers indicated (3x5 litres), after which 
portions were removed and assayed.
(б ) Protection by  substrate. The three enzymes in the 
presence of their substrates were treated with 
unlabelled phenylglyoxal hydrate and then dialysed 
against assay buffer as described in Table 2. The 
modified enzymes were then treated with a 10 0 -fold 
molar excess of phenyl[2-3H]glyoxal for 2h, the 
protein was precipitated on glass-fibre discs with 
trichloroacetic acid (Yang &  Schwert, 1972) and their 
3H content determined.
Discussion
The oxidation of acetophenone by Se02 proceeds 
via the formation o f an enol selenite ester that
Table 1. Inactivation o f  enzymes with phenylglyoxal 
Slow inactivation Rapid inactivation
Enzyme
E. coli alkaline phosphatase* 
(mol.wt. 89000)
Calf intestine alkaline phos­
phatase* (mol.wt. 140000) 
C. perfringens sialidaset 
(mol.wt. 56000)
Molar ratio of Time for 75% Molar ratio of Time for 100% 
phenylglyoxal inactivation phenylglyoxal inactivation 
Buffer to protein (min) to protein (min)
0.125M-NaHCO3 
(pH 7.5)
0.125 M-NaHCOj 
(pH 7.5) 
O.lM-Sodium 
acetate (pH 5.3)
103
103
6x10*
• Assayed by the method of Ghosh & Fishman (1968).
t  Assayed by determining sialic acid released horn sialyl-lactose by the method of Warren (1959).
Table 2. Protection o f  active sites o f  enzymes during rapid labelling by [3 H]phenylglyoxal 
The buffers used were the same as in Table 1.
Enzyme
Alkaline phosphatase* Phenyl phosphate
(E . coli )
Alkaline phosphatase* Phenyl phosphate 10s 
(calf intestine)
Sialidase Sialyl-lactose 10*
• In the presence of MgCl2 (5mol/mmol of enzyme).
Molar ratio of Molar ratio of Time for Molar ratio of 
phenylglyoxal substrate reaction phenyl[2-3H]glyoxal
Substrate to enzyme to enzyme (min) to enzyme
10s 10s 5 4.23
Number of 
arginine resi- 
dues/active 
site
1979
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rearranges and then decomposes to phenylglyoxal, 
two protons being lost during the reaction sequence 
(Corey & Schaefer, 1960):
C*H,COCH,*H + SeOj C*HSC=CH3H
C6H,COC3HO «------ C*HsCOCH3H
In the synthesis of phenyl[2-3H]glyoxal, the 
retention of 3H may be assisted by favourable isotope 
effects operating in the two proton-abstraction steps.
The phenyl[2-3H]glyoxal was used to determine 
the number of arginine residues in the active centres 
of two alkaline phosphatases and a sialidase. The 
interaction of the enzymes with unlabelled phenyl­
glyoxal was investigated over a molar range of 
phenylglyoxal/enzyme of 103—10s (Table 1), assaying 
at fixed time intervals until the inactivation was 
constant. The ënzymes were then dialysed and 
reassayed and in all cases the inactivation was 
irreversible with molar ratios of 3 x 103 or greater. 
The rate of inactivation was less at pH 5.3 than at 
7.5. Once the conditions for rapid inactivation had 
been determined, the inactivation was carried out on 
the enzymes in the presence of substrates. The 
concentrations of the latter enzymes were derived 
from the turnover number for each enzyme and were 
chosen so as to provide maximum protection of the 
active site. After 5 min the substrates and excess 
phenylglyoxal were removed by dialysis and the 
enzymes were treated with phenyl[2-3H]glyoxal 
(Table 2). The number of molecules of phenyl[2-3H]- 
glyoxal that bound to each enzyme molecule were 
then determined. This value is twice the number of 
arginine residues modified (Takahashi, 1968) and 
hence the number of arginine residues at or near the
active centres of the enzymes can be calculated. Our 
values for calf intestinal (1.8) and £. coli (2.1) alkaline 
phosphatase are close to that (2) obtained by Daeman 
& Riordan (1974) for E. co li alkaline phosphatase. 
We found that approx. 2 arginine residues are 
involved in the active site of the sialidase from C. 
perfringens. No data on the involvement of arginine 
residues in the active site of this enzyme have been 
reported, although we have observed (Kabayo & 
Hutchinson, 1977) that arginine residues are essential 
for the activity of sialidase from Streptom yces 
grise us.
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